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Joint models for longitudinal and survival data have been widely dis-
cussed in the literature. This thesis proposes a joint model using a stereo-
type model for the longitudinal ordinal responses and a Cox proportional
hazards model for survival time. Our current joint model has a new fea-
ture since no literature has examined the joint model under the stereotype
model. The stereotype model can improve the fit by adding extra score pa-
rameters, but it still has the advantage of requiring only a single parameter
to describe the effect of a predictor on the item response levels. We give an
example to model longitudinal ordinal data and survival data for patients
being followed up after treatments. The main focus is on modeling both
the quality of life data and the survival data simultaneously with a goal
of understanding the association between the two processes over time.
These two models are linked through a latent variable that characterizes
the quality of life of an individual and is assumed to underlie the hazard
rate. In other words, the latent variable serves as a shared variable in the
joint model. We present the joint model in two different aspects: one based
on a Bayesian approach and the other one a semiparametric approach us-
ing the EM algorithm. For the Bayesian approach, the latent variable is
treated as a continuous variable and is assumed to have a multivariate
normal distribution. The partial survival likelihood function is used in the
survival component of the Bayesian joint model, while the full likelihood
function is considered in the semiparametric joint model. In the latter ap-
proach the baseline hazard is assumed to be a step function and has no
parametric form. The latent variable in the semiparametric joint model
is then treated as a discrete variable. We illustrate our methodologies by
analyzing data from the Staccato study, a randomized trial to compare
two treatment methods, for Human Immunodeficiency Virus (HIV) infec-
tion of Thai patients on Highly Active Antiretroviral Therapy (HAART), in
which the quality of life was assessed with a HIV Medical Outcome Study
(MOS-HIV) questionnaire. Furthermore, we extend the study further to
the case of multiple failure types in the survival component. Thus, the
extension of the joint model consists of the stereotype model and the com-
peting risks model. The Bayesian method is employed to estimate all un-
known parameters in this extended joint model. The results we obtained
are consistent for both the Bayesian joint model and the semiparametric
joint model. Both models show that patients who had a better quality of
life were associated with a lower hazard of HIV progression. Patients on
continuous treatment also had a lower hazard of HIV progression com-
pared with patients on CD4-guided interruption treatment.
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Many biomedical and other follow-up studies are performed to collect re-
peated measurements of a response variable at multiple time points, as
well as to record time to an event of interest, and additional covariate in-
formation. Time to an event of interest can refer to time to death and can
also include other common events of interest such as time to recurrence of
symptoms, time to infection of a disease, etc. In a longitudinal study of
quality of life in which there is also an endpoint of interest, one may be
interested in finding any possible relationship between the quality of life
and the survival time of subjects. Quality of life may be one of the most
important factors that could be used to predict survival. It is also worth
identifying factors that jointly affect survival and quality of life. Various
approaches have been proposed in the literature for handling quality of
life and survival data separately (e.g. Guo and Carlin, 2004). However,
in the case when data regarding quality of life and survival are collected
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from the same subject, it is not ideal to perform a separate analysis on each
set of data. We need to consider the dependency between these two out-
comes. Therefore, there are potential gains in power in considering the
quality of life and survival time as two simultaneous processes. That is,
the change in quality of life over time and the time to an event of inter-
est can be modeled in a joint model in which parameters can be estimated
simultaneously.
An example we use to illustrate the joint model in this thesis is data
from the Staccato study. Staccato is a multicentre trial carried out by a
research collaboration from Switzerland, Australia and Thailand (Anan-
woranich and the Staccato study group, 2006). Their study was carried
out for an average of approximately three years from January 2002 until
November 2005. The majority of participants were Thai patients (about
80%) with Human Immunodeficiency Virus (HIV) infection and the re-
maining HIV patients came from Switzerland and Australia. The Staccato
study is a randomized trial of continuous anti-retroviral treatment com-
pared to CD4 guided interruption treatment. Patients on Highly Active
Antiretroviral Therapy (HAART), with viremia below 50 copies/ml and
CD4 cell count above 350 cells/µl were randomized into one of two differ-
ent treatment strategies. They also had to have been on a stable HAART
regimen for at least three months and have no evidence of pre-existing
drug resistance. Note that CD4 cell count is a measure of the number of
immune system cells, such as T-lymphocytes and monocytes, that have
3CD4 receptors (Carter, 2009). HIV causes gradual CD4 decline over sev-
eral years.
Data on demographics, medical history, clinical events and quality of
life were obtained from 548 patients (439 in Thailand, 100 in Switzerland
and nine in Australia). Only Thai patients were asked to complete the
Medical Outcome Study HIV Health Survey (MOS-HIV) questionnaire
(Wu et al., 1991, 1997) to evaluate the quality of life every 24 weeks be-
ginning at the baseline visit and at weeks 24, 48, 72, 96, 120 and 144 of
follow-up. Demographic information such as age, sex and date of HIV
diagnosis was also collected. Patients were assessed for CD4 count, viral
load, complete blood cell counts, clinical chemistry, clinical and labora-
tory adverse events, and HIV disease progression every four weeks over
the first 12 weeks, and every 12 weeks thereafter. Patients were classified
as being symptomatic if they manifested any symptoms listed in the clas-
sification system for HIV infection of the U.S. Center for Disease Control
(CDC) (Centers for Disease Control and Prevention, 1992).
The study objective in the Staccato trial was to evaluate a strategy of
CD4 guided interruption treatment, in comparison to continuous treat-
ment. Evaluation of quality of life was also presented in the Staccato
study using the data at baseline, week 24, week 48 and at the last visit.
The study may have been designed to address the primary question of the
treatment effect, but another interest could be to understand the associ-
ation between the quality of life and survival time or how the patients’
4 CHAPTER 1. INTRODUCTION
quality of life would affect their survival. Quality of life assessment is one
of the most important indicators for disease progression or any other end-
points in clinical trials because the quality of life may be predictive of sur-
vival. Therefore, to jointly summarize quality of life and survival (or time
to an event of interest), we propose a joint model by combining an item
response model and a survival model together. The quality of life data,
in contrast, were analyzed separately from survival in the Staccato study
(Nu¨esch et al., 2009). The main focus of this thesis is on modeling both
the quality of life data and the survival data simultaneously with a goal of
understanding the association between the two processes over time.
The item response model is used to model the quality of life data which
were measured by the MOS-HIV questionnaire, whereas the Cox propor-
tional hazards model is used to model time of progression to a symptom
listed in CDC which is CDC-B (more details about CDC classification will
be given in Chapter 5). These two models are linked through a latent vari-
able that characterizes the quality of life of an individual. In other words,
the longitudinal ordinal data (quality of life) and the survival data (time
to CDC-B progression) will be jointly modeled across seven time points
(baseline visit, 24, 48, 72, 96, 120 and 144 weeks).
The survival model described above focuses on only one endpoint event
of interest. We extend the study further to the case of multiple failure types
known as the competing risks model. The extension of the joint model
then consists of the item response model and the competing risks model.
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This extension will illustrate the joint model approach in other aspects and
will also provide an opportunity to establish if the effects of each covariate
are different for the different failure types.
1.1 Quality of Life Analysis
The Constitution of the World Health Organization (WHO) defines quality
of life as “ individuals’ perception of their position in life in the context of
the culture and value systems in which they live and in relation to their
goals, expectations, standards and concerns”. Quality of life refers to the
degree of excellence in an individual’s life at any given period of time
and can also change over time as our living situations change. Quality of
life measurements are important for assessing the impact on patients of
chronic disease and its treatment.
Quality of life is usually measured using an instrument in the form of a
questionnaire designed for patient completion. The questionnaire is gen-
erally composed of a set of questions or items relating to various dimen-
sions of quality of life, such as mental, physical, social, etc. The format
of responses to each item on a questionnaire may yield the binary cate-
gories “Yes/No” or frequently yields a series of ordered categories (e.g.
“Better/Unchanged/Worse”). Furthermore, quality of life data are gen-
erally longitudinal in nature with a questionnaire administered at a base-
line visit and subsequent repeated measurements at each follow-up time
point. However, one of the main problems in analyzing longitudinal qual-
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ity of life data is caused by missing data because patients might drop out
or withdraw before the end of the study. This missing data problem is
a common occurrence in a quality of life study where survival is also an
issue.
Quality of life data are often summarized into a categorical scale that
is either nominal or ordinal in nature. The standard methods for analyz-
ing nominal data such as logistic regression models and the Pearson’s chi-
squared test are adequate for providing results. Moreover, traditional ana-
lytical methods for quality of life data sometimes treat the ordinal scale as
continuous by assigning scores to the ordinal outcomes (e.g. scores vary
from 0 to 100, 100 indicating excellent quality of life). Likewise, the MOS-
HIV questionnaire in the Staccato study was divided into 10 subscores
ranging from 0 to 100 where greater values implied a better quality of life.
The summary scores were transformed to standardized z-scores, with a
mean of 50 and a standard deviation of 10. The results suggested that the
mean quality of life score at baseline was significantly lower in the CD4
guided interruption treatment compared to the continuous treatment.
We know that quality of life assessments are measured principally us-
ing questionnaires in the form of an ordinal scale. Ordinal logistic regres-
sion models, such as the proportional odds model and the partial propor-
tional odds model, are also well known for analyzing ordinal data (Mc-
Cullagh, 1980). Among other models, the most popular and commonly
used model for ordinal responses is the proportional odds model which is
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also known as the cumulative logit model. The model can be written in
logit form as
logit[P (Y ≤ j|X )] = αj − β ′X, j = 1, . . . , J − 1
This model is for a J-category ordinal response Y and X denotes a set of
predictors with corresponding effect parameters β . Note that the negative
sign in the predictor term makes the sign of each component ofX have the
usual interpretation in terms of whether the effect is positive or negative.
In the sense that if β > 0, higher levels of Y are more likely for higher val-
ues ofX . The parameters {αj} are the unknown intercept parameters and
called the cut points. Furthermore, this model compares the probability
of a response less than or equal to a given category (j = 1, . . . , J − 1) to
the probability of a response greater than this category. To fit the model,
maximum likelihood is the preferred method (Liu and Agresti, 2005). The
weighted least squares approach is also used in some early applications
of cumulative logit models (e.g. Williams and Grizzle, 1972) but this ap-
proach is designed for nonsparse contingency tables and cannot handle
continuous predictors.
The proportional odds model has the same effectsβ for each category j.
In other words, it provides a single estimate of the log odds ratio over the
cut points. McCullagh (1980) described this characteristic of the model as
the proportional odds assumption, hence the name proportional odds model.
Therefore, in the process of constructing the model, it is important to ver-
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ify whether the proportional odds assumption is satisfied. Peterson and
Harrell (1990) suggested that the score test can be used for testing this as-
sumption but the test may perform poorly for sparse data. In cases where
the proportional odds structure may be inadequate for model fit, alterna-
tive models are considered. Liu and Agresti (2005) concluded the strate-
gies to improve the fit include (1) trying different link functions such as
the log-log; (2) adding additional terms, such as interaction, to the linear
predictor; (3) generalizing the model by adding dispersion parameters; (4)
permitting separate effects for each logit for some but not all predictors;
(5) using the ordinary model for a nominal response.
Although we can assume the response categories are ordered, we do
not know the structure of this ordering with respect to a given explana-
tory variable. McKelveya and Zavoinab (1975), Winship and Mare (1984)
and Scott (1997) stated that we never know the true interval between the
adjacent response categories, even though the response categories are ex-
plicitly assumed to be equally spaced. Thus, in this thesis we generalize
the stereotype model (Anderson, 1984) for item responses to solve such com-
plicated measured scale problems and to capture the natural ordering of
the data.
The stereotype model can be thought of as a multinomial logistic model
constrained to respect the ordinal nature of the response categories (Lunt,
2005). Another motivation for the development of the stereotype model
is to relax the strong assumption in the proportional odds model which
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assumes that each predictor variable has the same effect at every level of
the response variable. The proportional odds assumption in Agresti (2010,
ch.3) states that the log cumulative odds ratio for any two values of the
covariates is constant across response categories. The stereotype model,
however, has more flexibility when analyzing an ordinal response since
the proportional odds assumption is no longer used.
Moreover, the stereotype model has the ability to reduce the number
of parameters by imposing constraints, without reducing the adequacy
of the fit (Agresti, 2010, ch.4). This model could also provide the distin-
guishability of the adjacent response categories and estimate how close
adjacent response categories are, whereas the proportional odds model
cannot evaluate this information. For this reason, the stereotype model
can be used in more complicated situations.
Although the stereotype model has many advantages and some attrac-
tive features, the model has not been widely used. This is probably be-
cause of the complication of the model structure due to multiplicative pa-
rameters and this nonlinearity causes computational challenges for model
fitting. The stereotype model in the literature has been fit through the
procedure of maximum likelihood. However, Ahn et al. (2009) proposed
a Bayesian approach to estimate the parameters in the stereotype model.
This showed a new contribution to the literature. Similarly, in this thesis
the Bayesian method is employed for parameter estimation. In addition,
the contribution of this study is that the stereotype model is accommo-
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dated in the joint model. This is a new application since no literature has
examined the stereotype model within a joint model. More details on the
stereotype model will be given in the next chapter.
1.2 Survival Analysis
For the survival component, we consider the Cox proportional hazards
model (Cox, 1972) to model time to an event of interest. The purpose of the
model is to explore the relationship between the survival of patients and
several explanatory variables. The Cox proportional hazards model for
survival time t is usually written in the form of the hazard model shown
below
h(t|X,β) = h0(t) exp(X ′β) (1.1)
This model provides the expression for the hazard at time t for an individ-
ual given a set of explanatory variables denoted byX . That is,X presents
the predictor variables which are being modeled to predict the hazard of
an individual. The hazard function above is the product of two functions.
The first one h0(t), is called the baseline hazard function. The second one
is the exponential of the linear termX ′β . The former function, h0(t), char-
acterizes how the hazard function changes as a function of survival time
and the latter function, exp(X ′β), characterizes how the hazard function
changes as a function of subject covariates. It can be seen that, the base-
1.2. SURVIVAL ANALYSIS 11
line hazard function is the function of t but does not involve X . On the
other hand, the exponential expression involves X but does not involve
t. Therefore, if all covariates are set to zero (exp(0) = 1), the formula is
reduced to the baseline hazard function. This is the reason why h0(t) is
frequently referred to as the baseline hazard function. Another important
point of the Cox proportional hazards model is that a parametric form of
the baseline hazard function, h0(t), does not have to be specified. Thus, the
Cox proportional hazards model is considered a semiparametric model.
The semiparametric nature is one of the reasons that makes the Cox pro-
portional hazards model popular and widely used. The main reason for
the popularity of the model is that, although the baseline hazard function
is unspecified, the covariate effects can still be estimated reasonably from
the exponential part of the model.
The Cox proportional hazards model parameters are usually derived
by maximizing a likelihood function. The formula for such a likelihood
function is called a partial likelihood function when the likelihood depends
only on the parameter of interest and does not involve the baseline hazard.
The partial likelihood function can be expressed as










where di is an event indicator, if individual failed, di = 1, otherwise di =
0. R(t(i)) is the set of individuals who are alive and uncensored at time
ti which is referred to as the risk set. Note that censored refers to those
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subjects in whom the event of interest is not observed, possibly due to
loss of follow-up, dropout of subjects or early termination of the study. As
can be seen from the partial likelihood function (1.2), the baseline hazard,
h0(t), cancels out from the likelihood and does not play any role in the
estimation. Thus, only the coefficient β can be estimated from this partial
likelihood function.
Alternatively, we can derive a full likelihood function for h0(t) and β in
the Cox proportional hazards model (1.1). This allows us to derive the
estimator for the baseline hazard h0(t). The estimator may be used when
combined with the estimated coefficients and specific covariate values to
estimate the survival probabilities or the hazard rate of particular interest
subjects. However, the baseline hazard is not easily calculated since it is
a function of time. Fleming and Harrington (1991) and Andersen et al.
(1993) demonstrated the counting process approach to derive the estima-
tor. Recently, Ren and Zhou (2011) presented the empirical likelihood pa-
rameterization to obtain the full-profile likelihood function.
In this thesis, we present both the partial likelihood function and the
full likelihood function by using different approaches for estimating pa-
rameters. The partial likelihood function is included in the joint model
and estimation is done by using the Bayesian approach. The full likelihood
function is included in another joint model and the parameters are esti-
mated simultaneously based on the Expectation-Maximization (EM) algo-
rithm (Dempster et al., 1977; McLachlan and Krishnan, 1997). Throughout
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this thesis, we will call the joint model that is evaluated by the Bayesian
approach as the Bayesian joint model. Another joint model implemented via
the EM algorithm is called the semiparametric joint model since this approach
is a semiparametric method with an unspecified baseline hazard function.
That is, the baseline hazard is assumed to be a step function and has no
parametric form.
1.3 Joint Model
We are interested in simultaneously investigating the relationship between
quality of life and time to CDC-B progression as well as identification of
factors that affect both variables. In order to do this, a joint model of lon-
gitudinal ordinal data and survival data is required. There is extensive
literature on the joint model from numerous authors. Typically a mixed
effects model and a Cox model or an accelerated failure time model have
been considered to jointly model longitudinal data and survival data with
shared random effects. The likelihood method based on the EM algorithm
(Dempster et al., 1977; McLachlan and Krishnan, 1997) was often used
with the joint model in literature, for instance, Tseng et al. (2005), Hsieh
et al. (2006) and Ding and Wang (2008). They proposed the same concept
of the joint modeling, that is to jointly model the survival time and its
longitudinal covariates.
However, the main challenge is computation since the likelihood func-
tion can be complicated. Bayesian methods have also received much at-
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tention. For example, Chi and Ibrahim (2007) presented the joint model of
quality of life and breast cancer progression. In their research, the multidi-
mensional longitudinal quality of life measurements were modeled using
a hierarchical mixed effects model while disease-free survival was mod-
eled by a parametric survival model. The quality of life data in their re-
search were transformed into a scale of 0 to 10 with smaller values re-
flecting a better quality of life whereas we use the raw scores from the
questionnaire to examine the stereotype model. Furthermore, Hu et al.
(2009) illustrated use of Bayesian methods in joint analysis of longitudinal
measurements and competing risks failure time data to compare the effec-
tiveness between two treatments of lung disease. They also suggested that
the Bayesian method can avoid high-dimensional integration and compu-
tational implementation.
Moreover, the joint model is becoming increasingly essential in AIDS
studies. The early development of the joint model in AIDS studies was
primarily motivated by characterizing the relationship between a longi-
tudinal biologic marker such as CD4 count or immune response and the
time to HIV/AIDS progression. For example, Huang et al. (2011) demon-
strated the joint modeling of three components (response, covariates, and
time-to-event processes) linked through random effects. The model was
applied to AIDS clinical studies that explored the relationship between
HIV dynamics and the time to decrease in CD4/CD8 ratio in the presence
of CD4 process with measurement errors. The methodology they used is
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the joint model with a skew-normal distribution which is the first attempt
at working on such a distribution. Other references in the literature to
joint models in AIDS studies include Lange et al. (1992), DeGruttola and
Tu (1994), Hoover et al. (1992) and Tsiatis et al. (1995).
Although the longitudinal biomarker (CD4 or immune response) can
be used as an indicator of a particular disease state, other factors such as
quality of life may also be an important predictor of survival. Thus, we
will alternatively perform the joint model in another application. That is,
our joint model is motivated by characterizing the relationship between
the longitudinal quality of life and time to HIV progression where the
biomarkers are treated as covariates in the survival component. This is be-
cause living with HIV can impact on the quality of life not only in physical
health but also in mental and social well-being. This could be the result
of the comprehensive treatment strategies, various and consecutive care
methods, and home care (Handford et al., 2006). A study of Saunders and
Burgoyne (2002) found that patients with better immunologic/virologic
outcomes showed slight improvements in the mean of quality of life, whereas
those with poorer clinical outcomes showed a slight deterioration. Liu
et al. (2006) stated that the quality of life of participants changed over the
HIV disease course and HAART enhanced mental health functioning. In
addition, many HIV/Acquired Immune Deficiency Syndrome (AIDS) pa-
tients struggle with social problems and cultural beliefs which can affect
their quality of life (Aranda-Naranjo, 2004).
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HIV has a significant impact on quality of life; hence the evaluation of
quality of life has become an important issue in the study of HIV. Often in
clinical trials where the primary endpoint is time to an event, patients are
monitored longitudinally by a questionnaire to assess the quality of life af-
ter receiving a particular treatment. Although these longitudinal measures
are frequently incomplete due to disease progression or treatment includ-
ing death, these measurements are also important because they may be
predictive of survival. The role of quality of life will become more promi-
nent in the future especially in many chronic diseases. The improvements
in survival depend not only on the given treatment, but are also associ-
ated with the quality of life. Therefore, methods that can model both the
longitudinal quality of life and survival component jointly are very useful
and essential in HIV clinical trials.
In the case of the joint model, the item response model and the sur-
vival model are usually linked through a latent variable. That is, the la-
tent variable serves as the shared variable or shared parameter in the joint
model. The latent variable is treated as a continuous variable and is as-
sumed to have a multivariate normal distribution in the Bayesian joint
model, whereas in the semiparametric joint model the latent variable is
treated as a discrete variable. Consequently, the latent variable in this the-
sis is assumed to express all information on the quality of life of subjects.
We will give a brief overview about the latent variable below.
There is a significant amount of information in medical studies that
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cannot be observed directly but does have a measurable impact on observ-
able characteristics, for example, a person’s intelligence or the strength of
an attitude, behavioral intentions, quality of life and personality abilities.
The information can only be measured indirectly by means of observable
indicators such as a questionnaire. The responses on a questionnaire from
an individual may be in the form of the level of agreement, health status or
patient symptom scores. Various types of scaling techniques have been de-
veloped for deriving information on an unobservable variable from the in-
dicators. The most widely used scaling method is a latent variable model.
A further use of the latent variable is to express the distribution of the
observed variables (X1, X2, . . . , Xm) in terms of a smaller number of latent
variables (θ1, θ2, . . . , θn) where n < m. The concern is to reduce the num-
ber of variables with as little loss of information as possible. Generally,
a questionnaire contains a set of questions (e.g. 50 or 70 questions) and
the number of subjects who complete the questionnaire may be 1000 re-
spondents. This is because the more questions we ask, the more accurate
results we might gain. If this is the case, we will have many variables to
analyze and it is too difficult to see any pattern in their interrelationship.
This problem can be solved by use of the latent variable model since this
latent variable is designed to collect all the information in the entire set of
questions into much fewer variables. Moustaki (2000) and Bartholomew
(1987) found that the number of latent variables typically is much smaller
than the number of questions.
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The basic assumptions and objectives of latent variable modeling can
be summarized as follows (Bartholomew et al., 2002) :
• A small set of latent variables is assumed to explain the interrelation-
ship in a set of observed response variables.
• Unobserved variables such as quality of life, intelligence, mathemat-
ical or verbal ability, racial prejudice, political attitude, consumer
preferences, which cannot be measured by conventional means, can
be quantified by assuming latent variables.
• Latent variable modeling is used to assign scores to sample units in
the latent dimensions based on their questionnaire responses. This
score is a numerical value that indicates an individual’s position on
the latent variable scale. This score can also be used to classify sub-
jects into groups by their characteristics.
The joint model not only allows investigation of both quality of life
and survival components, but also incorporates all information simul-
taneously with valid and efficient inference. Hogan and Laird (1997),
Xu and Zeger (2001) and Hsu et al. (2006) among others used the joint
model to make more efficient inference on the survival model by incor-
porating the longitudinal data as auxiliary information. In addition, Tsi-
atis and Davidian (2004) reviewed a brief overview of earlier work on
joint models. Recently, Wu et al. (2012) conducted a simulation study
on joint modeling of longitudinal and survival data, and illustrated that
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Bayesian methods have a similar performance to likelihood methods. Fur-
thermore, Tsiatis and Davidian (2001), Song et al. (2002) and Song and
Wang (2008) proposed the joint model in a semiparametric perspective.
Their approaches are semiparametric in that there is no parametric den-
sity function assumed for random effects.
Throughout this study, our joint model is composed of the stereotype
model and the Cox proportional hazards model. The stereotype model is used
to model the quality of life data, whereas the Cox proportional hazards
model is used to model the survival data. These two models share some
latent variables together. We consider two approaches: a Bayesian method
and a semiparametric method via an EM algorithm to obtain the parame-
ter estimation. Our current joint model has a new feature since there is no
literature on the joint model under the stereotype model. However, our
joint model is highly complicated due to unobserved variables, censor-
ing, missing data, semiparametric and nonlinear structure of the model.
Therefore, a major difficulty in a joint likelihood is computation in which
all parameters need to be estimated simultaneously.
1.4 Outline of the thesis
The proposed methods for analyzing the longitudinal ordinal responses
and the survival data are discussed in this thesis. The methodologies and
data applications are separately presented in different chapters.
Chapter 2 is a review of the stereotype model. Among other ordinal lo-
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gistic regression models, the stereotype model is more parsimonious and
more flexible for analyzing the ordered categorical data. Anderson (1984)
indicated that this model is particularly appropriate when the categories
are ordered. This chapter begins by reviewing the structure of the stereo-
type model that uses the reduced-rank regression idea to reduce the num-
ber of parameters. Yee and Hastie (2003) called it the reduced-rank multi-
nomial logit model. The stereotype models with fixed scores and ordered
scores are further described respectively. We review the methodologies to
fit the model that have been proposed in the literature. Model interpreta-
tion is also described.
Chapter 3 presents model structure and estimation methods for the
first approach which is the Bayesian joint model. The Bayesian joint model
is composed of the stereotype model and the Cox proportional hazards
model which are linked through a continuous latent variable. Because the
questions in the MOS-HIV questionnaire are different in the number of
response categories, we use the stereotype model to model the questions
that have ordered responses and use the binary model to model the ques-
tions that have binary responses. The partial survival likelihood function
is used in the survival component and the latent variable is modeled using
a linear regression model. Since the Bayesian approach is used to evalu-
ate the joint posterior density function, convergence diagnostic procedures
are given using both visual inspection and statistical diagnostic tests. We
construct many models so Bayesian model comparison is also considered.
1.4. OUTLINE OF THE THESIS 21
Chapter 4 presents model structure and estimation methods for the sec-
ond approach which is the semiparametric joint model. The semiparamet-
ric joint model consists of the stereotype model and the Cox proportional
hazards model which are linked through a discrete latent variable. The un-
specified baseline hazard function is also included in the joint model. EM
algorithm is used to estimate the model parameters by iterative computa-
tion between the expectation step and the maximization step. The baseline
hazard is iteratively estimated together with other parameters in the EM
steps by its nonparametric maximum likelihood. The profile Akaike infor-
mation : pAIC (Xu et al., 2006) is used for model comparison.
Chapter 5 illustrates the applications of two joint models: the Bayesian
joint model and the semiparametric joint model. The methods are applied
to data from the Staccato study.
Chapter 6 presents the extension of the joint model in the case of multi-
ple failure types in the survival component. The model is called the com-
peting risks model when multiple failure types are considered. Therefore,
the joint model in this chapter is composed of the stereotype model and
the competing risks model which are linked through a continuous latent
variable. The methods have a similarity to the Bayesian joint model in
Chapter 3 since other structures of the model are similar and only the sur-
vival component is different. In this chapter we present the methodology
and give an example by using pseudo data.
The last chapter (Chapter 7) is the conclusion and discussion.




Anderson (1984) proposed a multinomial logit model where the reduced-
rank regression idea was applied to non-Gaussian errors and referred to as
the stereotype model. He also indicated that this model is particularly useful
when the categories are ordered.
The reduced-rank regression was first introduced by Anderson (1951).
It is a multivariate linear regression method where the estimated matrix
of regression coefficients is of reduced rank and where several response
variables are related to the same set of explanatory variables.
The reduced-rank regression is suitable for situations where the re-
sponse variables are related to the predictor variables in a similar way. The
method can be useful when there are many responses and predictor vari-
ables. However, it has been restricted to data where the response variable
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is continuous and its use outside the Gaussian family is not mentioned
(Reinsel and Velu, 1998). This might be the main reason why reduced-
rank regression has only been used in a few applications.
Reduced-Rank Regression Model: we consider the multivariate linear
regression of Y on X of dimension q and p respectively. The multivariate
regression model is
Y = BX + ε
where Y is a column vector of q response variables , X is p-dimensional
column vector of the explanatory variables and ε is a q-dimensional col-
umn vector of errors, ε ∼ N(0,Σε). Thus, B is the regression coefficient
matrix of dimension q × p.
Commonly the regression coefficient matrixB is estimated by ordinary
least squares method and so far we have not considered the rank of trueB
but implicitly assumed that the resulting estimate B̂ will have a full rank,
m = min(p, q). However, Izenman (1975) introduced the term ‘reduced-
rank regression’ where in some situations the regression coefficient matrix
may not have a full rank. The hypothesis thatB has reduced rank less than
m is expressed as B = φβ ′ where φ is q × r matrix and β is p × r matrix,
both having rank r and r < m. This gives the reduced-rank model as
Y = φβ ′X + ε
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The reduced-rank r must be estimated from the data if it is not know from
the context (Aldrin, 2002).
2.2 The Stereotype Model
When the response variable is a categorical variable and consists of more
than two discrete outcomes , the multinomial logistic regression model is
used. In this case, the explanatory variable can be a continuous variable, a
categorical variable or both. The multinomial logistic regression model is
of the form









where the response variable Y categories are ` = 1, 2, . . . , L and category
` = 1 is treated as the baseline category to make the model identifiable,
i.e. a1 = 0 and B1 = 0. The B ` is the regression coefficient vector or the
covariate effects which has L − 1 parameters for each predictor Xi, i =
1, 2, . . . , p. The logit model can be represented as
log
[
P (Y = ` |X )




`X, ` = 2, . . . , L
This model is appropriate when the responses are unordered categories.
However, if the response is ordinal, this model has L − 1 parameters for
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each predictor Xi. In some research, if L and p are large, then the total
number of regression coefficients in the multinomial logistic regression
model would also be large. This would be difficult to interpret. Thus, it
is convenient to use the reduced-rank regression idea to reduce the num-
ber of parameters. Similarly, Lunt (2005) suggested that if we assume that
the regression function is the same for all categories, we can consider the
stereotype model as the non-linear form of the constrained multinomial
model. This model compares each category of the response variable with
the reference category.
If this is the case, the multinomial logistic regression model (2.1) can be
simplified to




k=2 exp(ak + φkβ
′X )
(2.2)
where φ` are scalars, ` = 1, . . . , L and a1 = φ1 = 0. Also, this model can be
defined using logits for pairs of categories as
log
[
P (Y = ` |X )
P (Y = 1 |X )
]
= a` + φ`β
′X, ` = 2, . . . , L
In this model, category ` = 1 is treated as the baseline category, a` is the
item intercept parameter , β is the covariate effect and φ` is the score of the
response categories and φ`βi represents the log odds for response Y = `
versus Y = 1 per unit increase in Xi.
Model (2.2) is referred to as the reduced-rank multinomial logit model (Yee
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and Hastie, 2003). Anderson (1984) called it the stereotype model. For rea-
sons of identification of the parameters, beside setting a1 = φ1 = 0, Ander-
son (1984) also recommended setting φL = 1, so that the model consists
actually of L− 1 model equations. For example, if there are five predictors
(X1, X2, . . . , X5) and four outcome categories of a tumor grade: grade 1,
grade 2, grade 3 and grade 4 (Y = 1, 2, 3, 4 respectively), this describes the
tumor size. The higher the grade, the larger the tumor size and the faster
the cancer grows. The stereotype model with a constraint φ4 = 1 is
log
[
P (Y = 2 |X )
P (Y = 1 |X )
]
= a2 + φ2(β1X1 + β2X2 + β3X3 + β4X4 + β5X5)
log
[
P (Y = 3 |X )
P (Y = 1 |X )
]
= a3 + φ3(β1X1 + β2X2 + β3X3 + β4X4 + β5X5)
log
[
P (Y = 4 |X )
P (Y = 1 |X )
]
= a4 + β1X1 + β2X2 + β3X3 + β4X4 + β5X5
On the other hand, the multinomial logistic regression model is
log
[
P (Y = 2 |X )
P (Y = 1 |X )
]
= a2 + β21X1 + β22X2 + β23X3 + β24X4 + β25X5
log
[
P (Y = 3 |X )
P (Y = 1 |X )
]
= a3 + β31X1 + β32X2 + β33X3 + β34X4 + β35X5
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log
[
P (Y = 4 |X )
P (Y = 1 |X )
]
= a4 + β41X1 + β42X2 + β43X3 + β44X4 + β45X5
It can be seen from the above that there are fewer parameters to be esti-
mated in the stereotype model which is 2L − 3 + p parameters while we
have (L− 1) + (L− 1)∗ p parameters in the multinomial logistic regression
model.
Model (2.2) is a one-dimensional stereotype model, (rank=1), since the
relationship between Y and X involves only one function of X , β′X . That
is, one function of X discriminates between all categories. In this model,
the β parameters no longer differ between the different categories of the
outcome and the score of the response categories is given by the φ` param-
eter. The maximum possible dimension of matrixB is the rank of the L×p
matrix which is at most r = min(L, p). For example, if p = 2 (number of
covariates = 2), the maximum dimension is two and a two-dimensional
stereotype model can be written as
P (Y = ` |X ) = exp(a` + φ`β
′X + ψ`η ′X )
1 +
∑L
k=2 exp(ak + φkβ
′X + ψkη ′X )
(2.3)
where ψ` are scalars, ` = 1, . . . , L and a1 = φ1 = 0. The model now de-
pends on the two functions of X which are β ′X and η ′X . Furthermore,
model (2.2) can be extended further for a higher dimension. Lunt (2005)
justified the concepts of dimensionality stating that if one combination can
distinguish between levels 1 and 2 , but a different one is required to distin-
guish between levels 2 and 3, the relationship is a two-dimensional stereo-
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type model. Examples of the use of multi-dimensional stereotype models
were not shown in the literature until Lunt (2005) presented the simplest
model and gave an example of a multi-dimensional stereotype model. He
also suggested that when the maximum dimension of a stereotype model
is used to evaluate probabilities, the likelihood function is exactly equiv-
alent to a multinomial logistic regression even if their interpretations and
the actual parameters are different. However, due to some of the com-
putational complexities and lack of suitable software for fitting the multi-
dimensional stereotype model, most studies in the literature showed one-
dimensional stereotype model such as Anderson (1984) and Greenland
(1994).
2.2.1 The Stereotype Model with Fixed Scores
The stereotype model has the same characteristic as the proportional odds
model in which an explanatory variable has a similar effect for each logit
and it is a special case of the adjacent-category logits. Also, the stereo-
type model can be used with both ordered and unordered categorical out-
comes. This can be considered from the scores of the outcome categories,
φ`. Greenland (1994) indicated that if the scores are fixed, it is not particu-
larly realistic in an assumption and also could be regarded as a disadvan-
tage of the stereotype model. Besides, if they are fixed as a constant and
equally spaced for each covariate, such as {φ` = (` − 1)/(L − 1)} for the
constraints φ1 = 0 and φL = 1 , the stereotype model is equivalent to the
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proportional odds version of the adjacent-categories logit model (Agresti,
2010). The relationship between these models can be shown below:
Suppose there are L outcome categories with probabilities P (Y = `),
which can be written as pi` and
∑
` pi` = 1 where ` = 1, 2, 3, . . . , L and the
first category is the baseline. The general adjacent-categories logit model






= a` + β
′
`X, ` = 2, 3, . . . , L (2.4)
This model gives the odds of responding in a higher category versus the
lower adjacent category. It also can be seen from the model above that the
linear combination of the predictor variables is required to discriminate
among the logits or the predictor variables have a different effect for each
logit. These logits also are a basic set equivalent to the baseline category
logit model used to analyze nominal response outcomes. If we assume







= a` + β
′
`X, ` = 2, 3, . . . , L (2.5)
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To see the connection between the adjacent-categories logit model and
the baseline category logit model, we consider a reparameterized baseline






































For example, suppose there are five outcome categories and we treat the




































































be seen, we have (` − 1) terms when we reparameterize the model. Fur-
thermore, when we add these (`− 1) terms as (2.6) in the general adjacent-







= a` + β
′
`X, ` = 2, 3, . . . , L
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′
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3X ) + (a2 + β
′
2X )

























= a∗` + β
∗′
` X
The covariate effects β∗ are subscripted by `. This means that the effects
vary according to the response paired with the baseline category. How-
ever, the general adjacent-categories logit model (2.4) is not more parsi-
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monious than the baseline category logit model (2.5). Thus, from model
(2.4) we can create a simple version by using a single parameter instead of






= a` + β
′X, ` = 2, 3, . . . , L (2.7)
Model (2.7) has the proportional odds assumption that the covariate ef-
fects are invariant among the logits. This is why it is called the propor-
tional odds for adjacent-categories logit model. The proportional odds
assumption is often used for a model to analyze ordinal responses. The









a` + (`− 1)β ′X (2.8)
= a∗` + β
′u`
where u` = (`−1)X . Thus, the adjacent-categories logits are a constrained
version of the baseline category logit model. Model (2.8) uses a single
parameter for the covariate effects and the effects depend on the distance
between categories, so this model recognizes the ordering of the response
scale.








P (Y = ` |X )
P (Y = 1 |X )
]
= a` + φ`β
′X, ` = 2, . . . , L
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if we treat {φ} as fixed and let φ` = (`−1), then the model becomes the pro-
portional odds version of the adjacent-categories logit model. Therefore,
for fixed scores on {φ}, the stereotype model has the form of a generalized-
linear model in the exponential family (Greenland, 1994). We can easily
use a generalized-linear model program via constrained polytomous lo-
gistic regression to fit a multinomial logistic regression model.
2.2.2 The Ordered Stereotype Model
Sometimes it is too difficult to assign fixed scores due to a lack of knowl-
edge and data information. Thus, the scores need to be estimated and
may be unequally spaced among the categories. Anderson (1984) also pro-
posed the order constraint with the monotone increasing 0 = φ1 ≤ φ2 ≤
. . . ≤ φL−1 ≤ φL = 1 to capture the ordinal nature of the outcomes. As
a result, the responses Y are treated as ordinal. The ordered stereotype
model is defined as
log
[
P (Y = ` |X )
P (Y = 1 |X )
]
= a` + φ`β
′X, ` = 2, . . . , L (2.9)
with 0 = φ1 ≤ φ2 ≤ . . . ≤ φL−1 ≤ φL = 1. When {φ`} are treated as
parameters with the non-decreasing constraints, we need to estimate not
only {a`,β}, but also {φ`}, satisfying the constraint for model (2.9). Such
a model is referred to as the ordered stereotype model. Monotone decreasing
{φ`} could be used but the sign of β would change. Since the scores of
response categories, φ`, are ordered, it could vary considerably between
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the two adjacent categories. When the two adjacent scores are indistin-
guishable, it is appropriate to constrain those adjacent scores to be equal
and refit the model. This corresponds to collapsing the response scale by
combining those two categories (Agresti, 2010). When φ` = φ`+1, this in-
dicates that the predictors do not have any effects on the probability of
having response `+ 1 against response `. Consequently, for a unit increase
in a predictor Xp, the log odds ratio φ`βp of category ` versus baseline cat-
egory 1 becomes larger when category ` is further away from category 1.
In other words, this ordered version describes a stochastic order of the re-
sponse Y subject to the linear combination β′X . Therefore, the higher the
value of βpXp, the more Y tends to move toward the high end of the re-
sponse scale in a particular predictor Xp. However, the ordered version of
the stereotype model is difficult to fit due to multiple constraints and lack
of standard software.
At this point, under the ordered model, to handle the identifiability
problem and conditional on ordering the parameters 0 = φ1 ≤ φ2 ≤ . . . ≤
φL−1 ≤ φL = 1, reparameterization is needed in terms of the differences as




γs, for ` = 2, . . . , L − 1, since φ1 = 0 and φL = 1. For
the purpose of making {φ`} increase in ` and be bounded by 1, we need to
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2.3 Model Interpretation
Interpretation of the parameter φ` is by comparing response probabilities
for two different response categories ` and `′. The response paired with
the baseline can be expressed as
log
P (Y = ` |X )
P (Y = `′ |X ) = log
P (Y = ` |X )
P (Y = 1 |X ) − log
P (Y = `′ |X )
P (Y = 1 |X )
= a` − a`′ + (φ` − φ`′)β′X
when {φ`} are fixed and equally spaced, the interpretation of the param-
eters is similar to the multinomial logistic regression model. This means
when φ` = φ`′ , log [P (Y = `|X )/P (Y = `′|X )] = a` − a`′ is a constant not
dependent on X . In that case, the model still holds with the same scores
if the response scale is collapsed by combining those two categories. If the
difference (a` − a`′) is positive, this means the total number of outcomes
in categories ` is greater than the total number of outcomes in categories
`′. In addition, when φ` = φ`′ , then X does not distinguish between re-
sponse ` and `′. This means that X is not predictive between the two cat-
egories. For example, suppose that diseases are graded on scales: least
severe, moderate and most severe. Patient’s age (X) is used to classify the
disease staging. If φ1 = 0, φ2 = φ3 = 1, this means age does not help to
predict how severe the damage is.
In the case that the scores are not equally spaced but two adjacent
scores have almost the same values, then two such respective categories
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might be collapsed and the estimation process should be fitted again. More-
over, when the difference (φ` − φ`′) is large, the odds of having response
` instead of `′ is strongly affected by the covariates. Also, the stereotype
model gives a way of estimating how close the adjacent response cate-
gories ` and `′ are, based on how close φ` and φ`′ are. In other words,
the distinguishability and order of outcome categories could be addressed
through these constraints.
When {φ`} are constrained to be ordered with monotone increasing
form, 0 = φ1 ≤ φ2 ≤ . . . ≤ φL−1 ≤ φL = 1, these scores are directly related
to the covariate effect. Therefore, the effect of the explanatory variables on
the first odds ratio is less than the effect on the second, and so on. Further-
more, the conditional distributions of Y are treated as ordinal according
to the value of βX when {φ`} are ordered. That is, the higher the value of
βX , the more Y tends to move toward the high end of the response scale.
Thus, for a particular predictorX , a value of β > 0 means that the response
Y tends to move toward higher values as X increases. Therefore, in this
model the influence of covariates is assessed through the components of
β. Likewise, the strength of the effect of each covariate can be expressed
through a single parameter β. Note that the effect of the covariates is as-
sumed constant across response categories. That is, the β parameter no
longer differs between the different levels of the response.
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The model simultaneously describes the effects of X on these L − 1
logits, log
[
P (Y=` |X )
P (Y=1 |X )
]
, ` = 2, . . . , L. From the `th logit, we have
P (Y = ` | X = u)/P (Y = 1 | X = u)




The explanatory variable X has coefficient φ`β. This represents the log
odds for response Y = ` versus Y = 1 with a unit increase in X . That is,
when X = u+ 1, the odds of response ` instead of ` = 1 are exp(φ`β) times
the odds when X = u. In other words, for a unit increase in a particular
predictor X , the log odds ratio φ`β for the response on level ` versus level
1 is larger in absolute value when category ` is farther from category 1.
2.4 Model Fitting
Since the stereotype model can be used with both ordered responses and
unordered responses (nominal responses), model fitting for both cases will
be discussed as follows. The stereotype model with unordered responses
has been shown in model (2.2) and model (2.3). The estimation of parame-
ters under these models can be fitted in a straightforward way by using the







P (Yi = `|X i)
]I(Yi=`) (2.10)
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where I(Y = `) denotes the indicator function of response Y = `. Then
models (2.2) and (2.3) are substituted into (2.10) and Lc(·) is maximized
with respect to the parameters of the model. Thus, the likelihood function
needs to be optimized iteratively. Gill and Murray (1972) suggested that
the Quasi-Newton algorithm be used. Anderson (1984) also presented the
numerical optimization method to fit the model. Similarly, Holtbrugge
and Schumacher (1991) used an iteratively reweighted least square (IRLS)
method to maximize the likelihood function. The stereotype model in
view of discriminant analysis was described by Feldmann (1993), who
also presented the maximum likelihood parameter estimation. Yee and
Hastie (2003) estimated the stereotype model by using the idea of the
reduced-rank multinomial logistic models (RR-MLM) and used VGAM
(Vector Generalized Additive Model) family function to estimate the pa-
rameters. However, VGAM ignores the ordered version of the stereotype
model since this model has ordered constraint on the parameters. It is dif-
ficult to estimate the model with such a constraint.
The stereotype model has also been treated as a nonlinear model with
multivariate response. The likelihood function was maximized directly
by using SAS software which supplies unconstrained optimization meth-
ods (Kuss, 2006). In detail, he defined a L-dimensional response vector of
dummy variable Y ∗ for every observation and wrote the stereotype model
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as a nonlinear model through
Y ∗i = f(Xi, a`, φ`, β) + εi
with





k=2 exp(ak + φkβXi)




k=2 exp(ak + φkβXi)
)
where εi is a L× 1 vector, E(εi) = 0 , Var(εiε′i) = Σ, Σ has (L− 1)× (L− 1)
dimensions and a1 = 0, φ1 = 0, φL = 1. The subscript i is for the ith obser-
vation. Two steps of the estimation procedure are required. Generalized
least squares and the maximum likelihood estimation are possible to esti-
mate the model parameters. Firstly, estimate Σ̂ for Σ from the residuals
of the model using maximum likelihood approach by assuming εi as in-
dependent and identically distributed (i.i.d) and εi ∼ N(0, Σ). The second
step is to minimize the sum squared of error by using generalized least
squares method.
SSE(a`, φ`, β, Σ̂) =
N∑
i=1
[Y ∗i − f(Xi, a`, φ`, β)]′Σ−1 [Y ∗i − f(Xi, a`, φ`, β)]
iterating this process further until convergence. Kuss (2006) also sug-
gested that to achieve reasonable estimates of the model parameters, good
starting values are needed. Therefore, the set of starting values for the
stereotype model (2.2) can be taken from the estimated parameters of the
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multinomial logit model. Indeed, we can use the last category of response
βL in the multinomial model as a starting point of β in the stereotype
model and a` can be taken from the multinomial model as well. In the
same way, {φ`} can be calculated from the relation β` = φ`β between the
multinomial model and the stereotype model.
The stereotype model with ordered responses has been shown in model
(2.9) with 0 = φ1 ≤ φ2 ≤ . . . ≤ φL−1 ≤ φL = 1. The difficulty in fitting
this ordered stereotype model is ordering constraints on the scores {φ`}.
Greenland (1994) suggested that the appropriate scores can be decided
or chosen in advance based on data from a pilot study or using general-
ized linear models that estimate the scores as additional parameters in the
model. Lunt (2005) also indicated that it is not strictly necessary to esti-
mate the {φ`} parameters at all since they may already be known from
background information or they may be constrained to take pre-specified
values base on expected spacings. Both of their suggestions tried to avoid
the difficulty in model fitting.
Since the stereotype model has the complicating factor of being multi-
plicative in the parameters, Greenland (1994) proposed an alternating al-
gorithm by alternating fixing between β and φ` while the other parameter
was estimated. He also suggested that this approach converged rapidly
and reliably when started with scores derived from the unordered polyto-
mous model. The proposed two-step iterative method consists of solving
at each step problems of different natures: the first step for the stereotype
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model (2.9) starts with selecting fixed scores {φ`}. If the set of {φ`} has
equally-spaced values, then this model is equivalent to the proportional
odds version of the adjacent-categories logit model. In the second step,
estimate β and α` with fixed {φ`} using ordinary maximum likelihood es-
timation. In this step φ`Xp is treated as a predictor. On repeating this itera-
tive process, treating the estimated β from the previous step as fixed (β ′X
being predictors) and {φ`} are treated as unknown parameters. Then re-
estimate {φ`} and repeat the alternative fixing process until convergence
occurs.
Furthermore, Ahn et al. (2009) applied Bayesian approach to estimate
both unordered and ordered stereotype models. He further proposed the
Monte Carlo based full Bayesian method and Expectation Conditional Max-
imization (ECM) algorithm for the estimation of model parameters in the
presence of a completely general missingness mechanism (Ahn et al., 2011).
In this study, we present the ordered stereotype model and use an al-
ternating algorithm which is an iterative two-step approach for selecting
fixed between φ` and β. More information about fitting parameters when
the stereotype model is accommodated in the joint model will be discussed
in Chapter 3 and Chapter 4.
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2.5 The Stereotype Model with Multi-item and
Longitudinal Data
Suppose we consider J item responses, Y1, Y2, . . . , YJ , which are designed
to serve as measures of the response frequencies of the quality of life items.
These items might represent how patients are feeling and the kinds of
things they are able to do. The possible answers correspond to the fol-
lowing options : poor , fair , good , very good and excellent. The direction
of ordering can be recorded from poor to excellent where low responses
imply a poor quality of life. This means each of Y is supported on the
ordered categorical set {1, 2, . . . , L} : {poor, . . . , excellent}. Patients’ an-
swers would also help to understand the effects of the medication they are
taking. However, the individual patient is the only person who can ex-
press a subjective concept about the quality of life and patients often over-
estimate their feelings. Information coming from family members, friends,
and caregivers can also be important. For these reasons, it has been dif-
ficult to use a specific reference level to estimate optimal quality of life.
Therefore, we could correct for the unreliability of these issues by using a
latent variable model in which the latent trait essentially plays the role of
the true quality of life. Throughout this thesis, we define θ to be a latent
random variable and we consider longitudinal designs with M protocol-
specified time points for quality of life data collection, t1, t2, . . . , tM . We
will present two different joint models: the Bayesian joint model and the
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semiparametric joint model. More information of both joint models will
be discussed in Chapter 3 and Chapter 4 respectively.
This thesis analyzes data from the Staccato study which examined Hu-
man Immunodeficiency Virus (HIV) infection in 354 patients. The re-
sponse variable was the assessment of the quality of life by using the Med-
ical Outcomes Study HIV Health Survey (MOS-HIV) which indicates how
patients are feeling every 24 weeks beginning at the baseline visit until the
end of the study. The MOS-HIV questionnaire is composed of many ques-
tions on physical and mental health. Each question is in the same ordered
general format but there is a difference in the number of ordered outcome
categories. Some questions have three responses (L = 3) and some ques-
tions have five responses (L = 5). However, we still can use the stereotype
models to model all questions/items simultaneously.
For the Bayesian joint model (in Chapter 3), the stereotype model used
for this example has the form
log
[
P (Yijm = ` | θi(tm))
P (Yijm = 1 | θi(tm))
]
= a` + φ`bjθi(tm) (2.11)
where ` = 2, . . . , Lj . A higher value of ` indicates a better quality of life.
In general, we can let each question has its own intercept (aj`) and score
(φj`). However, it will result in too many parameters. Thus, a simplifying
assumption is made to group the questions that have the same number
of ordered outcome categories into the same group. This may not be a
reasonable assumption since it assumes all items/questions with the same
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number of categories have equal intercepts and response category scores
regardless of the type of questions. This assumption could be relaxed by
allowing different a` and φ` values according to the type of questions and
number of response categories. However, for simplicity we retain the as-
sumption.
The response probabilities, P (Yijm = ` | θi(tm)) , are modeled through
P (Yijm = ` | θi(tm)) = exp(a` + φ`bjθi(tm))
1 +
∑L
k=2 exp(ak + φkbjθi(tm))
, ` = 1, 2, . . . , L
where Yijm denotes the response on question/item j for subject i at time tm
and θi(tm) is defined as the value of a continuous latent random variable
for subject i at time tm. An item intercept parameter is a` and the score
of outcome categories is φ`. In the previous section, β was defined as the
covariate effect but henceforth the strength of effect of each covariate from
item response j at different time point is specified by bj . This is because of
the complicated structure of our joint model which is composed of three
main models: the stereotype model, the regression model and the Cox
proportional hazards model. We need to change some notation in some
models in order to make them distinguishable.
From the stereotype model (2.11), we can conclude that exponentiat-
ing a φ`bj value gives an odds ratio for the odds of response ` instead of
response “poor” (` = 1) with a unit increase in θ. For example, the odds
ratio comparing the response “good” (` = 3) and response “poor” for a
1-unit increase in quality of life score is exp(φ3bj).
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For the semiparametric joint model (in Chapter 4), we construct the
joint likelihood function by using an idea of the finite mixture model. The
latent variable θ is treated as a discrete variable. Thus, the stereotype
model with discrete latent random variable becomes
log
[
P (Yijm = ` | θr)
P (Yijm = 1 | θr)
]
= a` + φ`(bj + θr)
where a` is an item intercept parameter and we set a1 = 0, bj is the item
slope coefficient, φ` is the score of the response categories and we consider
the ordered stereotype model with 0 = φ1 ≤ φ2 ≤ . . . ≤ φL−1 ≤ φL = 1.
The latent variable θr is defined to be a discrete latent random variable
taking one of the discrete values 1, 2, . . . , R.
Chapter 3
A Bayesian Joint Model
3.1 Introduction
Quality of life (QOL) and length of survival of patients are often evalu-
ated in clinical trials. Medical research also frequently focuses on the re-
lationship between quality of life and survival time of subjects since two
interventions can have very similar survival outcomes but have different
effects on a patient’s quality of life. In the Staccato study, the quality of
life assessments were measured regularly every 12 weeks after patients re-
ceived the treatment. Most of the quality of life scales were ordinal such as
good, fair, poor. This generated a sequence Y = (Y (t1), Y (t2), . . . , Y (tM))
of longitudinal quality of life data for each patient. Longitudinal data in-
volve repeated measurements of a response variable at a number of time
points. During the collection of the longitudinal quality of life data, time
to HIV progression was also considered in parallel. This can be referred to
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as the time-to-event data T .
Longitudinal data and time-to-event data can be analyzed as two sep-
arate end points. Alternatively, they can be jointly analyzed as one com-
bined end point if the two data components are likely to be related. That is
the Y and T processes may be dependent on each other. Although meth-
ods for separate analyses of the two data components are well established,
joint analysis of the two endpoints is still under study and is being increas-
ingly developed (Henderson, 2005). There are potential gains in power
in considering two endpoints simultaneously, such as considering quality
of life and survival time as two simultaneous processes. Many scientific
studies generate both longitudinal data and survival data simultaneously.
For example, Berridge and Whitehead (1971) presented a combination of a
proportional hazards model for the failure times and a continuation ratio
model for the ordinal category responses. Similarly, Ribaudo et al. (2000)
demonstrated the joint analysis of quality of life response and log survival
time. They indicated that the quality of life response might account for
different survival patterns. The estimation of the joint distribution gives
appropriately weighted estimates for the average quality of life response
pattern over the observed distribution of survival times.
Moreover, Wang et al. (2002) suggested that joint modeling quality of
life and survival could be used to combine information for summariz-
ing the outcome in terms of a patient’s risk of dying and this might be
predicted, in part, by his current quality of life. Chi and Ibrahim (2006)
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proposed a joint likelihood approach to jointly model multidimensional
quality of life and multivariate survival data to investigate the relation-
ship between quality of life, disease-free survival and overall survival in
the International Breast Cancer Study Group trial.
There are various approaches for the simultaneous analysis of quality
of life and survival data in literature. The most widely used approach in
clinical research is quality-adjusted survival analysis. This method com-
bines the amount of time that patients spend in a number of different
health states with weights reflecting the quality of life. The modeling re-
sults are used to create a composite measure of quality and quantity of
life. Although quality-adjusted survival analysis is extensively used and
researchers can overcome the problem of missing quality of life data due
to death, it does not adequately deal with missing data resulting from
dropout from the quality of life study prior to death. Alternatively, the
joint modeling approach may provide the means to model the dropout
processes explicitly (Billingham and Abrams, 2002).
This thesis investigates a joint model of longitudinal ordinal data and
survival data. This is illustrated using an application to the joint modeling
of quality of life measurements and survival time for HIV patients being
followed up after treatment. The ordinal quality of life measurements are
modeled using the stereotype model, while the survival time is modeled
using the Cox proportional hazards model. They are linked through a
continuous latent variable that is assumed to underlie the quality of life
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and the hazard rate. A well known example for the joint modeling ap-
plication is AIDS research and the primary motivation is to characterize
the relationship between a longitudinal continuous variable and time to
HIV/AIDS progression (Ibrahim et al., 2001). However, we demonstrate
the joint model in another application which is longitudinal quality of life
data and time to HIV/AIDS progression. Also, this shows a new feature
of joint modeling because we use the stereotype model to model the lon-
gitudinal ordinal data. This is the first time that the stereotype model is
used in a longitudinal ordinal and survival joint model.
We illustrate our methodology by analyzing data from the Staccato
study, a randomized trial to compare two methods of treatment : the con-
tinuous anti-retroviral treatment and the CD4 guided interruption treat-
ment (Ananworanich and the Staccato study group, 2006), for HIV infec-
tion of Thai patients on Highly Active Antiretroviral Therapy (HAART).
Randomized treatment continued during an average of approximately three
years. In order to analyze the impact of these two treatment methods on
the quality of life in Thai patients, Nu¨esch et al. (2009) calculated summary
scores of quality of life and transformed to standardized z-scores, with a
mean of 50 and a standard deviation of 10, and compared the standardized
scores between two treatment methods in the Staccato study. However, in
this thesis we do not use the method of summary scores. We will use the
raw scores from the quality of life questionnaire to analyze the data.
We are interested in the CDC stage at the end of the randomized treat-
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ment period as a survival endpoint of this study. Note that CDC is the
classification system of HIV disease stage by CD4 cell counts and by the
presence of specific HIV-related conditions defined by the U.S. Centers for
Disease Control and Prevention (CDC) (Centers for Disease Control and
Prevention, 1992). More information about the CDC stage will be given in
Chapter 5 (data application).
Patients were also monitored longitudinally with respect to biological
endpoints, such as the CD4 count, throughout the follow-up period. This
was done by taking immunologic or virologic measures in the case of in-
fectious diseases. A questionnaire was used to assess the quality of life
every 24 weeks beginning at the baseline visit and at weeks 24, 48, 72, 96,
120 and 144 respectively, (M protocol-specified time points for quality of
life data collection, t1, . . . , tM ). There was no information about quality
of life after 144 weeks, even though patients were followed up for sur-
vival. Often these longitudinal measures are incomplete but these mea-
surements are still important because they may be predictive of survival.
Furthermore, the optimal goals of treatment of HIV/AIDS patients are to
prolong their survival and to help them maintain a good quality of life.
Since the antiretroviral therapy is time consuming, the study of quality of
life among HIV/ AIDS patients receiving antiretroviral therapy would be
necessary to assess the success of the treatment. However, giving differ-
ent treatment strategies may affect the quality of life of treated patients.
Therefore, joint model methods are appropriate when it is considered that
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the evaluation of changes of quality of life over time and the survival end-
points may be dependent on each other. The joint model has an advantage
in dealing with the problem of missing quality of life data resulting from
dropout prior to death or withdrawal before the study has ended. This
is because of the incomplete nature of the data actually observed. The
quality of life data might not be completely collected at time tm. The com-
plete information is very rarely available on all patients. In spite of this,
the joint model has emerged as an effective way to gain information from
both components. Since the model is so complex with a high dimensional
data set, Bayesian methods have been considered and the parameters of
the model are estimated using the Metropolis-Hastings Algorithm.
3.2 Model Structure
The Bayesian joint model consists of an item response model and a Cox
proportional hazards model which are linked by the latent variables. To
create the item response part, we consider the item responses from the
MOS-HIV quality of life questionnaire at different time points during the
follow-up. For example, the questionnaire assesses the general health of
individuals and there is a question on health status that asks “In general
would you say your health is Poor, Fair, Good, Very good, Excellent ?”.
Although we can assume the categories are ordered, we do not know the
structure of this ordering with respect to a given explanatory variable.
Thus, the stereotype model for item responses is developed to solve such
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complicated measured scale problems. In the case of dichotomous out-
come data, for example the questionnaire asks “Does your health keep you
from working at a job, doing work around the house or going to school :
Yes or No ?”, the binary model is used for analysis.
If the quality of life information can only be measured indirectly by us-
ing observable indicators such as a questionnaire, a latent variable model
is used for deriving the unobservable variable from the indicators. The
latent variable is designed to collect all information in the set of questions
and it is treated as a shared variable in our joint model. That is it appears
as a covariate in both components. The joint likelihood of the ordinal lon-
gitudinal and survival data for a subject is specified by conditioning on
the latent variable which is assumed to have a multivariate normal distri-
bution. We generate the latent random variable for each individual to link
the quality of life and survival time together.
In the Staccato study, there are two survival endpoints, CDC-B and
CDC-C, but we consider only one clinical event, CDC-B, since there are
very few patients who experience CDC-C at the end of the study (five out
of 354). Then patients in category C are treated as censored in this ap-
proach. Thus, the clinical event CDC-B at the end of the randomized treat-
ment period is used as the survival endpoint in the survival part. The Cox
proportional hazards model is used to model time to diagnose the new
CDC-B. We also consider treatment group assignments and initial CD4
counts as time-independent covariates and the quality of life latent vari-
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ables that are created at failure time points as time-dependent covariates
in this part.
3.2.1 Item Response Models
To contribute to the joint model, there are two models in the item response
part: the stereotype model and the binary model since the MOS-HIV ques-
tionnaire has 35 items/questions with varying-dimensions. We will use
the binary model to model the binary data and the stereotype model to
model the ordinal data. Each question is in the same ordered general for-
mat from poor to excellent but there is a difference in numbers of ordered
outcome categories. The stereotype model can be used to model all items
simultaneously.
3.2.1.1 The Stereotype Model
We consider J item responses, Y1, Y2, . . . , YJ , which are designed to mea-
sure health related quality of life at M protocol-specified time points for
quality of life data collection, t1, t2, . . . , tM , and each of the Y ′s can be writ-
ten in the form of an ordered categorical set {1, 2, . . . , Lj}. The direction
of ordering can be recorded from poor to excellent. That is, a lower level
implies poor quality of life. The stereotype model is used to model the
probabilities of responding on level `, ` = 1, 2, . . . , Lj for each of the qual-
ity of life items and in this study the first category , ` = 1, is treated as the
baseline category. Therefore, Yijm is used to denote the jth item response
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of the ith subject at the mth time point, Yijm = 1, 2, . . . , Lj for i = 1, 2, . . . , n,




P (Yijm = ` | θi(tm))
P (Yijm = 1 | θi(tm))
]
= a` + φ`bjθi(tm) (3.1)
where
a` is an item intercept parameter and we set a1 = 0.
bj is an item slope coefficient and we assume bj > 0
φ` is a score for the outcome level and we consider the ordered stereo-
type model, 0 = φ1 ≤ φ2 ≤ . . . ≤ φL = 1, throughout this thesis.
θi(tm) is defined to be a continuous latent random variable that rep-
resents a quality of life score for the ith subject at the mth time point.
Note that the assumption bj > 0 is a very strict assumption and may
not always be necessary. This is reasonable when all the responses are or-
dered from low to high responses and when all items/questions show the
increasing rates of higher responses as θi increase. In the general case, we
can allow to take bj with any values from (−∞,+∞). This would allow the
questions/items with ordered responses that are negatively correlated to
θi to have negative coefficients. For example, a drug that improves quality
of life overall, but which has specific negative side effects that influence,
negatively, the response to just one or two questions.
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Given the latent variable, θi(tm), the responses Yijm, i = 1, . . . , n, j =
1, . . . , J, m = 1, . . . ,M are treated as independent called the local indepen-














k=2 exp(ak + φkbjθi(tm))
)yijm`
(3.2)
where yijm` = I(Yijm = `) represents the binary outcome (“Yes” and “No”)
on the response category ` for the ith subject, the jth item and the mth time
point. For example, when Yijm = 1, this means that subject i selects cate-
gory ` = 1 on question j at time tm. Then yijm1 = 1 and the other categories
yijm2 = 0, yijm3 = 0, . . . , yijmL = 0.
According to {φ`} with monotone increasing scores, the response Yijm
is treated as ordinal. The probabilities of {Yijm = `, ` = 1, . . . , Lj} depend
on the value of bjθi(tm). That is, when bjθi(tm) increases, then Yijm tends
to move toward the high end of the response scale. Therefore, to ensure
the model has the usual interpretation by which a higher score of θi(tm)
means a better quality of life, bj is constrained to be a non-negative value.
In other words, patients who have a greater value of θi(tm) would have a
high probability of responding to a high category. Since we ordered the
quality of life responses from poor to excellent (from low to high) and we
assume a positive correlation between quality of life and the probability of
responding in a high category for all items/questions, then patients in a
high category should have a better quality of life compared to the patients
in a low category.
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Although the numbers of response categories are not the same for all
questions, we still can use the stereotype models to model all items/questions
together. For example, one question in the MOS-HIV questionnaire is
“How has the quality of your life been during the past four weeks: very
bad, pretty bad, good and bad parts about equal, pretty good, very well?”.
This question has five ordinal categories (L = 5). On the other hand, a
question which assesses the physical domain and asks “Does your health
now limit you in bending, lifting or stooping: limited a lot, limited a little,
not limited” has just only three ordinal categories (L = 3). Thus, we can
create two different stereotype models to incorporate into the joint model
by allowing parameters a` and φ` to be different but share the same θi(tm).




P (Yijm = ` | θi(tm))
P (Yijm = 1 | θi(tm))
]
= aL` + φ
L
` bjθi(tm) (3.3)
where L refers to the number of ordered outcome categories for ques-
tion/item j. The assumption in Chapter 2, section 2.5 on page 44 is used
here.
3.2.1.2 The Binary Model
The binary model is appropriate when the response can be divided into
two categories, for example agree or disagree. This is a special case of the
stereotype model with L = 2 and the estimation of (φ1, φ2) = (0, 1). In this
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study, the participants were asked to answer some questions with “Yes”
or “No” responses. Each patient must be in one or the other category and
cannot be in both. For example, we could define yi = 0 if the ith patient
has been unable to do certain kinds or amounts of work because of his/her
health, otherwise yi = 1. When yi = 1, it implies good quality of life.
Once we view yi as a realization of a random variable Yi that can take
the values one and zero with probabilities pii and 1 − pii respectively, the
distribution of Yi can be written as
P (Yi = yi) = pi
yi
i (1− pii)1−yi
where yi = 0, 1.
Subsequently, we can construct a logit model for the qth binary question
at the mth time point as
log
[
P (Yiqm = 1)
1− P (Yiqm = 1)
]
= a∗ + b∗qθi(tm) (3.4)
where
a∗ is an intercept parameter.
b∗q is an item slope coefficient and b∗q > 0.
θi(tm) is a continuous latent random variable for the ith subject at
time tm.
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Exponentiating equation (3.4) we find that the odds for the ith unit are
given by
P (Yiqm = 1)
1− P (Yiqm = 1) = exp(a
∗ + b∗qθi(tm))
Solving for the probability P (Yiqm = 1) gives
P (Yiqm = 1) =
exp(a∗ + b∗qθi(tm))
1 + exp(a∗ + b∗qθi(tm))
Thus, the likelihood of the binary model can be expressed as









1 + exp(a∗ + b∗qθi(tm))
)yiqm ( 1
1 + exp(a∗ + b∗qθi(tm))
)1−yiqm
(3.5)
where Q is the number of binary questions and yiqm denotes the item re-
sponse for the ith subject with the qth item/question at the mth time point.
3.2.2 The Cox Proportional Hazards Model
Let T be a nonnegative random variable associated with the survival time
and assume that a probability distribution of T is described by a probabil-
ity density function f(t). The cumulative distribution function of T is then
given by
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and F (t) represents the probability that the survival time is less than some
value t. The survival function, S(t), is defined by
S(t) = P (T > t) = 1− F (t) (3.7)
This survival function, S(t), denotes a probability that the random vari-
able T exceeds the specified time t. In other words, the survival function
gives the probability that a person survives longer than some specified
time t.
The hazard function, denoted by h(t), specifies the instantaneous rate of








Using the the probability theory P (A|B) = P (AB)
P (B)
, the conditional proba-
bility of the hazard function h(t) is
P (t 6 T < (t+ ∆t))
P (T > t)
and this equal to
F (t+ ∆t)− F (t)
S(t)














is the definition of the derivative of F (t) with re-
spect to t, which is f(t) in equation (3.6). Thus, the relationship between
















H(t) is called the cumulative hazard function and H(t) can also be ob-
tained from the survival function by H(t) = − logS(t).
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In this thesis, the Cox proportional hazards model (Cox, 1972) is used
to model time to diagnose the new CDC-B and we also consider time-
independent covariates such as treatment group assignments and the ini-
tial CD4 count in the survival process.
In a proportional hazard model, it is assumed that the hazard function
for the failure time of the ith individual is of the form
lim
∆t→0
[P(t 6 Ti < (t+ ∆t)∣∣Ti > t,Xi, θ∗i )
∆t
]
= hi(t|Xi, θ∗i )
= h0(t) exp(θ
∗
i δ0 +Xiδ1) (3.9)
where P
(
t 6 Ti < t+ ∆t
∣∣Ti > t) = P (individual fails in the interval [t, t+ ∆t]∣∣
survival up to time t). This is defined as the probability of failure during a
very small time interval, assuming that the individual has survived to the
beginning of the interval, or as the limit of the probability that an indi-
vidual fails in a very short interval t + ∆t, given that the individual has
survived to time t.
The latent variable of quality of life, denoted by θ∗i , is a latent random
variable contributing to each individual’s underlying hazard. A time-
independent covariate (e.g. treatment) is represented by Xi and {δ0, δ1}
are regression coefficients. In general, the model can include more than
one covariate.
The baseline hazard function, denoted by h0(t), can be any shape as a
function of twith the condition h0(t) > 0. This is the nonparametric part of
the model and a linear component, (θ∗i δ0 + Xiδ1), is the parametric part of
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the model. Thus, the Cox proportional hazards model is a semiparametric
model. However, in this chapter we consider a partial likelihood function
that depends only on the parameter of interest. Methods for estimating
the baseline hazard function and the semiparametric model will therefore
be discussed in Chapter 4. The relevant likelihood function for the pro-











Cox (1972) called this equation (3.10) a partial likelihood function. This
likelihood function depends on n observed failure or censored time points
which are ordered and denoted by t(1) ≤ t(2) ≤ . . . ≤ t(n). Then t(i) is
the ith ordered survival time. The set of individuals who are alive and
uncensored at time ti is called the risk set expressed by R(t(i)) and di is an
event indicator. If an individual failed, di = 1 otherwise 0. In this study,
the endpoint is not a fatal illness or death but refers to progression to CDC-
B. Furthermore, in this survival part we also include a latent variable for
quality of life, θ∗i , at a failure time point which corresponds to time to CDC-
B progression. There are K distinct times at which failures are observed
and denoted by w1 < . . . < wk < . . . < wK where wk ∈ {t(1), t(2), . . . , t(n)}.
This means all observations have their own latent variables as quality of
life scores (θi) for each follow-up time point and we only calculate θ∗i for
patients who present with a diagnosis of the CDC-B event. Therefore, the
latent variables at this stage are treated as time-dependent covariates since
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these values change over time. All these values are determined by linear
interpolation between two known θ points. As an example, if individual
i failed at time wk, then we need to calculate θ∗i at time wk denoted by
θ∗i (wk). Since we know that tm < wk < tm′ where tm and tm′ correspond
to θi(tm) and θi(tm′) respectively, then the estimate of θ∗i (wk), the value
corresponding to wk, is given by linear interpolation as
θ∗i (wk) = θi(tm) +
wk − tm
tm′ − tm (θi(tm
′)− θi(tm))
3.2.3 The Regression Model
Wang et al. (2002) demonstrated the regression process to incorporate the
latent random variable into the joint model. We also used the same format
as Wang et al. (2002) to generate a latent variable for each individual to link
the quality of life and survival time together. The vector of latent variables
is viewed as a random vector, denoted by θi = (θi(t1), . . . , θi(tM))′. We as-
sume that θi ∼ MVN (µ(θi),Σ(ρ)) has a multivariate normal distribution,
where µ(θi) and Σ(ρ) are referred to as mean vector and covariance matrix
of θi, respectively and both of them are functions of time.
The regression part can be accommodated in the joint likelihood func-
tion by
Φ (θ;µ(θi),Σ (ρ)) (3.11)
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where Φ is the multivariate normal density function. We consider two
treatment methods (continuous and CD4-guided) as a covariate denoted
by X = 1 for continuous treatment and X = 0 for CD4-guided treat-
ment. The term µ(θi(tm)) = β0(tm) + β1(tm)Xi is referred to as the mean
of quality of life for each treatment group at time tm where β0(tm) and
β1(tm) denote the intercept and the coefficient of Xi at time tm respec-
tively and µ(θi) = (µ(θi(t1)), . . . , µ(θi(tM))). The regression coefficients
β1 = (β1(t1), . . . , β1(tM))
′ measure how treatment affects the quality of
life. The elements of Σ (ρ) follow a simple form of covariance parameteri-
zation as
cov(θtm , θtm′ ) = σ
2ρ|tm−tm′ |
where in this study we set the variance of θ, σ2, at all time point to be 1
similar to Wang et al. (2002). Then the covariance structure becomes
cov(θtm , θtm′ ) = ρ
|tm−tm′ |
where 0 6 m 6 6 denotes the time point which are in units of weeks. This
covariance structure is appropriate since the correlation between θ at dif-
ferent time points decreases as the time interval increases. As mentioned
above, quality of life data have been collected every 24 weeks beginning
at the baseline visit and at week 24, 48, 72, 96, 120, 144 respectively. Thus,
{t0, t1, t2, t3, t4, t5, t6} = {0, 24, 48, 72, 96, 120, 144} and we rescale by divid-
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ing all time points by 24 so {t0, t1, t2, t3, t4, t5, t6} becomes {0, 1, 2, 3, 4, 5, 6}.
3.2.4 The Full Likelihood Function
The joint likelihood function is obtained from combining the item response
part, the regression part and the survival part as follows :
L(a, b, φ,a∗, b∗, β,ρ, δ, θ) = LJ(a,b,φ|θ)LQ(a∗, b∗ |θ)Φ (θ;µ(θ),Σ (ρ))L(δ|θ) (3.12)
where the stereotype likelihoodLJ(a, b,φ|θ), the binary likelihoodLQ(a∗, b∗ |θ)
and the survival partial likelihood L(δ|θ) are defined in (3.2), (3.5), (3.10)
respectively and Φ (θ;µ(θ),Σ (ρ)) is the multivariate normal density func-
tion of the latent variable θ.
When questions in a questionnaire contain a different number of or-
dinal responses, we can use separate parameters in the stereotype model.
For example, suppose some questions have L1 levels and the others have
L2 levels. All of them are included in the joint model and the full likeli-
hood function from equation (3.12) can be written as
LJ(aL1 , aL2 , bL1 , bL2 ,φL1 ,φL2 |θ)LQ(a∗, b∗ |θ)Φ (θ;µ(θ),Σ (ρ))L(δ|θ) (3.13)
For simplicity, we only use notationsa, b andφ instead ofaL1 , aL2 , bL1 , bL2 ,φL1 ,φL2
in the later sections.
The joint model is represented graphically in Figure 3.1
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θi(tm)
i=1, . . . ,n
tm













j=1, . . . ,J
φ
`=1, . . . ,L
Figure 3.1: The joint model. If Yijm is binary, then φ = 1, a = a∗ and b = b∗.
J is number of items, K is number of distinct failure time points, M is
number of follow-up time points and n is number of individuals.
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3.3 Parameter Estimation
We can estimate all parameters in the item response models and survival
model simultaneously based on the joint likelihood function but this joint
model is highly complicated due to unobservable latent variables, censor-
ing and the nonlinear structures of the models. Therefore, we consider
a Markov Chain Monte Carlo algorithm by drawing values of parame-
ters from the joint posterior distribution. We use the Metropolis-Hastings
Algorithm (Metropolis et al., 1953) to estimate model parameters simulta-
neously.
The idea of the Metropolis-Hastings Algorithm is that we generate val-
ues from a proposal distribution, denoted by q(·|·), and we need to apply
criteria to determine whether to accept or reject the simulated values. The
criterion is calculated from ratios of the product of proposal and posterior
densities. This criterion is commonly referred to as the acceptance prob-
ability. We used flat prior distributions on all parameters to reflect lack
of prior information. The posterior density function is then proportional
to the joint likelihood function (3.12). Using the flat prior can lead to an
improper posterior distribution which can make the inference difficulty. It
is advisable to investigate the different prior.
Due to conditional independence relationships among the parameters,
the joint posterior can be written as a product of several distributions
which allows us to divide the parameter vector into blocks.
Suppose we have a parameter vector Θ that contains all parameters of
3.3. PARAMETER ESTIMATION 69
the likelihood function (3.12). We divided Θ intoK blocks, Θ = {Θ1,Θ2, . . . ,ΘK}
with the posterior of interest P (Θk|·). We then update all blocks one by one
when the other blocks remain fixed and are not affected.
The Metropolis-Hastings Algorithm for a single selected parameter vec-
tor iterates the following steps :
1. Select an arbitrary initial value for all Θ(0).
2. For each k in turn, sample Θnewk from the proposal distribution, q(Θ
new
k |Θcurk ),
which depends on the current state.
3. Calculate an acceptance probability as
r =
q(Θcurk |Θnewk )P (Θnewk |·)
q(Θnewk |Θcurk )P (Θcurk |·)
where P (Θnewk |·) is part of the posterior density function depending
on block Θk.
4. Sample a value u from the Uniform(0,1) distribution.
5. Accept the new value Θnewk as Θ
(t)
k if u ≤ min(1, r). Otherwise Θ(t)k =
Θcurk and the move is not allowed.
6. Change the iteration from t to t+ 1 and return to step 2 until conver-
gence to the posterior distribution is reached.
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The Estimation Procedure
The set of parameters that we need to estimate is {a, b,φ, a∗, b∗ ,β0,β1, ρ, δ, θ}
and we set a uniform prior for all parameters, P(·) ∝ 1.
At the tth iteration :
1. Updating parameters in the regression model.
1.1. Updating ρ. First, we generate ρ for creating covariance matrix,
Σ. The posterior distribution of ρ, P (ρ|·), is









(θi −µ(θi))′ (Σ(ρ))−1 (θi −µ(θi))
)
Given the current value, ρcur, propose a new value, ρnew, by tak-
ing a random draw from the truncated normal distribution with
truncated to the interval (0, 1), ρnew ∼ N(ρcur, σ2ρ) where σ2ρ = 1.
The proposed value, ρnew, is accepted with probability equal to









where Φ is the cumulative distribution function of the normal
distribution. If the proposed value is not accepted, then ρ(t)
equal to ρcur.
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1.2. Creating covariance matrix
∑
by using ρ from the previous
step. We have seven time points: 0 6 m 6 6, {t0, t1, t2, t3, t4, t5, t6} =
{0, 1, 2, 3, 4, 5, 6} which refer to quality of life data collection at




1 cov(θt0 , θt1) · · · cov(θt0 , θt6)
cov(θt1 , θt0) 1 · · · cov(θt1 , θt6)
...
... . . .
...
cov(θt6 , θt0) cov(θt6 , θt1) · · · 1

1.3. Updating β . There are two beta vectors to estimate and each
beta vector has seven time points. Then, we estimate each beta
one at a time.
β0 = {β01, β02, β03, β04, β05, β06, β07} and
β1 = {β11, β12, β13, β14, β15, β16, β17}
Thus, the posterior distribution of β , P (β |·), is
P
(






(θi −µ(θi))′ (Σ(ρ))−1 (θi −µ(θi))
)
where µ(θi) = β0 + β1X . For m = 1, . . . ,M , given the cur-
rent value, βcur0m , propose a new value, βnew0m , by taking a random
draw from the univariate normal distribution, βnew0m ∼ N(βcur0m , σ2β0m)
where σ2β0m = 1. The proposed value, β
new
0m , is accepted with
probability equal to the minimum of 1 and the ratio
r =
q(βcur0m |βnew0m )P (βnew0m |·)
q(βnew0m |βcur0m )P (βcur0m |·)
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q(βnew0m |βcur0m ) is 1, r is effectively just the likelihood ratio. If
the proposed value is not accepted, then β(t)0m equal to βcur0m . Up-
dating β1m can be done using the same procedure as updating
β0m.
2. Generating missing values.
Any missing item responses for the ith individual can be gener-
ated according to the response probabilities derived under the cur-
rent parameters of the stereotype model and the binary model. If the
response is ordinal, we generate such missing values from the stereo-
type model (3.1). Otherwise if the response is binary, we generate it
from the binary model (3.4). The missing values are filled in with
random draws from a multinomial distribution with the probability
equal to P (Yijm = `|current parameters). There are about 20 out of
354 patients with at least one question missing at the first time point.
This number increases in the succeeding follow-up time points up to
152 patients at the last time point.
3. Updating parameters in the stereotype model.
At this stage, a, b and φ are updated. The likelihood function of
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k=2 exp(ak + φkbjθi(tm))
)yijm`
where a1 = 0, bj > 0 and we set φ1 = 0 and φL = 1 to make the model
identifiable.
3.1. For updating φ, we reparameterize the parameters in terms of




γs for ` = 2, . . . , L − 1. If 0 = φ0 < φ1 < . . . < φL = 1
are L order statistics from the uniform distribution U(0, 1), then
{γs}, s = 1, . . . , L− 1, follows a Dirichlet(α1, . . . , αL−1) distribu-
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Given the current value, γ cur, propose a new value, γnew, by ran-
domly selecting one of {γs}, s ∼ U(2, L − 1), and taking a ran-
dom draw from the uniform distribution1, γnew′s ∼ U(0, γs−1 +
γs). Then, reparameterization all {γnew′s } to add to 1 by
γnew
′
s−1 = (γs−1 + γs)− γnew
′
s
The proposed value, γnew′s , is accepted with probability equal to
the minimum of 1 and the ratio
r =
q(γcurs |γnew′s )P (γnew′s |·)
q(γnew′s |γcurs )P (γcurs |·)
If the proposed value is not accepted, then γ(t)s equal to γcurs .
Next, convert {γs} to {φ`} for updating a and b respectively.














k=2 exp(ak + φkbjθi(tm))
)yijm`
where each a` is updated separately. Given the current value,
acur` , propose a new value, a
new
` , by taking a random draw from
the univariate normal distribution, anew` ∼ N(acur` , σ2a) where
σ2a = 1. The proposed value, anew` , is accepted with probabil-
ity equal to the minimum of 1 and the ratio
1Originally we (incorrectly) drew γnew
′
s ∼ U(max(0, γs − a),min(1, γs + a) and then
reparameterized all {γs} to sum up to 1. The corrected version we propose above prop-
erly accounts for the forward and reverse transition probability q(·|·).
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r =
q(acur` |anew` )P (anew` |·)
q(anew` |acur` )P (acur` |·)

















(anew` − acur` )2)
= 1
If the proposed value is not accepted, then a(t)` equal to a
cur
` .














k=2 exp(ak + φkbjθi(tm))
)yijm`
where each bj is updated separately. Given the current value,
bcurj , propose a new value, bnewj , by taking a random draw from
the normal distribution truncated at 0, bnewj ∼ N(bcurj , σ2b ) where
σ2b = 1 and bj > 0. The proposed value, bnewj , is accepted with
probability equal to the minimum of 1 and the ratio
r =
q(bcurj |bnewj )P (bnewj |·)
q(bnewj |bcurj )P (bcurj |·)






If the proposed value is not accepted, then b(t)j equal to b
cur
j .
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4. Updating parameters in the binary model.
Updating a∗ and b∗ for the binary model. The likelihood function
of a∗ and b∗ is expressed as model (3.5).
4.1. Updating a∗. The posterior distribution of a∗ , P (a∗|·), is









1 + exp(a∗ + b∗qθi(tm))
)yiqm ( 1
1 + exp(a∗ + b∗qθi(tm))
)1−yiqm
Given the current value, a∗cur, propose a new value, a∗new, by
taking a random draw from the univariate normal distribution,
a∗new|a∗cur ∼ N(a∗cur, σ2a∗) where σ2a∗ = 1. The proposed value,























(a∗new − a∗cur)2) = 1
If the proposed value is not accepted, then a∗(t) equal to a∗cur.
4.2. Updating b∗. The posterior distribution of b∗, P (b∗|·), is









1 + exp(a∗ + b∗qθi(tm))
)yiqm ( 1
1 + exp(a∗ + b∗qθi(tm))
)1−yiqm
where each b∗q is updated separately. Given the current value,
b∗curq , propose a new value, b∗newq , by taking a random draw
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from the normal distribution truncated at 0, b∗newq ∼ N(b∗curq , σ2b∗)
where σ2b∗ = 1 and b
∗
q > 0. The proposed value, b∗newq , is accepted
with probability equal to the minimum of 1 and the ratio
r =
q(b∗curq |b∗newq )P (b∗new|·)
q(b∗newq |b∗curq )P (b∗curq |·)






If the proposed value is not accepted, then b∗(t)q equal to b∗curq .
5. Updating parameters in the Cox proportional hazards model.
5.1. Generating latent variables at failure time points . We con-
sider the event that occurs for some objects and denote the K
time points corresponding to time to CDC-B by w1 < . . . < wK
(K failure time points). In this study, there are 26 failure time
points: w1 < . . . < w26. The values at the failure time points θ∗
determined by linear interpolation between two known θ points
as described in the previous section.
5.2. Generating δ = {δ0, δ1} by using θ∗ from previous step and δ is
the regression coefficient based on the partial likelihood func-
tion as shown in model (3.10).
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5.2.1 Updating δ0. The posterior distribution of δ0, P (δ0|·), is









Given the current value, δcur0 , propose a new value, δnew0 , by
taking a random draw from the univariate normal distribu-
tion, δnew0 ∼ N(δcur0 , σ2δ0) where σ2δ0 = 1. The proposed value,
δnew0 , is accepted with probability equal to the minimum of
1 and the ratio
r =
q(δcur0 |δnew0 )P (δnew0 |·)
q(δnew0 |δcur0 )P (δcur0 |·)

















(δnew0 − δcur0 )2)
= 1
If the proposed value is not accepted, then δ(t)0 equal to δcur0 .
5.2.2 Updating δ1. The posterior distribution of δ1, P (δ1|·), is









Given the current value, δcur1 , propose a new value, δnew1 , by
taking a random draw from the univariate normal distribu-
tion, δnew1 ∼ N(δcur1 , σ2δ1) where σ2δ1 = 1. The proposed value,
δnew1 , is accepted with probability equal to the minimum of
1 and the ratio
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r =
q(δcur1 |δnew1 )P (δnew1 |·)
q(δnew1 |δcur1 )P (δcur1 |·)

















(δnew1 − δcur1 )2)
= 1
If the proposed value is not accepted, then δ(t)1 equal to δcur1 .
6. Updating the latent variable.
Updating the latent variable, θ, for each individual. For the ith
individual from all parameters of the model, the posterior distribu-
tion of θi is proportional to the joint likelihood function (3.12).
P (θ|a, b, φ,a∗, b∗, β,ρ, δ) ∝ L(a, b, φ,a∗, b∗, β,ρ, δ, θ)
The initial value of θ(0) is obtained as follows: the baseline values,
θ
(0)
i1 , are obtained by converting the rank of the sum of baseline item
responses to quantiles of the standard normal distribution (Duncan








Then we generate the values of θ(0) for the other time points from a
multivariate normal distribution with mean equal to baseline values,
θ
(0)
i1 , and covariance equal to Σ(ρ
(0)).
80 CHAPTER 3. A BAYESIAN JOINT MODEL
At the tth iteration, given the current value, θcur, propose new values,
θnew, by taking a random draw from the multivariate normal distri-
bution, q(θnew ∼ MVN(θcur,Σ(ρ)). The proposed values, θnew, are















If the proposed values are not accepted, then θ(t) equal to θcur.
After updating all parameters from step 1 to step 6 has finished, change
the iteration from t to t+ 1 and repeat all six steps until convergence to the
target distribution is reached.
3.4 Convergence Diagnostics
After the joint models have reached the stationary distribution, samples
from the conditional distribution are used to determine the posterior dis-
tribution of parameters of interest. The questions are how long should the
burn-in period be and how many iterations do we need to run the chains
after burn-in. The iterations in the burn-in period should be discarded
since they are not part of the posterior distribution. Thus, the inference
is based on values that come from the posterior distribution. One way to
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observe is to see how well the chain is mixing or moving around the pa-
rameter space. Since the stationary distribution will always be unknown
in practice, convergence diagnostics of the chains are needed.
A convergence diagnostic procedure is a method for assessing how
long a Markov chain needs to run in order to obtain good estimates of
parameters. Although there are several approaches in the literature to
diagnose the convergence, throughout this thesis we assessed the conver-
gence by visual inspection using trace plot and density plot. Also, we used
two statistic diagnostic tests, Gelman and Rubin’s multiple sequence diag-
nostic (Gelman and Rubin, 1992) and Heidelberger and Welch diagnostic
(Heidelberger and Welch, 1983).
3.4.1 Visual Inspection
We used graphical diagnostics, trace and density plots, to assess conver-
gence. These two approaches are included in CODA (Convergence Di-
agnosis and Output Analysis) software (Best et al., 1996; Plummer et al.,
2006). CODA is available in R and also there are more formal diagnostic
tests that can be implemented using this package. Gilks et al. (1996) sug-
gested that visual inspection of the Monte-Carlo output-plots is the most
obvious and commonly used method for determining burn-in.
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3.4.1.1 Trace plot
A trace plot is a plot of the iteration number versus the value of the draw
of the parameter at each iteration. This plot can be very useful in assess-
ing convergence since it can show whether the chain has converged to its
stationary distribution or the chain is mixing well. If the chain remains
stable for a long period of time, this means there is a visual indication of
convergence.
3.4.1.2 Density plot
A density plot shows a smoothed probability density curve of the draws
or the distribution of the parameters. This plot gives an indication of the
mean and spread of the values obtain from the sampler. A classic sign
of non-convergence for most applications is multimodality of the density
estimate.
3.4.2 Statistical Diagnostic Tests
Although visual inspection is a commonly used method, there is a general
problem with the trace plot. If the chain remains attracted to a nonopti-
mal mode for a long period of time, there is no visual indication that this
area is not the desired highest density region (Gill, 2008). Therefore, as-
sessing convergence should be supported by more advanced techniques.
In this section, we consider two statistical approaches to diagnose the con-
vergence.
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3.4.2.1 Gelman and Rubin’s Multiple Sequence Diagnostic
The Gelman and Rubin approach (Gelman and Rubin, 1992) is based on
comparing two or more parallel chains drawn from different starting points
and checking that they are indistinguishable. Their method was illus-
trated by a comparison of the within and between chain variances for
each parameter. Approximate convergence is diagnosed when the vari-
ance within each chain should be the same or no less than the variance
between the different chains.
Suppose we have m parallel chains each of length n of each parameter
Θ. The values are denoted by Θij where i = 1, . . . ,m and j = 1, . . . , n.
The statistic for each parameter of interest (Θ) is based on the following
procedure :
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(m), . . . Θ
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2. Discard the first n draws in each chain.
3. Calculate the within-chain and between-chain variance.
























Θ¯i, Θ¯ is the grand mean (the mean of means
since each subchain is of equal length)
4. Calculate the estimated variance of the parameter as a weighted sum
of the within-chain and between-chain variance.







This estimate of the variance is unbiased for stationary distributions
if the starting points of the chain were actually drawn from the target
distribution.





The values of Rˆ near 1 mean the m chains are all operating on the
same distribution but in practice values less than roughly 1.1 or 1.2
are acceptable (Gelman, 1996). If Rˆ is high, then longer chains are
needed in order to achieve convergence.
The idea of this test is that before reaching convergence, the variance
within-chain (W ) underestimates total posterior variation in Θ because
the chains have not fully explored the target distribution. On the other
hand, V̂ ar(Θ) overestimates total posterior variance because the starting
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points are overdispered relative to the target. Once convergence has been
reached,this means that the parallel Markov chains are essentially over-
lapping.
3.4.2.2 Heidelberger and Welch Diagnostic
The Heidelberger and Welch method (Heidelberger and Welch, 1983) cal-
culates a test statistic based on Brownian bridge theory and uses the Cramer-
von-Mises test statistic to accept and reject the null hypothesis that the
Markov chain is from a stationary distribution. The diagnostic consists of
two parts: a stationarity test and a halfwidth test. The general form for
steps of the stationary test are then as follows:
1. Generating a chain of N iterations and specify an accuracy () and
an alpha level of the test (α).
2. Using the first 10% of chain values calculate the test statistic on these
samples and observe whether it indicates a tail value.
3. If the null hypothesis is rejected, the first 10% of the iterations are
discarded and the test is run again.
4. If the null hypothesis is again rejected, a further 10% of iterations are
discarded.
5. This process continues until either 50% of the data have been dis-
missed or the null hypothesis is accepted with the remaining itera-
tions. Otherwise, a longer run length is needed.
86 CHAPTER 3. A BAYESIAN JOINT MODEL
If the stationary test is passed, then the halfwidth analysis part of the
diagnostic is performed. The proportion of the data which passed the sta-
tionary test is used to calculate the halfwidth of the (1 − α)% credible in-
terval around the sample mean. If the halfwidth is less than the rough
estimate of the accuracy, , then the chain is considered to be converged.
Otherwise, a longer chain is required.
3.5 Bayesian Model Comparison
In this section, we consider the Bayesian Information Criterion (BIC) and
the Deviance Information Criterion (DIC) in order to make comparisons
among different models to find the best fitting model to the data.
3.5.1 The Bayesian Information Criterion (BIC)
Kass and Raftery (1995) suggest using the Bayesian Information Criterion
(BIC) as an estimate of the Bayes Factor (Kass and Raftery, 1995) for two
competing models. The BIC is defined as
BIC = −2`(Θˆ|x) + plog(N)
where `(Θˆ|x) is the maximized log likelihood value, p is the number of pa-
rameters in the model and N is the number of observation. This criterion
consists of two terms, the first one is twice negative value of the maxi-
mized log likelihood function and the second one depends on the number
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of parameters and the sample sizeN . The idea of BIC is to select one model
from all of the competing models that have the minimum BIC value. This
means the model with the lowest value of BIC is chosen as the best model.
3.5.2 The Deviance Information Criterion (DIC)
The Deviance Information Criterion (DIC) was described by Spiegelhalter
et al. (2002). There are two objectives for DIC: describing model fit and
model complexity as in the BIC.
The first quantity to define before considering the DIC is the Bayesian
deviance (Spiegelhalter et al., 2002). Suppose p(y|Θ) is the likelihood of a
model that we consider, y is the observed data and Θ is a vector of param-
eters. The Bayesian deviance is given by
D(Θ) = −2log[p(y|Θ)] + 2log[f(y)] (3.14)
where f(y) is a function of the data and f(y) also serves as a standardizing
factor. Spiegelhalter et al. (2002) suggested using f(y) = 1 (giving zero
contribution in equation (3.14)) since this term must be identical to calcu-
late both models and therefore it can be canceled out and does not need
to be known. As we mentioned above, in order to evaluate the Bayesian
model fit, we can insert a condition on the data y and taking an expectation
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over Θ in equation (3.14) as
D(Θ) = EΘ
[− 2log[p(y|Θ)|y] + 2log[f(y)]] (3.15)
where D(Θ) is called the posterior mean of Bayesian deviance. Subse-
quently, we define Θ˜ as a posterior estimate of Θ and insert into equation
(3.14) shown as
D(Θ˜) = −2log[p(y|Θ˜)] + 2log[f(y)] (3.16)
where D(Θ˜) is called the Bayesian deviance of the posterior mean. Then,
the effective dimension of the model is now defined by :
pD = D(Θ)−D(Θ˜) (3.17)
This pD is used to measure the model complexity for the effective num-




















= EΘ|y [−2log(p(Θ|y)/p(Θ))] + 2log(p(Θ˜|y)/p(Θ˜))
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The DIC is then defined by combining two terms (3.15) and (3.17) together
DIC = D(Θ) + pD = 2D(Θ)−D(Θ˜) (3.18)
Thus, the model that has the lowest DIC will have the highest posterior
probability and such a model should be selected.
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Chapter 4
A Semiparametric Joint Model
4.1 Introduction
The Cox proportional hazards model that we used in the survival part of
the joint model is known as a semiparametric model. Because the base-
line hazard, h0(t), is an unspecified function, this property makes the Cox
model a semiparametric model. The specific form of the model gives the
hazard function as a product of an unspecified baseline hazard, h0(t), and
an exponential expression involving the covariates. Although the baseline
hazard is not specified, it is still possible to estimate the covariate coef-
ficients in the exponential part of the model. As we did in the previous
chapter, we evaluated the effect of the covariates: treatment and quality of
life. The effect estimates were calculated without having to estimate the
baseline hazard function. The Cox model likelihood function without the
baseline hazard is called the partial likelihood function. This characterizes
91
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how the hazard function changes as a function of the covariates. If we also
need to describe how the hazard function changes as a function of survival
time, the baseline hazard function should be included in the model. The
likelihood function is then called the full likelihood function.
However, Cox (1972) stated that the estimated parameters from the
partial likelihood function would be asymptotically equivalent to those
from the full likelihood function. In the previous chapter, it was suffi-
cient to use the partial survival likelihood function since the Bayesian ap-
proach is based on the distribution of parameters. Thus, the partial like-
lihood function will give reliable enough results and we do not need to
worry about whether the wrong parametric form is chosen for the hazard
function (Kleinbaum and Klein, 2005). There are some applied settings in
literature that assumed the baseline hazard, h0(t), as a nuisance parame-
ter since it typically has a very high dimension and is difficult to calcu-
late. For example, Ye et al. (2008) evaluated the effect of the longitudinal
biomarker prostate specific antigen on the recurrence of prostate cancer in
a prostate cancer study. They proposed a penalized joint likelihood ap-
proach to avoid estimation of the baseline hazard function.
The full likelihood function is also widely used in literature such as
Tseng et al. (2005), Hsieh et al. (2006) and Dang et al. (2007). It is based
on all the observed data and it allows the estimation of the baseline haz-
ard function and the exponential expression simultaneously. Therefore,
this chapter demonstrates a semiparametric joint model where the base-
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line hazard function is included in the survival component, by specifying
the baseline hazard as a step function. The stereotype model is represented
in the item response part, while the semiparametric model is used in the
survival part. We present a shared latent variable in the case that it is as-
sumed to be a discrete variable to classify cases to their most likely group.
Each group may differ in patient characteristic or attitudes from the survey
responses. Furthermore, an advantage of using this methodology is that
it can be extended to cluster analysis (Pledger and Arnold, 2011). Since
the latent variable is treated as a discrete variable, the distribution of the
observed item responses is a finite mixture. This idea has been proposed
by Titterington et al. (1985) and a similar idea has also been expressed by
Woodruff and Hanson (1996). The EM algorithm for the finite mixture
can be used to estimate the parameters in such a complicated structure.
That is, the latent variables are estimated via the EM algorithm iteratively
together with other parameters, including the baseline hazard function.
Thus, the joint model in this chapter is a combination of the finite mixture
models and the semiparametric model. The finite mixture models and the
semiparametric model will be discussed in further sections.
4.2 Finite Mixture Models
Finite mixture models have been used in many fields, for instance biol-
ogy, genetics, medicine, economics and engineering. The finite mixture
approach was used to estimate the probability of developing AIDS after
94 CHAPTER 4. A SEMIPARAMETRIC JOINT MODEL
HIV infection and the distribution of the time interval from infection of
HIV to the date of diagnosis with AIDS (Lui et al., 1988; Struthers and
Farewell, 1989). Also, many statistical models involve finite mixture dis-
tribution in some way or other. The basic idea represents the subgroups
within an overall population and we need to allocate observations into
groups of homogeneous characteristic and similar observations. The pa-
rameters of the specified model are different for each subgroup. Finite
mixture models are often used for the purpose of clustering in order to
find a homogeneous group among data (Fru¨hwirth-Schnatter, 2006).
Consider Y as a random vector corresponding to the observed data
and assume that the distribution of Y should be heterogeneous across and
homogeneous within subgroups. As a result, Y has a different probability
distribution in each group. Let Y = (Y1, Y2, . . . , Yn) be independent and
assumed to be from the same parametric family P (Y |θ). In this case, pa-
rameters θ are different across the groups. A discrete variable r is defined
to be a group indicator which takes values in the set {1, 2, . . . , R}. The Y
then follows the distribution P (Y |θr) where θr is the parameter in group
r. The joint density of P (Y, θr) is given by
P (Y, θr) = P (Y |θr)P (θr) = P (Y |θr)pir
where pir represents the proportion or the prior probability that the ob-
servation Yi belongs to group r with corresponding density P (Y |θr). The
proportion pir for each distribution must be non-negative (pir > 0 for r =
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1, . . . , R) and
∑R
r=1 pir = 1.
The finite mixture distribution happens when we can observe only the
random variable Y but it is not possible to record the group indicator r for
each individual with unknown parameters θ. We then immediately have
the marginal density P (Y ) as shown below
P (Y ) =
R∑
r=1
P (Y |θr)pir (4.1)
= P (Y |θ1)pi1 + P (Y |θ2)pi2 + . . .+ P (Y |θR)piR








Estimation in the finite mixture models
Models with too many parameters are easy to lose identifiability. Since
the likelihood function form (4.2) is typically complicated, traditional op-
timization methods do not work. Therefore, the primary approach to esti-
mate the parameters in finite mixture models is the likelihood maximiza-
tion via the EM algorithm (Dempster et al., 1977; McLachlan and Krishnan,
1997).
The EM algorithm is an efficient iterative procedure to compute the
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maximum likelihood estimate in the presence of missing or incomplete
data. Each iteration of the EM Algorithm consists of two processes: an
expectation step (E-step) and a maximization step (M-step). This process
can be applied to the wide range of examples where there is incomplete
information such as truncated distributions, latent variable models and
mixture models.
• The E-step: the missing data are estimated given the observed data
and current estimate of the model parameters, using their expected
values.
• The M-step: the likelihood function is maximized under the assump-
tion that the missing data are known. Estimates of the missing data
from the E-step are used instead of the actual missing data.
Suppose Y is a random vector corresponding to the observed data, Z
is a random vector corresponding to the missing information and Θ is the
set of parameters. Then a complete data set exists (Y ,Z ) and the actual
observed data Y refers to the incomplete data. In this chapter, we assume
a latent variable, θ, to be a discrete variable. The latent variable θ can
take onR known discrete values θr with associated unknown probabilities
pir , r = 1, . . . , R. Thus, the product of the likelihoods for the individuals
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Equation (4.3) is called the incomplete data likelihood function and the
incomplete data log likelihood function is then
log
(

















and pir , r = 1, . . . , R
with
∑R
r=1 pir = 1 (0 < pir < 1). This incomplete data log likelihood is the
likelihood that we need to maximize. However, it does not have a simple
form and it involves the log of a sum, which is inconvenient. Therefore,
we need the EM Algorithm. If the incomplete data likelihood is difficult to
maximize, it will sometimes be the case that the complete data likelihood
is easier to work with.
The complete data likelihood function can be defined as
L(Θ|Y ,Z ) = P (Y ,Z |Θ)
Let Zir be the missing information, Zir = 1 if the ith individual is from
the rth group and 0 otherwise. Thus,
∑
r Zir = 1 for all i. The complete
data log likelihood becomes
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logL(Θ|Y ,Z ) = log [P (Y ,Z |Θ)]
= log
[




























Then, the expectation of the complete data log likelihood over Z, given
the observed data Y and the current estimates Θ(t), becomes
Q(Θ,Θ(t)) = EZ
[
















Yi | θr, β









P (Yi | θr, β)
)]












P (Zir = 1|Yi , Θ(t))log
(
P (Yi | θr, β)
)
(4.6)
The Expectation Step (E-step)
In the E-step we use the current parameter estimates Θ(t) to find the ex-
pected values of Zir. The expected value of Zir, a Bernoulli variable, is the
posterior probability of success for individual i being in group r given the
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= P (Zir = 1|Yi , Θ(t))
=
P (Yi|Zir = 1 , Θ(t))P (Zir = 1|Θ(t))∑R












Yi | θ(t)g , β(t)
) (4.7)
At the E-step of the tth iteration, the posterior probabilities (Ẑir) are calcu-
lated.
The Maximization Step (M-step)
We maximize equation (4.6) with respect to pir and Θ = (θ, β). Since they
are not related, the M-step estimates can be calculated in two parts. The
estimates of pir are easy to compute but the computation of the estimates
of Θ will typically require iterative numerical methods.
1. To find the estimates of pir, we use the Langrange multiplier ψ with
the constraint that
∑R



















P (Zir = 1|Yi , Θ(t)) + ψ = 0 (4.8)












i=1 P (Zir = 1|Yi , Θ(t))
n
= pi∗r

















∴ ψ = −n


















2. Similarly, to find the estimate of Θ in the second part of equation
(4.6), the derivative of the second term can be taken with respect to
Θ = (θ, β). The result is set to zero and solved for Θ.
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Since this part may not necessarily be of closed form, the computation of
the estimate of Θ means the complete data log likelihood of equation (4.5)
needs numerical maximization. Iteration between two steps (the E-step
and the M-step) is required until we reach convergence. This means the E-
and M-steps are alternated repeatedly until the absolute relative difference
between two consecutive iterations is close to zero. That is,
∣∣L(Θ(t+1)|Y ,Z )− L(Θ(t)|Y ,Z )∣∣∣∣L(Θ(t)|Y ,Z )∣∣ ≈ 0
Finally, each observation is assigned to the group having the highest pos-
terior probability that the observation originated from this group.
4.3 Semiparametric Model
In the survival part, we consider the Cox proportional hazards model.
This model is widely used, even though the baseline hazard function is
not specified. The parametric survival model is also available when a spe-
cific probability distribution is assumed for the survival times. We would
prefer to use the parametric model if we were sure of the correct model,
otherwise the Cox model will give reliable enough results (Kleinbaum and
Klein, 2005). Comparison of the parametric survival models and the Cox
model has been investigated in this thesis by using Wald test and stan-
dardized measures of variability (Nardi and Schemper, 2003) for the sur-
vival data only ignoring the ordinal responses. We found that the para-
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metric survival models perform more poorly than the Cox model. There-
fore, we prefer to use the Cox model to model the survival data in the joint
model.
The Cox model is referred to as the semiparametric model because,
while the baseline hazard function can take any form of probability distri-
bution, the covariates enter the model linearly. In other words, the hazard
function is the product of an unspecified baseline hazard and a parametric
function of the covariates. The Cox proportional hazards model is given
by
h(t|X,δ) = h0(t) exp(X ′δ) (4.9)
where h0(t) is a baseline hazard function, δ is an unknown parameter vec-
tor and X is a covariate vector. The baseline hazard function h0(t) can be
interpreted as the hazard when all covariate values are zero. According to
its semiparametric structure, the baseline hazard function is not specified
and the likelihood function of the Cox proportional hazards model does
not depend only on δ but also on h0(t). However, the baseline hazard h0(t)
is not as easily calculated because it depends on time. We now consider
how to estimate the baseline hazard, h0(t), which drops out of the par-
tial likelihood. Under the Cox proportional hazards model, the baseline
hazard function takes the form of a nonparametric maximum likelihood
estimate which is a discrete function. This finding has been shown by
Kalbfleisch and Prentice (2002). It has been supported by the work of Nel-
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son (1972) and Kaplan and Meier (1958). The nonparametric maximum
likelihood estimate of the baseline hazard h0(t) is also defined in Kiefer
and Wolfowitz (1956) which has discrete masses at each failure time.
The survival function for a model with hazard function (4.9) can be de-
fined as
S(t|X,δ) = exp(−H(t|X,δ)) (4.10)
where H(t|X,δ) is the cumulative hazard function at time t for an individ-















= exp(X ′δ)H0(t) or
= H0(t)e
X ′δ (4.11)
whereH0(t) is the cumulative baseline hazard function. Substituting equa-
tion (4.11) into (4.10), we then have the survival function for the general
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semiparametric hazard function as
S(t|X,δ) = exp(−H0(t)eX ′δ) (4.12)
The density function is obtained by multiplying the survivor function
and the hazard function. We denote the density function corresponding to
f(t|X,δ) which gives the probability of an individual failed at time t.
f(t|X,δ) = h(t|X,δ)× S(t|X,δ) (4.13)
The value of f(t|X,δ) is for a non-censored observation. If an individual
is still alive at time t, the probability of this event is S(t|X,δ). The value of
S(t|X,δ) is then for a censored observation. Consequently, these two func-







]di × [S(ti|X i, δ)]1−di (4.14)
where di = 0(censored) or 1(failed). Since f(t|X,δ) = h(t|X,δ)× S(t|X,δ)






]di × [S(ti|X i, δ)] (4.15)
Substituting (4.9) and (4.12) into (4.15), the full likelihood function includ-
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]di[ exp(−H0(ti)eX ′iδ)]} (4.16)
where
h0(t) is a positive-valued baseline hazard function.
H0(t) is a baseline cumulative hazard function.
di is an indicator of an individual i , di = 1 if we observe failure time,
otherwise di = 0.
Here we present the method of nonparametric maximum likelihood (NPMLE)
described in (Kalbfleisch and Prentice, 2002, section 4.3) and also in (Vaart,




λiδ(t − ti) where δ(·) is the Dirac delta function (see, for ex-
ample Arfken, 1985, p.481). Suppose ti are arranged in increasing order
t1 < t2 < . . . < tn and the hazard is zero between adjacent times. The
corresponding cumulative hazard function H0(ti) =
∑
p≤i
λp will be a step
function with jumps at the failure time ti.
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Hence, to estimate the baseline hazard λi, the log likelihood function (4.18)
has to be maximized with respect to λi and holding δ fixed. By differenti-
























We will use this idea to calculate the baseline hazard function in the
joint model in the next section.
4.4 Model Structure
The semiparametric joint model is composed of the item response model
and the survival model which is connected by a discrete latent random
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variable. The stereotype model is used to model the measure of quality
of life while the survival model is used to model time to diagnose the
new CDC-B. Additionally, in this thesis the idea of finite mixture models
has been used to create the semiparametric joint model. The literature on
joint models (for example, Song et al. (2002)) proposed a semiparametric
likelihood approach to joint between longitudinal and time-to-event data
using the EM algorithm for implementation. Another perspective from
McLachlan and McGiffin (1994) illustrated the use of finite mixture models
in survival analysis to investigate the distribution of time to re-operation
for the degeneration of xenograft values implanted in the aortic position of
patients. In this study, the EM algorithm was used to estimate the baseline
survival function.
4.4.1 The Stereotype Model
Since the response structure of the questionnaire is ordered, the stereotype
model is created to take into account the semiparametric joint model with
the discrete latent variable using the structure of finite mixture models
when we construct the likelihood function.
We consider J item responses, Y1, Y2, . . . , YJ , which are designed to
measure the quality of life with M protocol-specified time points for qual-
ity of life data collection, t1, t2, . . . , tM , and each of Y ′s can be written in the
form of ordered categorical set {1, 2, . . . , L}. The direction of ordering can
be recorded from poor to excellent. Subsequently, the stereotype model is
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used to model the probabilities of responding on level `, ` = 1, 2, . . . , L for
each of the quality of life items and in this study the first category, ` = 1,
is treated as the baseline category. Therefore, Yijm is used to denote the jth
item response of the ith subject at the mth time point, Yijm = 1, 2, . . . , L for
i = 1, 2, . . . , n, j = 1, 2, . . . , J and m = 1, 2, . . . ,M . The stereotype model
with the discrete latent variable can be illustrated as
log
[
P (Yijm = ` | θr)
P (Yijm = 1 | θr)
]
= a` + φ`(bj + θr) (4.20)
where
a` is an item intercept parameter and we set a1 = 0.
bj is an item slope coefficient and set b1 = 0.
φ` is a score for the outcome level and we consider the ordered stereo-
type model, 0 = φ1 ≤ φ2 ≤ . . . ≤ φL = 1.
θr is defined to be a discrete latent random variable or it can be re-
ferred to as an average of quality of life score of patients in group r
and set θ1 = 0.
Next, we will construct the likelihood function from the model (4.20) by
using the finite mixture idea to further contribute into the joint likelihood
function.
Let Y i = {(yi111, . . . , yi11L), . . . , (yijm1, . . . , yijmL), . . . , (yiJMi1, . . . , yiJMiL)},
then Y = (Y ′1, . . . ,Y ′n)′ be a random vector corresponding to the ob-
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served data of L ordered response categories for i = 1, 2, . . . , n in-
dividuals, j = 1, 2, . . . , J item responses and m = 1, 2, . . . ,Mi time
points. Note that Mi is the number of observed time points for indi-
vidual i.
Θ be all the parameters of the model.





















exp(a` + φ`(bj + θr))
1 +
∑L
k=2 exp(ak + φk(bj + θr))
)yijm`
(4.22)
and α = (a, b,φ). The yijm` represents the binary outcome (“Yes” and
“No”) on the response category ` for the ith subject, jth item and mth time
point. Each follow-up time point may have a different number of observa-
tions because some patient responses are missing. The latent variable θr in
this stereotype model contains all information of quality of life measure-
ment averaged over the visit time.















exp(a` + φ`(bj + θr))
1 +
∑L
k=2 exp(ak + φk(bj + θr))
)yijm`)
(4.23)
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with the parameters Θ = (α,θ) and pi where
∑R
r=1 pir = 1. Then the incom-










Y i | θr,α
))
(4.24)
This incomplete data log likelihood is the likelihood that we need to
maximize.
4.4.2 The Semiparametric Proportional Hazards Model
We consider the semiparametric proportional hazards model for the sur-
vival part in the joint model. In this approach the baseline hazard function,
h0(t), needs to be estimated.
Let X be the time-independent covariate which is the treatment in this
study.
θr be a latent discrete random variable which contains the effects of
group r on the hazard.
δ be all the parameters of the survival model.
In a proportional hazards model, it is assumed that the hazard function
for the failure time of the ith individual is of the form
lim
∆t→0




= h0(t) exp(θrδ0 +Xiδ1) (4.25)
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where P
(
t 6 Ti < t + ∆t
∣∣Ti > t) = P (individual fails in the interval [t, t +
∆t]
∣∣ survival up to time t). This is defined as the probability of failure dur-
ing a very small time interval, assuming that the individual has survived
to the beginning of the interval, or as the limit of probability that an indi-
vidual fails in a very short interval t + ∆t, given that the individual has
survived to time t.
































where h0(t) is a positive-valued baseline hazard function.
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This probability distribution is composed of parametric and nonparamet-
ric components. In our example, the Xi is the treatment (Continuation
anti-retroviral treatment, or CD4-guided interruption treatment). In gen-
eral, the model can have more than one covariate. The parameters in the
model include λi, δ0 and δ1. The λi is a nuisance parameter which is treated
nonparametrically (Begun et al., 1983). The parametric part is the expo-
nential function of the unknown regression coefficient (δ0 and δ1).
4.4.3 The Full Likelihood Function
The joint likelihood function is obtained from combining item response
part and survival part together as follows :
Let P
(
Y i | θr,α
)














exp(a` + φ`(bj + θr))
1 +
∑L





Ti, Di |λi, θr, δ
)














pir be the unknown probabilities, r = 1, . . . , R
Θ be all the unknown parameters of the model.
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The incomplete data likelihood function is the product of the likelihoods
for the individuals
















and the incomplete data log likelihood function is then
log
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Let Zir be the missing information, Zir = 1 if the ith individual was from
the rth group and 0 otherwise. The complete data log likelihood becomes
log
(
L(Θ|Y ,T ,D,Z )) = log [P (Y ,T ,D,Z |Θ)]
= log
[




































































Ti, Di |λi, θr, δ
)
are defined in equation (4.28)
and (4.29) respectively.
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4.5 Parameter Estimation
The incomplete data log likelihood (4.30) is the likelihood that we need to
maximize. However, it does not have a simple form and it involves the
log of summation, which is inconvenient. It may be also impossible to di-
rectly maximize this log likelihood in the semiparametric setting due to the
nonparametric component. If the incomplete data likelihood is difficult to
work with, it will sometimes be the case that the complete data likelihood
(4.31) can be easier. The EM Algorithm can be employed readily to esti-
mate the parameters in the joint model. Similar to equation (4.6), given
the observed data Y ,T ,D and the current estimates Θ(t), the expectation
of the complete data log likelihood is
Q(Θ,Θ(t)) = EZ
[
logP (Y ,T ,D,Z |Θ)
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P (Ti, Di |λi, θr, δ)
)]
× P (Zir = 1|Y i, Ti, Di, Θ(t))












P (Zir = 1|Y i, Ti, Di, Θ(t))log
(







P (Zir = 1|Y i, Ti, Di, Θ(t))log
(
P (Ti, Di |λi, θr, δ)
)
(4.32)
4.5.1 Baseline Hazard Estimation
Before starting the EM-step, we first consider the third part of the equation
(4.32) which is the survival part. This part is composed of the baseline



















As can be seen, this component has the baseline hazard λi and the update
of the hazard at the failure time for the ith individual depends on (θ, δ).
Thus, we need to determine the profile likelihood function using the same
idea that we used to obtain the result in (4.19) in the previous section.
That is, the log likelihood (4.33) has to be maximized with respect to λi
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r=1 P (Zpr = 1|Y p, Tp, Dp,Θ(t)) exp(θrδ0 +Xpδ1)
(4.34)
This λ̂i will be used in the E-step and the M-step.
The expectation of the complete data log likelihood will be calculated
in the E-step. The M-step consists of two parts since we maximize equa-
tion (4.32) with respect to pir and Θ = (θ,α, δ). Due to the fact that there
is no relationship between pir and Θ, the M-step estimates can be calcu-
lated separately. The estimates of pir are easy to compute but the computa-
tion of estimates of parameters Θ will typically require iterative numerical
methods. The E and M steps will be iteratively estimated together with
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the baseline hazard function which is replaced by its nonparametric max-
imum likelihood.
4.5.2 The E-step
In the E-step, we use the current parameter estimates Θ(t) to find the ex-
pected values of Zir of the complete data log likelihood. The expected
values of a Bernoulli distribution are the probability of success for indi-
vidual i being in group r given the observed data. Therefore, using Bayes’
rule, we can compute
E
[
Zir|Y i, Ti, Di, Θ(t)
]
= P (Zir = 1|Y i, Ti, Di, Θ(t))
=
P (Y i|Zir = 1, Θ(t))P (Ti, Di|Zir = 1, Θ(t))P (Zir = 1|Θ(t))∑R




















Ti, Di |λi, θ(t)g , δ(t)
)
Thus, the posterior class membership probabilities for the ith individ-
ual are defined by
P
(





















Ti, Di |λi, θ(t)g , δ(t)
)
(4.35)
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4.5.3 The M-step
In the M-step, we maximize equation (4.32) with respect to pir and Θ =
(θ,α, δ)












P (Zir = 1|Y i, Ti, Di, Θ(t))
2. The second and third parts of equation (4.32) are then numerically
maximized with respect to Θ = (θ,α, δ). The former is the item
response part and the latter is the survival part. Throughout this
process, the stereotype likelihood function needs to be optimized it-
eratively. Because of the complicating factor of being multiplicative
in parameters and the difficulty in fitting ordering constraints on the
scores {φ`}, an alternating algorithm (Greenland, 1994) is used to es-
timate the parameters in the model. That is, {φ`} and (bj + θr) are
alternately held fixed while the other is estimated. The update of pa-
rameters in the full likelihood survival function is also difficult be-
cause λi is non parametric. However, we use the two-step iterative
method to estimate all parameters in both models simultaneously.
The proposed iterative methods to maximize the likelihood function
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are described as follows:
2.1. Updating all parameters in Θ simultaneously with fixed φ` and
treating λi as a nuisance parameter using ordinary maximum
likelihood approach. In this step, φ` is treated as a known pre-
dictor.
2.2. Treating the estimated Θ from the previous step as fixed ((bj +
θr) being predictor) and φ` is treated as unknown parameter.
Updating φ` also uses the maximum likelihood estimation.
2.3. Calculating λi by plug-in the estimated parameters from the
previous steps (2.1. and 2.2.) into equation (4.34).
2.4. Iterating the alternative fixing process until convergence.
The estimated parameters from the M-step are returned into the E-step
until convergence.
The standard errors of the solution Θ̂ obtained from the EM algorithm,
can be estimated based on the observed information matrix. This requires
the Hessian matrix, which can be achieved by taking the second-order par-
tial derivatives of the log likelihood function. For example, with three pa-
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Taking the negative of the Hessian matrix yields the observed informa-
tion matrix and then inverting this matrix produces a matrix containing
the variances of the parameters on its diagonal and the asymptotic covari-
ances of the parameters in the off-diagonal position. The square root of
the diagonal elements is then the standard errors.
However, when estimating the standard error of φˆ`, we encountered
the difficulty that the standard error of φˆ` was not straightforward to cal-
culate. This is because we treated φ` as the ordered constraint and we
used the two-step fitting approach to evaluate the models. This means
while φ` and bj were alternately fixed, in fact φ` was also estimated in
one step of each iteration. Greenland (1994) indicated that this estima-
tion can cause incorrect estimates of the standard errors as it ignores the
sampling variability due to the estimation of the other group of param-
eters. For this reason, he recommended using the bootstrap to estimate
valid standard errors. Holtbrugge and Schumacher (1991) demonstrated
an iterative reweighted least square (IRLS) for actual estimation. Direct
maximization of the likelihood function with a quasi-Newton method was
presented by Kuss (2006) to solve this problem. This approach depends on
the first and second derivatives of the likelihood function that uses finite
difference methods for the first derivatives and the approximated Hessian
matrix is gradually built up as the iteration proceed. Although the three
different methods above give standard errors that are valid in principle,
the inferences from the standard errors are still not recommended when
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the scores, φ`, are estimated (Greenland, 1994).
4.6 Model Comparison
Akaike’s information criterion (AIC) is the most widespread information
criterion which compares all candidate models at once and does not re-
quire nested alternative models (Akaike, 1973). AIC is defined as
AIC = −2 logL(·) + 2k
where L(·) is the likelihood and k is the number of parameters in the
model. The small values represent a better overall fit with all informa-
tion criteria. However, Xu et al. (2006) proposed the associated criterion
of AIC that is the profile Akaike information (pAIC) for models with nui-
sance parameters. They developed an AIC using the profile likelihood
function. Only the parameters of interest are selected for pAIC calcula-
tion. In this study, we use the pAIC for comparing models since we have
nuisance parameter, λ, in the joint model. We will discuss the idea of pAIC
below.
Let our semiparametric joint model be parameterized by Θ andλ, where
Θ is the set of parameters of the stereotype model and the Cox propor-
tional hazards model but the baseline hazard λ is not included. Then
Θ = (a, b, φ, θ, δ) is the parameter of interest and the baseline hazard λ
is the nuisance parameter. The pAIC approach is interested in selecting
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the parameter of interest Θ, while leaving the nuisance parameter λ the
same across all competing models. This idea is similar to Claeskens et al.
(2003). As a result, the semiparametric joint model now is indexed by Θ
alone. Obviously, if Θ and λ have a finite dimension p and q respectively,
the AIC for (Θ,λ) is −2 logL(·) + 2(p+ q). On the contrary, the pAIC for Θ
is −2 logL(·) + 2p.
Therefore, the profile AIC can be expressed as
pAIC = −2 logL(·) + 2p
where L(·) is the likelihood and p is the number of parameters of interest
in the model. The smaller pAIC is preferred as with the standard of AIC.




In this study we analyze data from the Staccato study (Ananworanich and
the Staccato study group, 2006) which is a randomized trial of two treat-
ment methods, the continuous anti-retroviral treatment compared to the
CD4-guided interruption treatment.
Method 1: Continuation anti-retroviral treatment (control): Drugs are
continued or changed according to current guidelines and good clinical
practice.
Method 2: CD4-guided interruption treatment : Drugs are discontin-
ued and reintroduced according to CD4 count, with Highly Active An-
tiretroviral Therapy (HAART) being administered only if CD4 count is
< 350 cells/µl.
Patients on HAART, with viremia below 50 copies/ml, CD4 count above
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350 cells/µl and no evidence for pre-existing drug resistance were ran-
domized to one of two methods. Note that the most common measure
used to assess immunological health of a HIV patient is the CD4 cell count.
Higher CD4 cell counts indicate a strong immune system that is more pre-
pared to resist infection. Lower CD4 cell counts indicate a higher risk of
CDC-C class (details of CDC-C will be given below). Viral load is a mea-
sure of the amount of virus in the blood plasma. A lower viral load is
preferable and may indicate successful treatment of the disease. These
two markers are often used to evaluate a patient’s success on treatment.
When a patient begins a successful treatment regimen, the viral load may
drop drastically and fall below a detectable level. The CD4 cell count may
take longer to respond or may not respond at all. As viral load decreases,
we may expect the CD4 cell count to increase as the immune system has
time to recover.
Clinical Status
CDC is the classification system of HIV disease stage by CD4 count
and by the presence of specific HIV-related conditions. The definition of
AIDS includes all HIV-infected individuals with CD4 count of less than
200 cells/µL (or CD4 percentage < 14%) as well as those with certain
HIV-related conditions and symptoms. Although the fine points of the
classification system are rarely used in the routine clinical management
of HIV-infected patients, a working knowledge of the staging criteria (in
particular the definition of AIDS) is useful in patient care. In addition, the
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CDC system is used in clinical and epidemiological research.
The clinical categories of HIV infection (Centers for Disease Control
and Prevention, 1992) are defined as follows :
Category A (Asymptomatic, Acute HIV, or Persistent generalized lym-
phadenopathy) : consists of one or more of the conditions listed be-
low in an adolescent or adult (greater than or equal to 13 years) with
documented HIV infection. Conditions listed in Categories B and C
must not have occurred. The conditions are :
• Asymptomatic HIV infection
• Persistent generalized lymphadenopathy
• Acute (primary) HIV infection with accompanying illness or
history of acute HIV infection.
Category B (Symptomatic conditions) : consists of symptomatic condi-
tions in an HIV-infected adolescent or adult that are not included
among conditions listed in clinical Category C and that meet at least
one of the following criteria:
• the conditions are attributed to HIV infection or are indicative
of a defect in cell-mediated immunity.
• the conditions are considered by physicians to have a clinical
course or to require management that is complicated by HIV
infection.
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Category C (AIDS-indicator conditions) : includes the clinical conditions
listed in the AIDS surveillance case definition (Centers for Disease
Control and Prevention, 1987).
For classification purposes, Category B conditions take precedence over
those in Category A. For example, someone who previously had a condi-
tion that once met the criteria for Category B but now is asymptomatic
should be classified in clinical Category B. For classification purposes,
once a Category C condition has occurred, the person will remain in Cate-
gory C.
We are interested in only the clinical events CDC-B at the end of the
randomized treatment period as the survival endpoint in the survival model
in our study. This is because there are very few patients who experience
CDC-C at the end of the study (five out of 354). The patients in category-C
are then treated as censored observations.
Medical Outcome Study HIV Health Survey (MOS-HIV)
Throughout this study, a randomized trial of two treatment methods
continued for an average of approximately three years, and this was fol-
lowed by a period of 12 to 24 weeks continuous treatment, for patients in
both arms. The patient’s quality of life was measured at various points
during this period of study by using the Medical Outcome Study HIV
Health Survey (MOS-HIV) questionnaire (Wu et al., 1991, 1997). Patients
were asked to complete the validated Thai version of MOS-HIV question-
naire every 24 weeks beginning at the baseline visit, and at weeks 24, 48,
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72, 96, 120 and 144 respectively. There is no information about quality of
life after 144 weeks, even though patients were followed up for survival.
Patients were also monitored longitudinally with respect to the biologic
endpoints throughout the follow-up period, such as CD4 count and HIV
viral load.
The MOS-HIV questionnaire was developed to assess aspects of func-
tional status and well-being in HIV-infected patients in clinical trials. It
has been extensively used in clinical trials and is available in 20 languages.
Among other languages, the MOS-HIV questionnaire has been translated
into Thai and used in several studies (Ichikawa and Natpratan, 2004; Anan-
woranich et al., 2005; Cardiello et al., 2005; Nu¨esch et al., 2009; Chariyalert-
sak et al., 2011). In the Staccato study (Nu¨esch et al., 2009), quality of life
scores were calculated by dividing them into 10 subscores ranging from 0
to 100 (greater value indicates better quality of life). Then the summary
scores were transformed to standardized scores, with a mean of 50 and
a standard deviation of 10. A similar approach, which treated the scores
as continuous values vary from 0 to 100, is used by Wachtel et al. (1992)
and Ciconelli et al. (1999). However, since the quality of life scales tend to
generate discrete, asymmetrical and limited distributions, the traditional
methods such as t-test and linear regression that assume the standard nor-
mal assumption may not be appropriate (Abreu et al., 2008). By contrast,
in this study we use the raw scores which are derived from the ques-
tionnaire since we consider the ordinal nature of the data. The ordinary
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rank, for example, corresponds to the following options: poor(1), fair(2),
good(3), very good(4) and excellent(5). Some questions have three out-
come categories; the ordinal ranking is defined as: poor(1), good(2), and
excellent(3). We use all questions to contribute to the stereotype models
as described in Chapter 2 and Chapter 3. Although this causes a multidi-
mensional variable in the model, the more questions we include, the more
accurate results we obtain. However, we use a latent variable to represent
the true scores of the quality of life. The latent variable is not directly ob-
servable but we can estimate it from the observed variables through their
characteristics. In other words, the latent variable contains all the informa-
tion from the observations of the quality of life. Moreover, the principle of
the latent variable is to express the distribution of the observed variables
in terms of a small number of latent variables. This is supported by Mous-
taki (2000), who reported that the number of latent variables typically is
less than the number of observed variables.
In this chapter, we apply the methodologies to data from the Staccato
study by using both a Bayesian joint model (Chapter 3) and a semipara-
metric joint model (Chapter 4). According to the model selection and
MCMC diagnostics, we construct a number of models for the Bayesian
joint model approach with different covariates in the survival part and
different initial values for each model. We also construct a number of mod-
els for the semiparametric joint model approach with different covariates
in the survival part and a different number of groups for the purpose of
5.2. DATA ANALYSIS : BAYESIAN JOINT MODEL 129
model comparison. However, because each model contains many param-
eters, we do not have space to report all models. In this chapter we will
illustrate only one Bayesian joint model for an interpretation and illus-
trate some parameters for the MCMC diagnostics. Similarly, for the semi-
parametric joint model we will present the pAIC of the candidate models
and the estimated values of the selected model that has the smallest pAIC.
The summary of all fitted models for the Bayesian joint model approach
is shown in Appendix A and the semiparametric joint model approach is
shown in Appendix B.
5.2 Data Analysis : Bayesian Joint Model
Approach
We analyze three different models. The item response part and the regres-
sion part are the same for all models but the survival part is different in
terms of the covariates. The first model has quality of life and treatment as
covariates, the second model has quality of life, treatment and initial CD4
count as covariates and the third model has quality of life, treatment, ini-
tial CD4 count and an interaction between treatment and initial CD4 count
as covariates. We report here only two models since the interaction term
in the third model is not significant.
1. Model 1 : This model has two covariates which are quality of life
and treatment in the survival part. The item response part consists
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of two stereotype models and a binary model. The stereotype model
can be expressed as
log
[
P (Yijm = ` | θi(tm))
P (Yijm = 1 | θi(tm))
]
= aL` + φ
L
` bjθi(tm)
Because the numbers of response categories are not the same for all
questions, we created two stereotype models to model all questions
together by allowing parameters a` and φ` to be different but share
the same θi(tm). The first stereotype model is used to model the set
of questions that has five ordinal categories (L = 5). The other one is
used to model the set of questions that has three ordinal categories
(L = 3). The binary model is used to model the set of questions that
has two categories and such a model can be shown as
log
[
P (Yiqm = 1)
1− P (Yiqm = 1)
]
= a∗ + b∗qθi(tm)
The Cox proportional hazards model is used in the survival process.
There are two covariates in Model 1, so the model has the form
h(t|θ∗i , Xi) = h0(t) exp(θ∗i δ0 +Xiδ1)
The baseline hazard h0(t) is excluded from the Bayesian joint model.
In this model, X refers to treatment, X = 1 for the continuation
anti-retroviral treatment and X = 0 for the CD4-guided interruption
treatment.
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We generate the latent variable θi = (θi(t1), . . . , θi(tM))′ to link the
quality of life and survival time together. We assume that
θi ∼ MVN (µ(θi),Σ(ρ)) with µ(θi(tm)) = β0(tm) + β1(tm)Xi and the
elements of Σ (ρ) follow a simple form of covariance parameteriza-
tion as cov(θtm , θtm′ ) = ρ
|tm−tm′ |.
There are 68 parameters in Model 1, which consist of 51 parameters
in the item response part, 15 parameters in the regression part and 2
parameters in the survival part.
2. Model 2 : This model has three covariates which are quality of life,
treatment and initial CD4 count in the survival part. As mentioned
above, the difference between Model 1 and Model 2 is the covariates
in the survival part. Thus, the Cox proportional hazards model can
be written as
h(t|θ∗i , X1i, X2i) = h0(t) exp(θ∗i δ0 +X1iδ1 +X2iδ2)
In this model, X1 refers to treatment, X1 = 1 for the continuation
anti-retroviral treatment andX1 = 0 for the CD4-guided interruption
treatment. The covariateX2 refers to initial CD4 count,X2 = 1 for the
initial CD4 count > 350 and X2 = 0 for the initial CD4 count < 350.
There are 69 parameters in Model 2, which consist of 51 parameters
in the item response part, 15 parameters in the regression part and 3
parameters in the survival part.
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5.2.1 Convergence Diagnostics
5.2.1.1 Graphical Diagnostics : Trace and Density Plots
Because there are many parameters in each model, we illustrate the trace
and density plots for some parameters only. The other parameters are










































N = 100000   Bandwidth = 0.01125
Figure 5.1: Trace and Density Plots of b1 and b2 of model 1
Figure 5.1 shows two common visual diagnostics: trace plots and den-
sity plots of parameters b1 and b2 of the stereotype model. From the trace
plots, the chains start with an initial value which is a considerable distance
from the target distribution. As can be seen from the figure, the first few
thousand iterations should be discarded. After that the chains appear to
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be mixing very well and have settled into a stable running mean.
Figure 5.2 provides the trace and density plots of parameters δ0 and δ1
of the Cox proportional hazards model. Both chains are mixing well with
very small fluctuations and retain the same pattern along a period of time.


















































N = 100000   Bandwidth = 0.04895
Figure 5.2: Trace and Density Plots of δ0 and δ1 of model 1
The density plots show an indication of the mean and spread of the
values obtained from the sampler. As can be seen from the second column
in figure 5.1 and 5.2, the mean appears to be around the value 3, 2.2, -0.2
and -1 for parameters b1, b2, δ0 and δ1 respectively. These are similar to
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the center of the chains from the trace plots that appear to be close to such
values as well. A multimodality of the density estimate is a classic sign of
nonconvergence for most applications (Gill, 2008), but this is not apparent
here.
5.2.1.2 Statistical Diagnostics
We illustrate the statistical diagnostics of Model 1 only in this section. The
other models diagnostics are shown in Appendix A.
Gelman and Rubin’s Multiple Sequence Diagnostic
We illustrate the Gelman and Rubin diagnostic (Gelman and Rubin, 1992)
with four separate chains from several different starting points. This is be-
cause we need to show that the Markov chains converge to the same target
distribution regardless of the starting point. Thus, it would be best to se-
lect different initial values for all four chains to avoid a local maximum
problem. Each chain is run for 100,000 iterations with the first 40,000 iter-
ations discarded. The coda package in R is used to produce the following
results (Table 5.1), which show no evidence of nonconvergence.
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Table 5.1: Gelman and Rubin Diagnostic, Model 1
Model Parameter Point est. 97.5% quantile Multivariate
(R̂) psrf
Stereotype Model a2 1.19 1.65
1.15
(5 levels) a3 1.19 1.65
L = 5 levels a4 1.21 1.71
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table (5.1) continued from previous page




















Stereotype Model a2 1.03 1.08
1.01
( 3 levels ) a3 1.02 1.06
L = 3 levels b1 1 1
1
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table (5.1) continued from previous page
Model Parameter Point est. 97.5% quantile Multivariate
(R̂) psrf
b6 1 1
φ2 1.01 1.05 -
Binary Model a 1 1.02 -
Q = 2 questions b1 1 1.01
1
b2 1 1.00

















Cox’s Model δ0 1.02 1.08 -
δ1 1 1 -
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The idea of Gelman and Rubin’s diagnostic is to compare the variances
within chain and the variance between chains (see Chapter 3). The large
deviation between these two variances indicates nonconvergence. From
Table 5.1, the potential scale reduction factor (psrf) or R̂ in the third col-
umn is the square root of the ratio of the estimated variance and the vari-
ance within the chain. If the R̂ statistic is large, this means the variance be-
tween chains is substantially greater than the variances within the chain.
Thus, longer chains are required to improve convergence to the target dis-
tribution. If the R̂ statistic is close to 1, we can conclude that each of the
four chains are all operating on the same distribution and they are likely
to reach the target distribution. However, in practice R̂ is acceptable if the
value is less than roughly 1.1 or 1.2 (Gelman, 1996).
The Gelman and Rubin approach also produces an upper 97.5% confi-
dence limit of R̂ as in the fourth column of Table 5.1. At this point, R̂ has
an F-distribution and because we are only concerned with a large R̂ value
then only the upper 97.5% confidence limit is reported.
Heidelberger and Welch Diagnostic
The Heidelberger and Welch test (Heidelberger and Welch, 1983) is com-
posed of two parts: a stationary test and a halfwidth test as shown in the
third column and the forth column respectively in Table 5.2.
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Table 5.2: Heidelberger and Welch Diagnostic, Model 1
Running the Heidelberger and Welch Diagnostic at  = 0.1 and α = 0.05
Model Parameter Stationary Test Halfwidth Test P-value
Stereotype Model a2 passed passed 0.122
(5 levels) a3 passed passed 0.116
L = 5 levels a4 passed passed 0.096
J = 32 questions a5 passed passed 0.079
b1 passed passed 0.108
b2 passed passed 0.265
b3 passed passed 0.065
b4 passed passed 0.171
b5 passed passed 0.214
b6 passed passed 0.058
b7 passed passed 0.164
b8 passed passed 0.151
b9 passed passed 0.103
b10 passed passed 0.154
b11 passed passed 0.100
b12 passed passed 0.107
b13 passed passed 0.118
b14 passed passed 0.108
b15 passed passed 0.354
b16 passed passed 0.345
b17 passed passed 0.073
b18 passed passed 0.077
continued on next page
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table (5.2) continued from previous page
Model Parameter Stationary Test Halfwidth Test P-value
b19 passed passed 0.156
b20 passed passed 0.053
b21 passed passed 0.087
b22 passed passed 0.122
b23 passed passed 0.071
b24 passed passed 0.064
b25 passed passed 0.175
b26 passed passed 0.226
b27 passed passed 0.148
b28 passed passed 0.118
b29 passed passed 0.126
b30 passed passed 0.186
b31 passed passed 0.198
b32 passed passed 0.123
φ2 passed passed 0.215
φ3 passed passed 0.061
φ4 passed passed 0.056
Stereotype Model a2 passed passed 0.052
( 3 levels ) a3 passed passed 0.175
L = 3 levels b1 passed passed 0.368
J = 6 questions b2 passed passed 0.417
b3 passed passed 0.297
b4 passed passed 0.175
b5 passed passed 0.259
b6 passed passed 0.435
continued on next page
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table (5.2) continued from previous page
Model Parameter Stationary Test Halfwidth Test P-value
φ2 passed passed 0.075
Binary Model a passed passed 0.874
Q = 2 questions b1 passed passed 0.680
b2 passed passed 0.256
Regression Model ρ passed passed 0.757
β0(t0) passed passed 0.665
β0(t1) passed passed 0.203
β0(t2) passed passed 0.074
β0(t3) passed passed 0.409
β0(t4) passed passed 0.393
β0(t5) passed passed 0.312
β0(t6) passed passed 0.225
β1(t0) passed passed 0.454
β1(t1) passed passed 0.420
β1(t2) passed passed 0.463
β1(t3) passed passed 0.936
β1(t4) passed passed 0.592
β1(t5) passed passed 0.261
β1(t6) passed passed 0.235
Cox’s Model δ0 passed passed 0.576
δ1 passed passed 0.306
The null hypothesis for the stationary test is that the chain is currently
in a stationary distribution. The halfwidth test is performed when some
proportion of the data are found to be consistent with stationarity in order
to estimate the mean values. The test statistic is the Cramer-von-Mises as
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mentioned in Chapter 3. We first assess the whole chain which is 100,000
iterations at  = 0.1 (an accuracy) and α = 0.05 (an alpha level of the test).
Then we evaluate the first 10% of the chain iterations and calculate the test
statistic to see whether to accept or reject the null hypothesis. If the null
hypothesis is rejected, the first 10% of the chain iterations are discarded
and the test is run again. We repeat the process until the null hypothesis
is accepted with the remaining 60,000 iterations. It can be seen from the
p-value in Table 5.2 that all of the chain values are greater than the alpha
level of the test (α = 0.05). This means the chain passes the stationary
test and subsequently the chain that is not discarded from the first part
is taken to test the halfwidth. To perform the halfwidth test, the coda
package calculates half the width of the (1-α)% credible interval around
the mean. If the ratio of the halfwidth and the mean is lower than a rough
estimate of the variance of the sample mean or some accuracy ( = 0.1),
then the chain passes the test. From Table 5.2, the chain is considered to
be converged since the halfwidth is less than the rough estimate of the
variance.
After we discard a burn-in from the chains, the next step is to use the
remaining iterations to calculate the model checking criteria. In this thesis
we use the Bayesian information criterion (BIC) and the Deviance Infor-
mation Criterion (DIC).
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5.2.2 Bayesian Model Selection
The BIC and DIC are based on the posterior distribution of the log likeli-
hood or the deviance. The BIC also depends on the sample size as well
as the number of parameters. For the calculation procedures, we apply a
multiple imputation approach proposed by Rubin (1987, 1996) to the crite-
rion calculation since missing data have been involved in our joint model.
Multiple imputation is done by repeating the imputation process several
times in order to capture some of the uncertainty associated with the esti-
mation of missing data. Missing values are generated from an appropriate
imputation model (the posterior distribution of missing data); typically
between 3 and 10 sets are sufficient (Rubin, 1987). The posterior estimates
are obtained by averaging the results over the imputed samples.
Since our joint model contains many parameters and some of them are
the latent variables, the DIC is used to overcome the problem of needing
to identify the number of parameters in the model which is required for
calculating the BIC. For both methods, smaller values represent a better
overall fit.
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Table 5.3: Model Comparison, BIC and DIC
Model BIC DIC
Model 1 1605155 1602788
Model 2 1653515 1603696
In Table 5.3 we report BIC together with DIC. Although we used different
initial values in several runs, the BIC and DIC estimates obtained never
varied by more than 0.5. The comparison of the BIC and DIC between
Model 1 and Model 2 suggests that Model 1 is the best fit to the data since
it has the lowest BIC and DIC values. Model 1 consists of the item response
part, the regression part and the survival part with two covariates: quality
of life and treatment. The next section shows the posterior mean and the
95% credible interval for each parameter of Model 1.
5.2.3 Posterior Summary
For Model 1, we ran the chain for a total of 100,000 iterations with a burn-in
period of 40,000 iterations. We used the last 60,000 iterations for parame-
ter estimation. After the burn-in iterations were discarded, the posterior
results are summarized as follows :
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Table 5.4: The Posterior Summary , Model 1
Model Parameter Mean Standard Error 95% Credible Interval
Stereotype Model a2 0.948 0.036 (0.873,1.012)
(5 levels) a3 2.855 0.031 (2.799,2.921)
L = 5 levels a4 3.441 0.036 (3.361,3.520)
J = 32 questions a5 3.656 0.038 (3.573,3.732)
b1 3.241 0.112 (3.021,3.459)
b2 2.287 0.093 (2.104,2.471)
b3 0.914 0.081 (0.753,1.071)
b4 0.926 0.080 (0.765,1.085)
b5 2.292 0.095 (2.109,2.482)
b6 3.999 0.132 (3.746,4.262)
b7 2.603 0.102 (2.401,2.813)
b8 4.355 0.138 (4.092,4.632)
b9 1.372 0.085 (1.027,1.541)
b10 5.028 0.155 (4.725,5.336)
b11 1.945 0.088 (1.778,2.123)
b12 2.664 0.103 (2.464,2.866)
b13 3.859 0.127 (3.617,4.123)
b14 3.305 0.117 (3.075,3.534)
b15 2.842 0.107 (2.637,3.500)
b16 2.428 0.100 (2.232,2.627)
b17 3.234 0.115 (3.012,3.458)
b18 2.437 0.099 (2.242,2.636)
continued on next page
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table (5.4) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
b19 2.294 0.095 (2.110,2.480)
b20 2.033 0.092 (1.860,2.211)
b21 2.422 0.098 (2.232,2.614)
b22 2.038 0.095 (1.853,2.229)
b23 2.392 0.982 (2.204,2.587)
b24 2.848 0.106 (2.645,3.058)
b25 2.197 0.098 (2.008,2.390)
b26 1.425 0.082 (1.265,1.591)
b27 1.091 0.092 (1.727,2.088)
b28 1.020 0.082 (0.857,1.183)
b29 0.395 0.083 (0.231,0.551)
b30 0.018 0.017 (0.0004,0.065)
b31 0.967 0.084 (0.806,1.134)
b32 2.117 0.095 (1.936,2.304 )
φ2 0.024 0.008 (0.007,0.039)
φ3 0.351 0.006 (0.338,0.364)
φ4 0.707 0.007 (0.692,0.720)
Stereotype Model a2 1.846 0.097 (1.668,2.032)
( 3 levels ) a3 3.642 0.096 (3.461,3.829)
L = 3 levels b1 1.996 0.106 (1.787,2.206)
J = 6 questions b2 1.374 0.087 (1.206,1.552)
b3 1.560 0.095 (1.378,1.748)
b4 1.324 0.086 (1.159,1.495)
b5 1.075 0.078 (0.929,1.236)
b6 0.643 0.077 (0.492,0.792)
continued on next page
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table (5.4) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
φ2 0.196 0.034 (0.126,0.259)
Binary Model a 3.357 0.166 (3.043,3.692)
Q = 2 questions b1 1.039 0.109 (0.833,1.255)
b2 0.931 0.090 (0.766,1.109)
Regression Model ρ 0.367 0.030 (0.307,0.426)
β0(t0) -0.033 0.065 (-0.160,0.090)
β0(t1) -0.679 0.076 (-0.822,-0.527)
β0(t2) -0.706 0.079 (-0.864,-0.553)
β0(t3) -0.693 0.083 (-0.852,-0.530)
β0(t4) -0.642 0.101 (-0.848,-0.441)
β0(t5) -0.713 0.121 (-0.954,-0.487)
β0(t6) -1.108 0.309 (-1.689,-0.444)
β1(t0) 0.095 0.112 (-0.128,-0.312)
β1(t1) 0.058 0.124 (-0.181,-0.303)
β1(t2) 0.259 0.124 (0.020,-0.504)
β1(t3) 0.260 0.133 (0.0003,-0.519)
β1(t4) 0.133 0.162 (-0.187,-0.446)
β1(t5) 0.138 0.189 (-0.223,-0.510)
β1(t6) 0.746 0.491 (-0.309,-1.619)
Cox’s Model δ0 -0.202 0.192 (-0.577,-0.182)
δ1 -1.032 0.464 (-1.998,-0.198)
Table 5.4 shows the estimate of all parameters in the Bayesian joint model
and their standard errors with a 95% credible interval except the latent
variables θ. Beginning with the item response models, two stereotype
models are included in the Bayesian joint model since the questions in
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the questionnaire contain a different number of ordinal categories. One
has five ordinal categories (L = 5) and the other has three ordinal cat-
egories (L = 3). These two stereotype models were fitted simultane-
ously. The score parameters φ` are monotonically increasing in both mod-
els as expected as follows: φL=5 = {0, 0.024, 0.351, 0.707, 1} and φL=3 =
{0, 0.196, 1}. We can see how close adjacent response categories ` and `′
are, based on how close φ` and φ`′ are. Also, the distinguishability and
order of outcome categories can be addressed through these constraints.
Relative to the ordering for the former stereotype model, the estimated φ2
is not far from φ1. We can group the score parameters into four values,
φ1 = φ2, φ3, φ4 and φ5 for distinguishability of categories. These corre-
spond to four groups of distinguishable response categories in MOS-HIV
questionnaire (poor and fair, good, very good, excellent). Likewise, the re-
sponse categories for the latter stereotype model are distinguishable from
one another relative to their standard errors.
The item slope coefficients b indicate the influence of the quality of life
scores θ on how patients select the response category. All of the coeffi-
cients b are constrained to be positive which means patients who have
greater quality of life scores would have a high probability of respond-
ing to a high category. From the MOS-HIV questionnaire we ordered the
response categories from low to high (poor to excellent); then patients in
a high category should have a better quality of life compared to the pa-
tients in a low category. This suggests the higher the value of bjθi(tm), the
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greater probability of choosing the excellent categories. Furthermore, the
stereotype model allows each individual to have a different probability of
responding depending on the strength of the question. For example, for
a fixed value of θi(tm), say θi(tm) = θ and θ > 0, the odds of responding
category ` instead of 1 for question 10 against question 30 equals
P (Y = ` | θ, b10)/P (Y = 1 | θ, b10)










means the probability of responding category ` in question 10 is higher
than question 30. Likewise, the odds of responding Y = 1(patients are
able to do certain kinds or amounts of work by themselves without health
problems) for question 1 against question 2 of the binary model equals
P (Y = 1 | θ, b1)/P (Y = 0 | θ, b1)





The estimate of the odds ratio (5.2) equals exp
(
(1.039 − 0.931)θ). This
means the probability of responding Y = 1 in question 1 is higher than
question 2.
The quality of life scores θ and the treatment effect are the covariates
of the Cox proportional hazards model. The estimates of δ0 and δ1 shown
in Table 5.4 represent the regression coefficients of the quality of life and
the treatment respectively. Since δ0 is a negative value, this implies that
a higher quality of life score or a better quality of life is associated with
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a reduced hazard for having CDC-B. In a similar manner, a negative re-
gression coefficient δ1 means that the hazard of progression to CDC-B of
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Figure 5.3: Mean quality of life estimates
Figure 5.3 illustrates the estimated mean quality of life using the form
of µ(θ(tm)) = β0(tm) + β1(tm)X in the regression model. The mean qual-
ity of life here is a function of time since the data were collected every
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24 weeks. The regression coefficients {β1(tm), m = 0 . . . , 6} describe how
treatment affects the quality of life. In this figure we see that the mean
quality of life of the patients on a continuous treatment (dashed line) is
higher than the mean quality of life of the patients on CD4-guided treat-
ment (solid line). This shows a connection to the results we obtained from
the survival model and the stereotype model. However, the mean qual-
ity of life of both treatment methods are slightly similar at the first week
visit. After that they all markedly decrease within 24 weeks and then
the mean quality of life improves with continuous treatment but not with
CD4-guided treatment.
The Bayesian joint model approach generated the latent variables for
all individuals (n = 354) with every follow-up time point (m = 7). In to-
tal, there are n × m = 354 × 7 elements in θ. The posterior quality of life
scores are randomly selected from some patients (a patient number 28 and
a patient number 39) to present here as shown in Figure 5.4. Patient num-
ber 28 (dashed line) is on continuous treatment and the other patient is
on CD4-guided treatment. The quality of life scores increase and decrease
during the follow-up period. This implies that not only the treatment but
also other aspects of functioning have an impact on the quality of life. The
study about HAART (antiretroviral drugs) and its effect on quality of life
in the literature has been controversial. Some studies found overall quality
of life improved with the use of HAART (Nieuwkerk et al., 2002; Carrieri
et al., 2003) but Gill et al. (2002) among others, reported that physical qual-
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Figure 5.4: Posterior quality of life scores
ity of life decreased under HAART.
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5.3 Data Analysis : Semiparametric Joint Model
Approach
To illustrate the semiparametric joint model, we also used data from the
Staccato study for our analysis and we used 32 questions from the MOS-
HIV questionnaire where each question has five response categories. Here,
the baseline hazard function is calculated whereas it is not included in the
Bayesian joint model. The latent variable is treated as a discrete variable
while it is assumed to be a continuous variable in the Bayesian joint model.
The semiparametric joint model consists of the stereotype model and the
Cox proportional hazards model. The two models are linked through a
discrete latent variable that is assumed to underlie the quality of life and
the hazard. In this section, although our work has focused on the joint
model in another aspect, we also consider the model comparison.
5.3.1 Model Comparison
We constructed various semiparametric joint models that have the same
structure of the stereotype model but each model has different covariates
included for the survival part of the model such as treatment, sex and age.
The number of discrete latent variables or the number of groups which are
accommodated in the stereotype model and the Cox proportional hazards
model are also different across the models. The profile Akaike informa-
tion criterion (pAIC) is used for model selection since we have nuisance
154 CHAPTER 5. DATA APPLICATION
parameters in the models. The summary of the profile Akaike information
criterion is shown in Table 5.5 below. The number of groups for the dis-
crete latent variables in the model is represented by Ngr and the number
of parameters is Npar.
Table 5.5: The summary of profile Akaike information criterion (pAIC)
Covariates in the survival part Ngr Npar pAIC
(a) QOL and treatment 2 38 126764.2
(b) QOL, treatment and initial CD4 count 2 39 119005.51
(c) QOL and treatment 3 39 116466.3
(d) QOL, treatment and initial CD4 count 3 40 116468.3
(e) QOL, treatment, initial CD4 count and age 3 41 116594.8
(f) QOL, treatment, initial CD4 count, age and sex 3 42 116611.0
(g) QOL, treatment, initial CD4 count, age and weight 3 42 116841.1
(h) QOL, treatment, age and sex 3 41 116480.8
(i) QOL, treatment, initial CD4 count and sex 3 41 116483.8
(j) QOL, treatment and age 3 40 116465.3
(k) QOL, treatment and sex 3 40 116464.0
(l) QOL and treatment 4 40 115603.4
(m) QOL, treatment and CD4 count 4 41 115605.4
(n) QOL and treatment 5 41 115205.2
continued on next page
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table (5.5) continued from previous page
Model Ngr Npar pAIC
(o) QOL and treatment 6 42 115217.8
Table 5.5 presents the profile Akaike information criterion (pAIC) for each
model and the model with the smaller pAIC is preferred. It can be seen
from Table 5.5 that the range of pAIC among the models is very small.
However, the pAIC values suggest that Model (n) is the most suitable
model to this data set. Model (n) includes effects of the treatment, and
quality of life as defined by the latent discrete variable with five groups
in the survival part. In the following the estimated parameters and the
standard errors of selected model are given in Table 5.6.
5.3.2 Estimated parameters
Table 5.6: EM estimate from the selected model
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table (5.6) continued from previous page





















continued on next page
5.3. DATA ANALYSIS : SEMIPARAMETRIC JOINT MODEL 157
table (5.6) continued from previous page
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Table 5.6 shows the estimated parameters and their standard errors
from the EM algorithm approach. The results suggest that for this data
set patients belong to five different groups classified by their quality of life
score θr. Treatment is included as a predictor together with the quality of
life in the survival part. All of the coefficients b are positive values which
mean positive effects. Since bj expresses the strength of the jth question,
the higher value of b, the higher the probability that patients respond to
a high category in such questions. For example, if b1 > b2, the probabil-
ity that patients will respond in a high category for question one is higher
than question two. Similarly, θr serves as a quality of life score of patients
in group r; the greater the value of θ the higher the probability of the pa-
tient responding to a high category. This also indicates that the patients
who are in a group with the high value of θ, have a better quality of life.
As mentioned above, there are two predictors in the survival part. The
regression coefficient δ0 is the coefficient of quality of life and it has a neg-
ative value. This result suggests that better quality of life is associated
with a reduced hazard of having CDC-B. Likewise, δ1 corresponds to the
effect of treatment and it shows a negative value. This means the patients
on continuous treatment have a lower hazard of CDC-B progression than
the patients on CD4-guided treatment.
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Figure 5.5: Cumulative baseline hazard function
The cumulative hazard function as shown in Figure 5.5 is obtained
from the calculation of (4.34) with the EM algorithm in Chapter 4. The
graph shows the increasing step function or monotonic increasing in time
by definition. However, in most applications, we typically describe how
long the study subjects live rather than how quickly they die. Thus, the
survival function has received more attention than the baseline cumu-
lative hazard function in terms of interpretation. The survival function,
S(t), can be derived from the cumulative hazard function H(t) by S(t) =
exp(−H(t)).
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Figure 5.6: Estimated survival function
The estimated survival function is illustrated in Figure 5.6. It decreases
sharply for approximately the first 24 weeks. The graph significantly de-
clines again from week 40 to week 72. There are larger drops in the steps
in the graph from week 72 to week 144 due to the small number of patients
still at risk but many of these are censored during the follow-up time. The
initial steep decrease is because there is a high rate of progression to CDC-
B in the first 24 weeks. The progression rate then decreases and remains at
about the same level for the remainder of the follow-up period.
Chapter 6
The Extension of the Joint Model
6.1 Introduction
In Chapter 3 we consider a single outcome CDC-B as the survival end-
point. In this chapter we focus on the multiple survival endpoints since
sometimes patients may fail from different causes or patients may face dif-
ferent risks. If this is the case, it may not be appropriate to use the classical
survival techniques. Thus, in this chapter we extend the Bayesian joint
model from Chapter 3 by presenting the specific methods to deal with the
case of multiple failure types. The situation where several causes of failure
are possible and all of them are of equal interest is known as the competing
risks (Putter et al., 2007). If failures are different causes of death, only the
occurrence of the first of them can be observed. The term competing risks
also refers to data when subjects under study are at risk of more than one
mutually exclusive event and the interest is in the first failure; the remain-
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ing failures are competing events. Gooley et al. (1999) also defined com-
peting risks as events whose occurrence either precludes the occurrence
of another event under investigation or fundamentally alters the proba-
bility of occurrence of this other event. Examples of competing risks are
often found in medical studies such as cancer and heart disease where the
competing risks could be competing causes of death. In clinical cancer
research, individuals undergoing treatment for surgical resectable disease
may experience recurrence near the removed tumor, metastatic recurrence
at other sites, occurrence of a second cancer, or death resulting from non-
cancerous causes before any of these events (Dignam and Kocherginsky,
2008). In another example of competing risks, the primary outcome was
the onset of dementia and other types of events were stroke and death in
a study on a community-based cohort of patients diagnosed with atrial
fibrillation between 1986 to 2000 in Olmsted Country, Minnesota United
States (Miyasaka et al., 2007).
The competing risks model as a survival component in the joint model
has been increasingly considered in medical studies. Elashoff et al. (2007)
considered a more general joint model, which incorporates the compet-
ing risks model for the survival endpoint, using a likelihood approach.
However, their EM algorithm involved intractable computation for high
dimension integrals. Furthermore, Williamson et al. (2008) demonstrated
a cause-specific hazards sub-model to allow for competing risks, with a
separate latent association between longitudinal measurements and each
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cause of failure. They also used the EM algorithm to estimate the param-
eters of interest where the random effects were treated as missing data.
Hu et al. (2009) developed a Bayesian method for joint modeling of a lin-
ear mixed effects model and a competing risks model. They indicated
that the Bayesian approach can avoid the difficulty of implementation for
high-dimensional random effects, unlike the likelihood approach. Des-
landes and Chevret (2010) also proposed a joint model of competing risks
with longitudinal responses using the Bayesian method. Although vari-
ous studies on the joint model have been proposed, no one has applied
the stereotype model to longitudinal ordinal data. Recently, Li et al. (2010)
presented a joint model for longitudinal ordinal measurements and com-
peting risks failure time data, but they used a partial proportional odds
model to model the longitudinal ordinal data. Therefore, this thesis is the
first to apply the stereotype model to the joint model of competing risks
and longitudinal ordinal data.
6.2 Model Structure
In this chapter we present the joint model which is composed of an item re-
sponse model to model quality of life data and the competing risks model
is used to model survival times with multiple endpoints. These two mod-
els are linked by a latent variable process. Similarly, we consider the
Bayesian method to estimate the parameters as we did in Chapter 3 since
the model is very complicated with a high-dimensional data set.
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The stereotype model is used to create the item response term and for
demonstration we consider only the questions that have five response cat-
egories from the measure of quality of life MOS-HIV questionnaire. The
fitting procedure is the same as in Chapter 3, except the survival process
part; we illustrate with two event types in the competing risks model. In
general, one may extend to more event types. Next, we discuss the com-
peting risks model.
6.2.1 The Competing Risks Model
In a simple survival model, the hazard function for the failure time is given
by
h(t|X ) = lim
∆t→0
[P(t 6 T < (t+ ∆t)∣∣T > t,X)
∆t
]
where t is the time to failure andX is a covariate vector.
In a competing risks model, the observed data are represented by the
time of failure t, covariate X and the cause of failure k. Suppose there is
a risk of experiencing K(k = 1, . . . , K) event types. The contribution of
each individual to the likelihood is specified through a joint distribution
of (t, k). For cause k, we can write the cause-specific hazard as
hk(t|X ) = lim
∆t→0
[P(t 6 Tk < (t+ ∆t), event = k∣∣Tk > t,X)
∆t
]
The numerator is defined as the conditional probability that an individual
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with covariateX fails in an interval t+∆t and the cause of failure is the kth
cause, given that the individual has survived to time t or no failure of any
kind has occurred thus far. We turn the probability into a rate by dividing
by ∆t and then taking the limit as ∆t→ 0. This further represents the rate
of occurrence of the kth failure. The overall hazard h(t|X ) for any type of
failure at time t is the sum of the cause-specific hazards hk(t|X ). Thus, the





This shows each individual must fail from only one cause out of K causes.
The overall survival function can be defined as
S(t|X ) = e−H(t|X )
whereH(t|X ) is the cumulative risk and can be factorized into theK func-
tions as follows











We can also define a cause-specific density function of failures at time
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t as follows
fk(t|X ) = hk(t|X )S(t|X )






Suppose we have n individuals (i = 1, 2, . . . , n) and K event types
(k = 1, 2, . . . , K). Under the assumption of independent observations,
the contribution of a given observation with failure due to risk k to the










where di = 1 if we observe the failure time and it is 0 if we observe a
censoring. The cause of failure index k takes a value from 1 to K and is
undefined for censored cases. The indicator di allows us to write the two
types of terms as follows:
For the censored cases, an individual censored at time ti contributes to
the probability of being alive at that time presented by S(ti|X i). On the
other hand, if the individual fails at time t from cause k, we can write the
density in terms of the hazard and survival functions as hki(ti|X i)S(ti|X i).
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Since S(t|X ) = ∏Kk=1 Sk(t|X ), we can write the likelihood function












Let dik indicate whether an individual i fails from cause k and
di =
∑
k dik because each individual can fail from one cause only. We can



























h0k(tki) is a baseline hazard function of an event type k.
H0k(tki) is a baseline cumulative hazard function of an event type k.




λiδ(t − ti) where δ(·) is the Dirac delta function. We
now make the assumption that the survival time is discrete and the base-
line hazard is zero between adjacent failure times. The baseline cumula-
tive hazard H0k(tki) =
∑
j:j≤i
λkj will be a step function with jumps at tki
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whenever dik = 1.










































To determine the partial likelihood function, the log likelihood func-
























Plugging (6.7) into (6.4), we will obtain the corresponding partial like-
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The overall partial likelihood is a product of K partial likelihoods which
is one for each type of failure. Therefore, at time tki the contribution is the
conditional probability that an individual i fails of cause k given the risk
set at tki where all other causes of failure are treated as censored observa-
tions. In standard survival analysis, the risk set is defined as the group
of individuals who are alive and uncensored at each failure time (Collett,
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2003). In a similar manner, the risk sets in the competing risks analysis are
defined in standard survival analysis but are modified to allow for com-
peting events. That is, individuals who have a competing event can be
removed from all later risk sets for the event of interest (Pintilie, 2006).
In addition, the partial likelihood in (6.8) can be maximized by sepa-









The expression above implies that we can simply demonstrate sepa-
rate model fits for each event type where the remaining event types and
the censoring are now censored. For example, for two possible failure
types (event 1 and event 2), we could fit two separate proportional haz-
ards models. The first one is modeled by using event type 1 and censoring
is indicated by event type 2 and censored observations. The second one is
modeled by using event type 2 and censoring is indicated by event type 1
and censored observations.
In the survival part of the joint model, since we consider multiple causes
of failure, the competing risks model should be employed to handle this
issue. We assume that all event types are of equal interest. The likelihood
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This partial likelihood function includes survival times and censored
observations which are ordered and denoted by t(k1) ≤ t(k2),≤ . . . ,≤ t(kn)
for all K causes. Then t(ki) is the i
th ordered survival time for cause k at
time t(ki). The set of individuals who do not fail from cause k and are un-
censored at time t(ki) is called the risk set and expressed by R(t(ki)). More-
over, in this survival part we include treatment, X , as a covariate. We also
include a latent variable for quality of life, θ∗i , at a failure time point for all
event types. This means all observations have their own latent variables
as quality of life scores (θi) for each follow-up time point and we only
calculate θ∗i for patients who failed from cause k only. Therefore, the la-
tent variables at this stage are treated as a time-dependent covariate since
these values change over time. All these values are determined by linear
interpolation between two known θ points as described in Chapter 3.
6.2.2 The Full Likelihood Function
The stereotype model, the regression model and the competing risks model
are then combined together to obtain the joint likelihood function. The full
likelihood function can be expressed as







where the stereotype likelihood L(a, b,φ|θ) and the competing risks partial
likelihood L(δ|θ) are defined in (3.2) and (6.10) respectively. The multi-
variate normal density function of the latent variable, Φ (θ;µ(θ),
∑
(ρ)), is
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described in Chapter 3 on pages 64-65.
6.3 Parameter estimation
In this chapter, we still consider the Metropolis-Hastings Algorithm (Metropo-
lis et al., 1953) to estimate model parameters simultaneously. The proposal
distribution is denoted by q(·|·) and the criteria need to be applied whether
to accept or reject the simulated values. Additionally, the criterion is calcu-
lated from ratios of the product of proposal and posterior densities. This
criterion is commonly referred to as the acceptance probability and the
proposal distribution gives the probability of the new values given the cur-
rent values. We used the flat prior distributions on parameters so that the
posterior density function is proportional to the joint likelihood function
(6.11). The Metropolis-Hastings Algorithm steps for updating parameters
have been described in Chapter 3.
The Estimation Procedures
The set of parameters that we need to estimate is {a, b,φ,β0,β1, ρ, δ, θ}
and we set a uniform prior for all parameters, P(·) ∝ 1.
At the tth iteration :
1. Updating parameters in the regression model.
This step is the same procedure as the estimation procedure step 1 in
Chapter 3, section 3.3 on pages 70-71.
6.3. PARAMETER ESTIMATION 173
2. Generating missing values.
This step is the same procedure as the estimation procedure step 2 in
Chapter 3, section 3.3 on page 72.
3. Updating parameters in the stereotype model.
This step is the same procedure as the estimation procedure step 3 in
Chapter 3, section 3.3 on pages 72-75.
4. Updating parameters in the competing risks model.
4.1. Generating latent variables at failure time points. The values
at failure time points, θ∗, are determined by linear interpolation
between two known θ points as described in Chapter 3.
4.2. Generating δk = {δ0k, δ1k}, k = 1, . . . , K, by using θ∗ from pre-
vious step and δk is the regression coefficient for event type
k based on the partial likelihood function as shown in model
(6.10).
4.2.1 Updating δ0k. The posterior distribution of δ0k, P (δ0k|·), is










Given the current value, δcur0k , propose a new value, δ
new
0k ,
by taking a random draw from the univariate normal dis-
tribution, δnew0k ∼ N(δcur0k , σ2δ0k) where σ2δ0k = 1. The proposed
value, δnew0k , is accepted with probability equal to the mini-
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mum of 1 and the ratio
r =
q(δcur0k |δnew0k )P (δnew0k |·)
q(δnew0k |δcur0k )P (δcur0k |·)

















(δnew0k − δcur0k )2)
= 1
If the proposed value is not accepted, then δ(t)0k equal to δ
cur
0k
4.2.2 Updating δ1k. The posterior distribution of δ1k, P (δ1k|·), is










Given the current value, δcur1k , propose a new value, δ
new
1k , by
taking a random draw from the univariate normal distri-
bution, δnew1k ∼ N(δcur1k , σ2δ1k) where σ2δ1k = 1. The proposed
value, δnew1k , is accepted with probability equal to the mini-
mum of 1 and the ratio
r =
q(δcur1k |δnew1k )P (δnew1k |·)
q(δnew1k |δcur1k )P (δcur1k |·)

















(δnew1k − δcur1k )2)
= 1
If the proposed value is not accepted, then δ(t)1k equal to δ
cur
1k .
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5. Updating the latent variable.
The posterior distribution of θi is proportional to the joint likeli-
hood function (6.11).
P (θ|a, b, φ, β, ρ, δ) ∝ L(a, b, φ, β, ρ, δ, θ)
This step is the same procedure as the estimation procedure step 6 in
Chapter 3, section 3.3 on pages 79-80.
After we have finished updating all parameters from step 1 to step 5,
we changed the iteration from t to t + 1 and repeated all five steps until
convergence is reached.
6.4 Application to Pseudo Data
Since this chapter concerns the competing risks model for the survival part
of the joint model, we have to consider the case of multiple failure types
such as CDC-B and CDC-C. We use data from the Staccato study but we
still consider only CDC-B as a survival endpoint. This is because there
were very few patients, five out of 354, who experienced CDC-C at the
end of the study. We do not have sufficient information to treat CDC-C
as an additional failure type. For that reason the patients in category-
C are treated as censored observations. Thus, the CDC-B events (Anan-
woranich and the Staccato study group, 2006) are classified into two cat-
egories for the purpose of the study. Some CDC-B events are grouped
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together, without any conditions on the medical point of view, in order
to demonstrate the methodologies. The first category is composed of the
following symptomatic conditions : candidiasis oropharyngeal, candidi-
asis vulvovaginal (persistent, recurrent, or unresponsive to theropy) and
herpes zoster (shingles), involving at least two distinct episodes or more
than one dermatome. The second category consists of the following symp-
tomatic conditions : oral hairy leukoplakia, peripheral neuropathy and
pruritic papular eruptions. Henceforth, suppose that patients are at risk
with two possible failure types, CDC-B(1)(22 patients) and CDC-B(2)(14
patients), and all other events are treated as censored. We are interested
in estimating the risk or incidence of each particular event type over time
from an initial stating point (t0). Also, we assume that both of the fail-
ure types are of equal interest and that each subject can experience only
one type of event at any particular time. Treatment group assignments
have been considered as a covariate in this study. Because the majority of
classification is symptomatic conditions, this causes patients in the same
treatment to be in the same risk type. We need to generate patients for an-
other treatment to get enough data to demonstrate the method. Therefore,
the following results are not based on real data.
Since we used the Bayesian approach to estimate the parameters, we
do need to check the convergence of the model. The details of conver-
gence diagnostics have already been given in Chapter 3. We will not show
the results of the convergence diagnostics here but we will illustrate the
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posterior summary after the chain iterations are discarded. We ran the
chain for 100,000 iterations and a burn-in period is 30,000 iterations. The
posterior results are summarized as follows :
Table 6.1: The Posterior Summary
Model Parameter Mean Standard Error 95% Credible Interval
Stereotype Model a2 0.844 0.025 (0.796,0.893)
(5 levels) a3 1.686 0.025 (1.636,1.739)
L = 5 levels a4 1.556 0.027 (1.504,1.609)
J = 32 questions a5 0.994 0.033 (0.925,1.067)
b1 0.018 0.016 (0.0004,0.060)
b2 0.778 0.047 (0.687,0.871)
b3 1.435 0.062 (1.317,1.559)
b4 1.886 0.077 (1.742,2.042)
b5 1.037 0.053 (0.937,1.148)
b6 0.174 0.043 (0.090,0.255)
b7 0.967 0.052 (0.869,1.073)
b8 0.384 0.043 (0.297,0.471)
b9 1.716 0.074 (1.569,1.861)
b10 0.411 0.044 (0.326,0.498)
b11 1.308 0.060 (1.193,1.432)
b12 0.517 0.042 (0.435,0.601)
b13 0.566 0.045 (0.476,0.654)
b14 0.659 0.045 (0.572,0.748)
b15 1.061 0.054 (0.959,1.169)
continued on next page
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table (6.1) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
b16 1.418 0.063 (1.294,1.548)
b17 0.839 0.049 (0.746,0.938)
b18 0.752 0.046 (0.664,0.846)
b19 0.453 0.042 (0.370,0.536)
b20 0.768 0.047 (0.676,0.863)
b21 0.813 0.048 (0.720,0.911)
b22 1.272 0.060 (1.155,1.390)
b23 0.770 0.047 (0.678,0.864)
b24 0.526 0.044 (0.438,0.614)
b25 1.260 0.060 (1.144,1.379)
b26 0.550 0.045 (0.464,0.643)
b27 0.519 0.043 (0.433,0.604)
b28 1.445 0.064 (1.324,1.574)
b29 1.967 0.083 (1.808,2.135)
b30 2.840 0.118 (2.617,3.079)
b31 1.303 0.062 (1.182,1.429)
b32 0.885 0.048 (0.788,0.978)
φ2 0.026 0.017 (0.001,0.069)
φ3 0.282 0.015 (0.252,0.313)
φ4 0.554 0.011 (0.531,0.578)
Regression Model ρ 0.230 0.021 (0.186,0.271)
β0(t0) -0.020 0.067 (-0.153,0.114)
β0(t1) 1.539 0.099 (1.343,1.732)
β0(t2) 1.692 0.098 (1.498,1.884)
β0(t3) 1.634 0.108 (1.425,1.851)
continued on next page
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table (6.1) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
β0(t4) 1.765 0.125 (1.516,2.001)
β0(t5) 1.623 0.165 (1.276,1.935)
β0(t6) 2.048 0.371 (1.409,2.875)
β1(t0) 0.055 0.115 (-0.163,0.278)
β1(t1) 0.164 0.150 (-0.127,0.469)
β1(t2) -0.176 0.148 (-0.475,0.113)
β1(t3) 0.167 0.163 (-0.164,0.477)
β1(t4) -0.231 0.191 (-0.606,0.147)
β1(t5) -0.117 0.239 (-0.584,0.343)
β1(t6) -0.778 0.527 (-1.893,0.155)
Competing Risks Model δ0(1) -0.297 0.198 (-0.692,0.085)
δ1(1) -0.199 0.474 (-1.179,0.690)
δ0(2) -1.712 0.395 (-2.561,-0.990)
δ1(2) -0.413 0.663 (-1.810,0.790)
Table 6.1 shows the estimated parameters and their standard errors with
95% credible interval of the joint model that consists of the stereotype
model, the regression model and the competing risks model. The follow-
ing results are not based on the real data since we generated some of the
data to get enough information to demonstrate the method. The coeffi-
cients b in the stereotype model suggest the influence of the quality of life
score on how patients selected the response category. The coefficients φ
imply how close adjacent response categories are. In the regression model,
the coefficients β could indicate the treatment effects. It can be seen that
there are two sets of coefficients in the competing risks model since we are
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interested in two failure types: CDC-B(1) and CDC-B(2). We use the com-
peting risks model because sometimes the covariate effects will differ sig-
nificantly across the different failure types. However, the example in this
chapter gives similar results in both failure types. In this particular case,
the negative coefficients δ1(1) and δ1(2) show the patients who received a
continuous treatment have a lower hazard of progression to CDC-B(1) and
CDC-B(2) respectively. In the same way, the negative coefficients δ0(1) and
δ0(2) suggest that a higher quality of life is related to a reduced hazard of
having CDC-B(1) and CDC-B(2).
Chapter 7
Conclusion
We developed joint models for the association between longitudinal ordi-
nal responses and the survival process using data from the Staccato study
for the application. The aim of the analysis was to investigate the rela-
tionship between the quality of life and the time to CDC-B progression.
Also, another aim was to simultaneously determine the factors that affect
the quality of life and time to CDC-B progression. We used the stereotype
model to model the quality of life of patients since this model is capable
of capturing the ordinal nature of the data. This model also gives a nat-
ural interpretation. That is, a patient at a higher score of quality of life
should have a higher probability of responding in a higher response cate-
gory. This is because the direction of ordering can be recorded from poor
to excellent where a low response implies a poor quality of life. Moreover,
the stereotype model can improve the fit by adding extra score parame-
ters, but it still has the advantage of requiring only a single parameter to
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describe the effect of a predictor. We would prefer the stereotype model
on the grounds of parsimony and flexibility over other ordinal logistic re-
gression models.
We subsequently considered the Cox proportional hazards model to
model time to CDC-B progression. The covariate variables such as sex,
age and treatment were included in the joint model to predict the hazard
of an individual. However, the model comparison test showed that only
treatment and the shared latent variable were enough to model the change
of hazard function although other covariates could be important. The re-
sults we obtained here are the same for both the Bayesian joint model and
the semiparametric joint model. Note that the shared latent variable in-
dicates the unobservable quality of life of an individual. The advantage
of using the latent variable is that one can reduce the number of variables
since it contains all information on the quality of life. That is, in the stereo-
type model and the Cox proportional hazards model, the latent variable
was assumed to be a covariate representing quality of life for each indi-
vidual. Another advantage is that the latent variable generates a more
realistic quality of life score than a summed scale score of the observed
responses. This is because the latent variable derives from a model which
allow a nonlinear relationship between satisfaction and question response
categories.
For the Bayesian joint model, all questions in the MOS-HIV question-
naire were modeled by the stereotype model and the binary model. Al-
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though the number of response categories was different, we still can use
the stereotype model to model all items/questions simultaneously. We
used the binary model which is a special case of the stereotype model with
L = 2 to model the questions that have binary responses. The partial sur-
vival likelihood function was used in the survival component. This means
the baseline hazard was canceled out in the joint likelihood function. The
shared latent variable was assumed to be a continuous variable. The mod-
els were fitted using the Markov Chain Monte Carlo (MCMC) techniques
through the Metropolis-Hasting Algorithm. The results from the Bayesian
joint model suggested that the patients who had a better quality of life
were associated with the lower hazard of the progression to CDC-B. The
patients on continuous treatment had a better quality of life compared
with the patients on CD4-guided interruption treatment.
For the semiparametric joint model, the baseline hazard was included
in the joint likelihood function. This caused our joint model to become
more complicated since the baseline hazard had no parametric form and
was treated as a step function. The shared latent variable was defined as
a discrete variable. The benefit of having a discrete latent variable in the
model is that we could classify patients to their most likely group. Each
group was composed of a set of individuals who were homogeneous with
respect to their characteristics or their attitudes from quality of life survey
responses. The latent variables then represented the average of quality
of life scores of patients in each group. The stereotype model was used
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to model the ordinal responses which had five categories from the MOS-
HIV questionnaire. We determined the joint likelihood function by using
the idea of finite mixture models which are often used for the purpose
of clustering. The EM algorithm was employed to estimate all unknown
parameters including the unknown baseline hazard through iterative esti-
mation. The results from the semiparametric joint model showed that we
could classify the patients from the Staccato study by their quality of life
scores into five groups. The patients who were in the group of high value
of quality of life score had a better quality of life.
The results from both models the Bayesian joint model and the semi-
parametric joint model are consistent in view of assessing quality of life
and survival analysis. The better quality of life was related to a reduced
hazard of having CDC-B. Furthermore, the patients on continuous treat-
ment had a lower hazard of CDC-B progression and had a better quality
of life compared with the patients on CD4-guided interruption treatment.
In this thesis, we demonstrate how these two approaches can be done in
terms of joint modeling. We cannot compare the value of parameter esti-
mates between these two approaches directly. The Bayesian joint model is
more flexible in that the quality of life score, θi, is allowed to vary by indi-
vidual and by time point. Furthermore, grouping of individuals to quality
of life score categories as is done in the semiparametric approach can be
quite arbitrary. We also can add more covariates that we assume to affect
quality of life in the regression part of the Bayesian joint model. In the re-
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gression model, we can relate different covariates with the latent variable
and the stereotype model can in turn relate the questionnaire responses
with the latent variables.
Generally, standard methods for the joint model of longitudinal and
survival data allow for one failure type with an assumption of indepen-
dent censoring. However, we extended the joint model approach to allow
for competing risks data. The method was applied to modified data from
the Staccato study, since the original data did not suit the competing risks
model and our aim was to illustrate the joint model approach in another
aspect. At the survival endpoint, we presented two competing risks: CDC-
B(1) and CDC-B(2). The competing risks model is useful when a follow-up
setting may terminate due to more than one failure type and the covari-
ate effects might differ significantly across the different failure types. The
results from our analysis were similar in both cases. That is, the patients
on the continuous treatment had a lower hazard on CDC-B(1) and CDC-
B(2). The results also showed the lower hazard on CDC-B(1) and CDC-B(2)
when the patients had a better quality of life. However, these results are
not based on the real data since we used pseudo data to demonstrate the
method.
Joint model approaches are appropriate when the quality of life and
the survival endpoints are likely to be related. The significance of the con-
tribution of this thesis is the development of two joint model approaches
incorporated with the stereotype models. This is a new application since
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no literature has examined the stereotype model within a joint model. As
mentioned, the stereotype model is very useful and flexible, especially
with the ordinal data. In spite of this, our joint model can be applied
to any ordinal data and survival data. Furthermore, the joint model can
cope with the problem of missing data due to dropout prior to death or
withdrawal before the end of the study. This is because the joint model
approach has the ability to gain information from both components effec-
tively. In practice, it is relatively complicated by the nature of the data;
for example, the quality of life data might not be completely collected at
the follow-up time and the uncensored survival information might not be
available for all subjects. These two components could be linked through
the latent variable when the joint model method is used. The latent vari-
able is able to gather all information from several quality of life variables
together. This could reduce the number of parameters in the model.
The models were implemented in the R programming language. How-
ever, we found that the model evaluation is computationally time con-
suming since our models have a complex structure and high-dimensional
data. Although MCMC techniques are particularly useful for a complex
model, the drawback of MCMC is computational time required. The sam-
pling procedures that underlie the MCMC methods generally require a
very large number of iterations before model parameters can be reliably
estimated. It also needs to reach convergence of all parameters for esti-
mates to be reliable. The difficulty is when there are many parameters in
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the model to estimate. It takes several days for estimation run and more
for more complex models or when analyzing large amount of data. Param-
eter estimation by using the EM algorithm for semiparametric joint model
was much quicker in this study. According to the slow execution, MCMC
should be implemented on a high level programming environment that
can execute much faster such as C programming language.
Some research areas will be considered in future work. First, we will
study the model misspecification issue for the joint model. If the item re-
sponse model is misspecified, are the parameter estimates for the survival
model (or the regression model) still valid ? If not, then a good choice of
the item response model is important and it is better to choose the item
response model which has as few assumptions as possible. Also, we will
evaluate the situations where the choice of the item response model is less
important.
As mentioned in Chapter 4, the discrete latent variable can be extended
to the cluster analysis. This methodology can classify the individuals to
their most likely group. The other benefit is to reduce the dimensionality
of the problem so that there are fewer parameters in the model to be esti-
mated. Another possible further research is improvement on the R-code
of programming to make it faster and easy to use, such as writing an R
package for the joint model.







This model consists of two stereotype models, the binary model, the re-
gression model and the Cox proportional hazard model. There are two
predictors (quality of life and treatment) in the survival component. The
posterior summary for model 1 has already been given in chapter 5. Thus,
this section will show only the convergence diagnostics of model 1.
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Figure A.7: b29, b30, b31 and b32 from the stereotype model (L = 5)
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(b) β0(t2) and β0(t3)
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(d) β1(t3) and β1(t4)
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Figure A.17: δ0 and δ1 from the Cox proportional hazards model
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Model 2
This model consists of two stereotype models, the binary model, the re-
gression model and the Cox proportional hazard model. There are three
predictors (quality of life, treatment and initial CD4 count) in the survival
component. Graphical diagnostics by trace and density plots and two sta-
tistical diagnostics : Gelman and Rubin’s multiple sequence diagnostic
and Heidelberger and Welch Diagnostic are given. The posterior results
are summarized as follows.
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Figure A.24: b29, b30, b31 and b32 from the stereotype model (L = 5)
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(b) β0(t2) and β0(t3)
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(b) δ2
Figure A.34: δ0, δ1 and δ2 from the Cox proportional hazards model
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Statistical Diagnostics
Gelman and Rubin’s Multiple Sequence Diagnostic
Table A.1: Gelman and Rubin Diagnostic, Model 2
Model Parameter Point est. 97.5% quantile Multivariate
(Rˆ) psrf
Stereotype Model a2 1.06 1.06
1.31
(5 levels) a3 1.29 1.98
L = 5 levels a4 1.11 1.42
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table (A.1) continued from previous page























Stereotype Model a2 1.03 1.07
1.01
( 3 levels ) a3 1.04 1.06
L = 3 levels b1 1.00 1.01
J = 6 questions b2 1.01 1.01
continued on next page
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table (A.1) continued from previous page







φ2 1.02 1.06 -
Binary Model a 1.03 1.11 -
Q = 2 questions b1 1.03 1.12
1.02
b2 1.01 1.01

















Cox’s Model δ0 1.02 1.11 -
δ1 1 1 -
continued on next page
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table (A.1) continued from previous page
Model Parameter Point est. 97.5% quantile Multivariate
(Rˆ) psrf
δ2 1 1 -
Heidelberger and Welch Diagnostic
Table A.2: Heidelberger and Welch Diagnostic, Model 2
(running the Heidelberger and Welch Diagnostic at  = 0.1 and α = 0.05)
Model Parameter Stationary Test Halfwidth Test P-value
Stereotype Model a2 passed passed 0.234
(5 levels) a3 passed passed 0.297
L = 5 levels a4 passed passed 0.120
J = 32 questions a5 passed passed 0.144
b1 passed passed 0.576
b2 passed passed 0.057
b3 passed passed 0.117
b4 passed passed 0.099
b5 passed passed 0.214
b6 passed passed 0.229
b7 passed passed 0.258
b8 passed passed 0.373
b9 passed passed 0.334
b10 passed passed 0.155
b11 passed passed 0.191
continued on next page
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table (A.2) continued from previous page
Model Parameter Stationary Test Halfwidth Test P-value
b12 passed passed 0.595
b13 passed passed 0.305
b14 passed passed 0.334
b15 passed passed 0.100
b16 passed passed 0.099
b17 passed passed 0.189
b18 passed passed 0.169
b19 passed passed 0.505
b20 passed passed 0.356
b21 passed passed 0.315
b22 passed passed 0.348
b23 passed passed 0.172
b24 passed passed 0.500
b25 passed passed 0.075
b26 passed passed 0.188
b27 passed passed 0.214
b28 passed passed 0.070
b29 passed passed 0.055
b30 passed passed 0.268
b31 passed passed 0.050
b32 passed passed 0.599
φ2 passed passed 0.210
φ3 passed passed 0.354
φ4 passed passed 0.199
Stereotype Model a2 passed passed 0.724
continued on next page
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table (A.2) continued from previous page
Model Parameter Stationary Test Halfwidth Test P-value
( 3 levels ) a3 passed passed 0.363
L = 3 levels b1 passed passed 0.254
J = 6 questions b2 passed passed 0.171
b3 passed passed 0.405
b4 passed passed 0.465
b5 passed passed 0.778
b6 passed passed 0.152
φ2 passed passed 0.752
Binary Model a passed passed 0.887
Q = 2 questions b1 passed passed 0.740
b2 passed passed 0.213
Regression Model ρ passed passed 0.933
β0(t0) passed passed 0.602
β0(t1) passed passed 0.407
β0(t2) passed passed 0.101
β0(t3) passed passed 0.278
β0(t4) passed passed 0.495
β0(t5) passed passed 0.323
β0(t6) passed passed 0.053
β1(t0) passed passed 0.680
β1(t1) passed passed 0.875
β1(t2) passed passed 0.962
β1(t3) passed passed 0.515
β1(t4) passed passed 0.340
β1(t5) passed passed 0.416
continued on next page
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table (A.2) continued from previous page
Model Parameter Stationary Test Halfwidth Test P-value
β1(t6) passed passed 0.263
Cox’s Model δ0 passed passed 0.153
δ1 passed passed 0.417
δ2 passed passed 0.824
The Posterior Summary
Table A.3: The Posterior Summary , Model 2
Model Parameter Mean Standard Error 95% Credible Interval
Stereotype Model a2 0.8983 0.026 (0.843,0.945)
(5 levels) a3 1.843 0.024 (1.793,1.890)
L = 5 levels a4 1.686 0.029 (1.632,1.739)
J = 32 questions a5 0.961 0.037 (0.882,1.035)
b1 0.228 0.067 (0.094,0.362)
b2 1.764 0.083 (1.603,1.927)
b3 2.714 0.106 (2.509,2.920)
b4 3.705 0.137 (3.438,3.982)
b5 2.419 0.105 (2.212,2.625)
b6 0.763 0.071 (0.626,0.907)
b7 2.372 0.103 (2.178,2.579)
b8 1.185 0.075 (1.038,1.335)
b9 3.789 0.140 (3.516,4.067)
continued on next page
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table (A.3) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
b10 1.282 0.077 (1.135,1.434)
b11 3.046 0.119 (2.818,3.282)
b12 1.241 0.077 (1.090,1.396)
b13 1.510 0.081 (1.351,1.434)
b14 1.664 0.084 (1.501,1.835)
b15 2.667 0.112 (2.451,2.895)
b16 3.502 0.136 (3.235,3.774)
b17 2.117 0.096 (1.930,2.304)
b18 1.773 0.085 (1.606,1.944)
b19 1.086 0.072 (0.940,1.231)
b20 1.673 0.083 (1.508,1.841)
b21 1.847 0.086 (1.684,2.021)
b22 2.718 0.112 (2.499,2.943)
b23 1.709 0.084 (1.547,1.877)
b24 1.311 0.077 (1.157,1.465)
b25 2.749 0.110 (2.532,2.965)
b26 1.203 0.075 (1.060,1.354)
b27 1.121 0.072 (0.986,1.266)
b28 2.772 0.108 (2.563,2.991)
b29 3.459 0.140 (3.196,3.793)
b30 4.232 0.173 (3.897,4.584)
b31 2.498 0.105 (2.302,2.709)
b32 1.913 0.092 (1.737,2.095)
φ2 0.099 0.010 (0.075,0.115)
φ3 0.272 0.009 (0.252,0.289)
continued on next page
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table (A.3) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
φ4 0.588 0.008 (0.571,0.602)
Stereotype Model a2 1.501 0.052 (1.397,1.605)
( 3 levels ) a3 2.101 0.055 (1.989,2.210)
L = 3 levels b1 0.608 0.067 (0.475,0.747)
J = 6 questions b2 1.306 0.097 (1.127,1.502)
b3 0.981 0.080 (0.826,1.147)
b4 1.043 0.085 (0.884,1.217)
b5 1.444 0.103 (1.251,1.657)
b6 1.547 0.116 (1.332,1.789)
φ2 0.129 0.031 (0.088,0.208)
Binary Model a 2.172 0.101 (1.977,2.369)
b1 1.025 0.108 (0.816,1.239)
b2 0.799 0.080 (0.643,0.961)
Regression Model ρ 0.342 0.028 (0.284,0.397)
β0(t0) -0.009 0.066 (-0.142,0.120)
β0(t1) 0.789 0.077 (0.637,0.945)
β0(t2) 0.783 0.079 (0.629,0.945)
β0(t3) 0.800 0.085 (0.632,0.961)
β0(t4) 0.818 0.098 (0.614,1.008)
β0(t5) 0.722 0.134 (0.460,0.978)
β0(t6) 0.643 0.237 (0.145,1.098)
β1(t0) 0.026 0.112 (-0.196,0.244)
β1(t1) 0.033 0.127 (-0.222,0.279)
β1(t2) 0.201 0.132 (-0.057,0.456)
β1(t3) 0.225 0.138 (-0.045,0.496)
continued on next page
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table (A.3) continued from previous page
Model Parameter Mean Standard Error 95% Credible Interval
β1(t4) 0.089 0.158 (-0.228,0.401)
β1(t5) 0.159 0.217 (-0.278,0.582)
β1(t6) 0.358 0.414 (-0.403,1.194)
Cox’s Model δ0 -0.162 0.189 (-0.531,0.212)
δ1 -1.037 0.463 (-2.023,-0.195)
δ2 0.341 0.654 (-0.794,1.787)
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Appendix B
EM procedure and Results
The EM algorithm for the semiparametric joint model is presented in Fig-
ure B.1. In the initialization step (iteration 0), Θ(0) is defined as the ini-
tial values for set of parameters in the stereotype model, λ(0) is defined
as the baseline hazard initial values for all individuals and δ(0) is defined
as the initial values for set of parameters in the Cox proportional hazards
model. Next, we iterate between the expectation and maximization step
until convergence. At iteration t, we substitute Θ(t−1), λ(t−1) and δ(t−1) into
equation (4.32) to obtain the log likelihood value, `(Θ(t), λ(t), δ(t)), at itera-
tion t. Convergence is reached if the absolute relative difference between
two consecutive iterations is close to zero.
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and δ(t−1), obtain E(t)
Maximize `(Θ(t−1), λ(t−1), δ(t−1)) to obtain
Θ(t) and δ(t) by using an alternating al-
gorithm (fixing between φ` and (bj + θr))
Calculate λ(t) from
Θ(t), δ(t) and E(t)
t ≥ 2 t = t + 1














Model(a) Model(b) Model(c) Model(d) Model(e) Model(f) Model(g)
a2 0.844(0.027) 0.844(0.026) 0.844(0.027) 0.844(0.027) 0.844(0.027) 0.844(0.027) 0.845(0.027)
a3 1.086(0.044) 0.832(0.049) 0.300(0.043) 0.300(0.043) 0.295(0.043) 0.297(0.043) 0.300(0.043)
a4 1.184(0.065) 0.154(0.066) -0.649(0.061) -0.649(0.061) -0.653(0.061) -0.649(0.061) -0.650(0.061)
a5 0.145(0.113) -1.836(0.109) -3.342(0.106) -3.343(0.106) -3.350(0.106) -3.341(0.106) -3.353(0.106)
b2 1.688(0.132) 2.406(0.133) 2.504(0.131) 2.505(0.131) 2.510(0.131) 2.504(0.131) 2.515(0.131)
b3 3.110(0.138) 4.328(0.137) 4.578(0.136) 4.578(0.136) 4.588(0.136) 4.582(0.136) 4.584(0.136)
b4 4.193(0.144) 5.135(0.142) 5.465(0.142) 5.466(0.142) 5.475(0.142) 5.470(0.142) 5.474(0.142)
b5 2.275(0.134) 2.863(0.133) 3.035(0.133) 3.035(0.133) 3.043(0.133) 3.038(0.133) 3.044(0.133)
b6 -0.259(0.136) 0.233(0.138) 0.166(0.135) 0.167(0.135) 0.170(0.135) 0.1649(0.135) 0.177(0.135)
b7 2.168(0.134) 2.687(0.133) 2.836(0.133) 2.837(0.133) 2.844(0.133) 2.839(0.133) 2.846(0.133)
b8 0.084(0.135) 0.667(0.137) 0.609(0.133) 0.610(0.133) 0.613(0.133) 0.607(0.133) 0.620(0.133)
b9 3.704(0.141) 4.619(0.139) 4.903(0.140) 4.903(0.140) 4.913(0.140) 4.907(0.140) 4.911(0.140)
b10 -0.050(0.135) 0.495(0.138) 0.427(0.133) 0.428(0.133) 0.430(0.133) 0.424(0.133) 0.438(0.134)
b11 2.801(0.136) 3.584(0.134) 3.785(0.134) 3.786(0.134) 3.794(0.134) 3.789(0.134 3.794(0.134)
b12 1.286(0.133) 1.625(0.132) 1.710(0.132) 1.711(0.132) 1.720(0.132) 1.715(0.132) 1.719(0.132)
b13 0.837(0.133) 1.414(0.135) 1.409(0.132) 1.410(0.132) 1.412(0.132) 1.407(0.132) 1.421(0.132)
b14 1.274(0.133) 1.657(0.132) 1.719(0.132) 1.720(0.132) 1.726(0.132) 1.721(0.132) 1.729(0.132)
b15 2.179(0.134) 2.747(0.133) 2.881(0.132) 2.881(0.132) 2.888(0.132) 2.883(0.132) 2.891(0.132)
b16 2.849(0.136) 3.533(0.135) 3.716(0.134) 3.716(0.134) 3.723(0.134) 3.718(0.134) 3.726(0.134)
b17 1.556(0.133) 2.051(0.133) 2.127(0.132) 2.128(0.132) 2.134(0.132) 2.128(0.132) 2.138(0.132)
b18 1.730(0.133) 2.224(0.132) 2.326(0.131) 2.327(0.131) 2.333(0.131) 2.328(0.131) 2.336(0.131)
b19 1.392(0.133) 1.782(0.132) 1.861(0.131) 1.862(0.131) 1.869(0.131) 1.863(0.131) 1.871(0.131)
b20 1.949(0.133) 2.500(0.133) 2.623(0.132) 2.623(0.132) 2.631(0.132) 2.625(0.132) 2.633(0.132)
b21 1.843(0.133) 2.364(0.133) 2.472(0.132) 2.473(0.132) 2.479(0.132) 2.474(0.132) 2.482(0.132)
b22 2.105(0.134) 3.133(0.136) 3.228(0.133) 3.229(0.133) 3.231(0.133) 3.225(0.133) 3.239(0.133)
b23 1.096(0.133) 2.170(0.135) 2.223(0.131) 2.224(0.131) 2.227(0.131) 2.221(0.131) 2.232(0.131)
b24 0.447(0.133) 1.413(0.136) 1.420(0.132) 1.420(0.132) 1.424(0.132) 1.418(0.132) 1.429(0.132)
b25 2.254(0.134) 3.144(0.136) 3.238(0.133) 3.239(0.133) 3.241(0.133) 3.236(0.133) 3.251(0.133)
b26 1.295(0.132) 2.406(0.133) 2.528(0.131) 2.528(0.131) 2.537(0.131) 2.531(0.131) 2.533(0.131)
b27 1.894(0.132) 2.307(0.131) 2.433(0.131) 2.433(0.131) 2.442(0.131) 2.436(0.131) 2.442(0.131)
b28 3.596(0.140) 4.445(0.138) 4.716(0.138) 4.716(0.138) 4.725(0.138) 4.720(0.138) 4.725(0.138)
b29 4.705(0.151) 5.697(0.149) 6.097(0.149) 6.097(0.149) 6.109(0.149) 6.104(0.149) 6.105(0.149)
b30 6.410(0.182) 7.671(0.181) 8.242(0.180) 8.242(0.180) 8.257(0.180) 8.252(0.180) 8.245(0.180)
b31 3.473(0.140) 4.276(0.139) 4.539(0.139) 4.540(0.139) 4.549(0.139) 4.544(0.139) 4.548(0.139)
b32 2.156(0.135) 2.757(0.134) 2.900(0.133) 2.901(0.133) 2.908(0.133) 2.903(0.133) 2.909(0.133)
continued on next page
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table (B.1) continued from previous page
Parameter
Estimated value (SE)
Model(a) Model(b) Model(c) Model(d) Model(e) Model(f) Model(g)
φ2 0.000 0.000 0.000 0.000 0.000 0.000 0.000
φ3 0.472 0.343 0.366 0.366 0.367 0.367 0.366
φ4 0.472 0.556 0.568 0.568 0.568 0.568 0.567
δ0 10(0.059) -0.143(0.047) -0.19(0.061) -0.205(0.085) -0.431(0.094) -0.473(0.090) -0.365(0.119)
δ1 -0.983(0.062) -0.975(0.060) -0.958(0.432) -0.984(0.444) 0.024(0.303) 0.271(0.315) -0.313(0.356)
δ2 - 0.019(0.113) - 0.025(0.265) 2.154(0.256) 2.238(0.270) 3.469(0.465)
δ3 - - - - -0.217(0.013) -0.26(0.016) -0.169(0.022)
δ4 - - - - - 1.279(0.328) -0.266(0.023)
θ2 3(0.072) 3.015(0.222) 2.583(0.047) 5.278(0.058) 5.280(0.058) 5.278(0.058) 5.275(0.058)
θ3 - - 5.279(0.058) 2.583(0.047) 2.586(0.047) 2.584(0.047) 2.588(0.047)




Model(h) Model(i) Model(j) Model(k) Model(l) Model(m) Model(o)
a2 0.844(0.027) 0.844(0.027) 0.844(0.027) 0.844(0.027) 0.846(0.027) 0.846(0.027) 0.844(0.027)
a3 0.294(0.043) 0.296(0.043) 0.298(0.043) 0.299(0.043) 0.104(0.051) 0.102(0.051) 0.047(0.045)
a4 -0.653(0.061) -0.656(0.061) -0.650(0.061) -0.650(0.061) -1.038(0.077) -1.040(0.077) -1.094(0.065)
a5 -3.343(0.106) -3.354(0.106) -3.343(0.106) -3.344(0.106) -4.025(0.138 ) -4.028(0.138 ) -4.184(0.115)
b2 2.501(0.131) 2.514(0.131) 2.505(0.131) 2.507(0.131) 2.584(0.134) 2.585(0.134) 2.614(0.133)
b3 4.580(0.136) 4.587(0.136) 4.579(0.136) 4.581(0.136 4.720(0.139) 4.721(0.139) 4.772(0.139)
b4 5.4679(0.142) 5.475(0.142) 5.467(0.142) 5.468(0.142) 5.590(0.145) 5.591(0.145) 5.663(0.145)
b5 3.035(0.133) 3.044(0.133) 3.037(0.133) 3.037(0.133) 3.114(0.136) 3.115(0.136) 3.160(0.135)
b6 0.160(0.134) 0.176(0.135) 0.165(0.135) 0.168(0.135) 0.202(0.138) 0.202(0.138) 0.190(0.137)
b7 2.836(0.133) 2.846(0.133) 2.838(0.133) 2.839(0.133) 2.914(0.135) 2.914(0.135) 2.959(0.135)
b8 0.603(0.133) 0.619(0.133) 0.608(0.133) 0.611(0.133) 0.661(0.137) 0.662(0.137) 0.653(0.136)
b9 4.905(0.140) 4.913(0.140) 4.905(0.140) 4.906(0.140) 5.028(0.142) 5.029(0.142) 5.095(0.142)
b10 0.419(0.133) 0.436(0.133) 0.426(0.133) 0.429(0.133) 0.470(0.137) 0.470(0.137) 0.460(0.136)
b11 3.786(0.134) 3.795(0.134) 3.787(0.134) 3.788(0.134) 3.888(0.137) 3.889(0.137) 3.944(0.137)
b12 1.712(0.132) 1.720(0.132) 1.713(0.132) 1.713(0.132) 1.764(0.135) 1.765(0.135) 1.794(0.134)
b13 1.402(0.132) 1.418(0.132) 1.408(0.132) 1.411(0.132) 1.466(0.135) 1.467(0.135) 1.478(0.134)
b14 1.717(0.131) 1.728(0.132) 1.720(0.132) 1.721(0.132) 1.774(0.135) 1.774(0.135) 1.800(0.134)
b15 2.879(0.132) 2.890(0.132) 2.882(0.132) 2.883(0.132) 2.960(0.135) 2.961()0.135 3.005(0.135)
b16 3.714(0.134) 3.725(0.134) 3.717(0.134) 3.718(0.134) 3.812(0.137) 3.813(0.137) 3.868(0.137)
b17 2.124(0.132) 2.137(0.132) 2.128(0.132) 2.130(0.132) 2.192(0.135) 2.192(0.135) 2.223(0.134)
b18 2.324(0.131) 2.335(0.131) 2.327(0.131) 2.328(0.131) 2.390(0.134) 2.390(0.134) 2.423(0.134)
b19 1.860(0.131) 1.871(0.131) 1.863(0.131) 1.864(0.131) 1.916(0.134) 1.917(0.134) 1.945(0.134)
continued on next page
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table (B.2) continued from previous page
Parameter
Estimated value (SE)
Model(h) Model(i) Model(j) Model(k) Model(l) Model(m) Model(o)
b20 2.622(0.132) 2.632(0.132) 2.624(0.132) 2.625(0.132) 2.695(0.135) 2.696(0.135) 2.734(0.134)
b21 2.470(0.132) 2.481(0.132) 2.473(0.132) 2.474(0.132) 2.539(0.135) 2.540(0.135) 2.577(0.134)
b22 3.221(0.133) 3.237(0.133) 3.227(0.133) 3.230(0.133) 3.342(0.136) 3.342(0.136) 3.379(0.135)
b23 2.217(0.131) 2.233(0.131) 2.222(0.131) 2.225(0.131) 2.321(0.134) 2.321(0.134) 2.338(0.134)
b24 1.414(0.132) 1.429(0.132) 1.418(0.132) 1.422(0.132 1.502(0.135) 1.503(0.135) 1.505(0.134)
b25 3.231(0.133) 3.248(0.133) 3.237(0.133) 3.240(0.133) 3.346(0.136) 3.347(0.136) 3.385(0.135)
b26 2.530(0.131) 2.537(0.131) 2.529(0.131) 2.530(0.131) 2.643(0.134) 2.644(0.134) 2.663(0.133)
b27 2.434(0.131) 2.442(0.131) 2.435(0.131) 2.435(0.131) 2.506(0.133) 2.507(0.133) 2.543(0.133)
b28 4.717(0.138) 4.725(0.138) 4.718(0.138) 4.719(0.138) 4.829(0.141) 4.830(0.141) 4.889(0.141)
b29 6.102(0.149) 6.107(0.149) 6.100(0.149) 6.100(0.149) 6.217(0.152) 6.219(0.152) 6.302(0.152)
b30 8.253(0.180) 8.253(0.180) 8.243(0.180) 8.246(0.180) 8.413(0.183) 8.416(0.183) 8.520(0.183)
b31 4.541(0.139) 4.549(0.139) 4.541(0.139) 4.542(0.139) 4.634(0.141) 4.635(0.141) 4.706(0.141)
b32 2.899(0.133) 2.909(0.133) 2.901(0.133) 2.902(0.133) 2.972(0.136) 2.972(0.136) 3.013(0.136)
φ2 0.000 0.000 0.000 0.000 0.000 0.000 0.000
φ3 0.368 0.366 0.367 0.367 0.363 0.363 0.365
φ4 0.568 0.568 0.568 0.568 0.573 0.573 0.570
δ0 -0.349(0.078) -0.346(0.078) -0.193(0.087) -0.226(0.078) -0.173(0.041) -0.186(0.041) -0.173(0.050)
δ1 -0.429(0.291) -0.334(0.290) -0.99(0.447) -0.897(0.433) -0.95(0.442) -0.966(0.442) -0.937(0.435)
δ2 0.047(0.004) 1.881(0.162) 0.036(0.007) 0.714(0.296) - 0.02(0.099) -
δ3 -0.537(0.328) -0.2(0.307) - - - - -
θ2 5.286(0.058) 5.281(0.058) 5.281(0.058) 5.279(0.058) 2.270(0.097) 3.973(0.097) 3.788(0.064)
θ3 2.586(0.047) 2.586(0.047) 2.584(0.047) 2.583(0.047) 3.971(0.694) 6.273(0.694) 11.019(0.716)
θ4 - - - - 6.271(0.115) 2.271(0.115) 5.407(0.073)
θ5 - - - - - - 2.234(0.062)
θ6 - - - - - - 7.171(0.087)




MOS-HIV HEALTH SURVEY  
 
 
INSTRUCTIONS TO THE STUDY COORDINATOR: 
 
The following questionnaire asks the patient about many aspects of his/her health and health care.  
It should be given to the patient prior to the clinical exam and preferably in a quiet secluded area 
(e.g., exam room or other office). 
 
It is important to be familiar with the content and format of the questionnaire before giving it to study 
participants.  At the first visit, please begin by telling the participant: 
 
"We would like you to answer some questions about how you are feeling and the kinds of 
things you are able to do.  Your answers will help us understand the effects of the 
medication you are taking.  We appreciate your filling out this questionnaire." 
 
You should then briefly go over the format of the questions and how to complete them.  Have the 
participant complete the questionnaire before vital signs, history and physical are completed. 
 
The questionnaire is very brief and should take no more than 10 minutes to complete.  Before 
giving the patient the questionnaire, please fill out the header(s) and DETACH THIS PAGE. 
 
Each question is in the same general format.  Note that the patient is always asked to check one 
box for each question.  All questions refer to the PAST 4 WEEKS. 
 
Collect the completed questionnaire before the clinical exam.  Before going on, review the 
questionnaire for omissions.  If the participant missed any of the questions, point this out and have 
him/her complete the omissions. 
 
PLEASE COMPLETE THE FOLLOWING ITEMS AFTER PATIENT COMPLETES THE 
QUESTIONNAIRE OR AFTER YOU ASCERTAIN THAT THIS IS NOT POSSIBLE: 
 
1. How was the questionnaire completed? ............ 1  Self administered by the study participant  
               2  Face-to-face interview that you conducted 
               3  Phone interview 
               4  Not completed 
               5  Other 
 
  If Other, specify:                                                                              
 
2. If you answered 2 or 4, please indicate the reason(s) why:               
 
  
Patient refused initially: …………………………….… 1 Yes  2 No 
Patient's reading level not adequate: ………………………………. 1 Yes  2 No 
There was not enough time: ………………………………. 1 Yes  2 No 
Patient forgot reading glasses: ………………………………. 1 Yes  2 No 
Other reason: ………………………………. 1 Yes  2 No 
If Other, specify:                                                                     
             





INSTRUCTIONS TO PATIENT: Please answer the following questions by placing a "　"  
         in the appropriate box. 
 
  
1. In general, would you say your health is:           (Check One) 
   
Excellent ………………………………………………………..... 1  
Very Good ………………………………………………………..... 2  
Good ………………………………………………………..... 3  
Fair ………………………………………………………..... 4  




2. How much bodily pain have you generally had during the past 4 weeks?  (Check One) 
               
None  ……………………………………………………....... 1  
Very Mild ……………………………………………………....... 2  
Mild ……………………………………………………....... 3  
Moderate ……………………………………………………....... 4  
Severe ……………………………………………………....... 5  
Very Severe ……………………………………………………....... 6  
 
 
   
3. During the past 4 weeks, how much did pain interfere with your normal work (or your normal 
 activities, including work outside the home and  housework)?     (Check One) 
 
Not at all ………………………………………………………....... 1  
A little bit ………………………………………………………....... 2  
Moderately ………………………………………………………....... 3  
Quite a bit ………………………………………………………....... 4  
Extremely ………………………………………………………....... 5  
 
 








4. The following questions are about activities you might do during a typical day.  Does your health 
 now limit you in these activities?  If so, how much? 
 
 
(Check one box on each line.) YES, limited a lot 
 
YES, 





a. The kinds or amounts of vigorous activities 
you can do, like lifting heavy objects, running 








b. The kinds or amounts of moderate activities 
you can do, like moving a table, carrying 













































5. Does your health keep you from working at a job, doing work around the house or going to school?  
                            (Check One) 
 
………………………………………………………………………........ 1  Yes 
……………………………………………………….............................. 2  No 
  
             
 
6. Have you been unable to do certain kinds or amounts of work, housework, or schoolwork because of 
 your health?                   (Check One) 
  
………………………………………………………………………........ 1  Yes 






For each of the following questions, please check the box for the one answer that comes closest  
to the way you have been feeling during the past 4 weeks. 
 
  

























How much of the time, 
during the past 4 
weeks, has your 
health limited your 
social activities (like 

































How much of the time, 
during the past 4 
weeks: 
      



























































 e. Have you felt so 
down in the 
dumps that 
nothing could 
























 For each of the following questions, please check the box for the one answer that comes 






















9. How often during the 
past four weeks: 






































Did you feel 
tired? 
 












Did you have 
enough energy to 
do the things you 
















Did you feel 






































Did you feel 

















Were you afraid 








































10. How much of the time, 
during the past 4 
weeks: 
      
  
a. 

































Did you forget 
things that 
happened recently, 
for example, where 
you put things and 






















Did you have 
trouble keeping 
your attention on 




































11. Please check the box that best describes whether each of the following statements is true or false 












a. I am somewhat ill. 1  2  3  4  5  
b. I am as healthy as anybody I 
know. 
1  2  3  4  5  
c. My health is excellent. 1  2  3  4  5  




12. How has the quality of your life been during the past 4 weeks?  That is, how have things  
 been going for you?                   (Check One) 
   
Very well; could hardly be better ……………………………………… 1  
Pretty good ……………………………………… 2  
Good and bad parts about equal ……………………………………… 3  
Pretty bad ……………………………………… 4  




13. How would you rate your physical health and emotional condition now compared to 4 weeks  
    ago?                       (Check One) 
 
Much better  ………………………………………………………..... 1  
A little better ………………………………………………………..... 2  
About the same ………………………………………………………..... 3  
A little worse ………………………………………………………..... 4 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